Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACY1,Aminoacylase-1,29478,0.188499515862197,0.00424777361039648,0.18017387958582,0.196825152138574,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.28874082551763,0.00571017824757542,0.277548876152383,0.299932774882878,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADIPOQ,Adiponectin,24966,-0.245023539913013,0.00456079136923038,-0.253962690996705,-0.236084388829322,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFM,Afamin,24966,0.0582048137922924,0.00134005134897288,0.0555783131483056,0.0608313144362793,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGR3,Anterior gradient protein 3,28764,0.170462705455117,0.00412020822990007,0.162387097324512,0.178538313585721,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGRP,Agouti-related protein,29786,0.292919127890354,0.00335931136780478,0.286334877609456,0.299503378171251,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APCS,Serum amyloid P-component,24726,0.117166737995813,0.00236159443764517,0.112538012898028,0.121795463093597,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,29218,0.0913812616707935,0.00205148000316911,0.0873603608645821,0.095402162477005,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCHE,Cholinesterase,24528,0.090539076497111,0.00191815671827148,0.0867794893292989,0.0942986636649231,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C9,Complement component C9,24951,-0.164354530531405,0.00364836301420769,-0.171505322039252,-0.157203739023557,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.210379465709185,0.00509721705673085,0.200388920277993,0.220370011140378,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL16,C-C motif chemokine 16,29820,0.147341362497513,0.00362328097806134,0.140239731780513,0.154442993214513,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL23,C-C motif chemokine 23,29581,0.144020011003354,0.00283901917921362,0.138455533412096,0.149584488594613,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL27,C-C motif chemokine 27,29478,0.245582721940057,0.00412037511206532,0.237506786720409,0.253658657159705,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN1,CCN family member 1,29301,0.386889023049023,0.00487346551450761,0.377337030640588,0.396441015457458,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300LG,CMRF35-like molecule 9,29443,-0.104285251317261,0.00260407774561652,-0.10938924369867,-0.099181258935853,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0860555070059764,0.00220601523652011,0.081731717142397,0.0903792968695558,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD4,T-cell surface glycoprotein CD4,29383,0.10671301046272,0.00203644380006472,0.102721580614593,0.110704440310847,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR2,Cadherin-related family member 2,29349,0.197634971802328,0.00503063870710881,0.187774919936395,0.207495023668262,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.343910383823986,0.00725228761920753,0.32969590009034,0.358124867557633,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES1,Liver carboxylesterase 1,29489,0.334782335901921,0.0054120524287371,0.324174713141596,0.345389958662246,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFH,Complement factor H,23693,0.0711855077779517,0.00160215639883676,0.0680452812362316,0.0743257343196717,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFI,Complement factor I,24966,0.0603632489359356,0.00136891173343477,0.0576801819384035,0.0630463159334678,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFP,Properdin,24966,0.0703021604601652,0.00158256193525253,0.0672003390670702,0.0734039818532601,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHMP6,Charged multivesicular body protein 6,24922,0.165780566691167,0.00389275548254714,0.158150765945374,0.173410367436959,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN3,Contactin-3,29443,0.102225001231287,0.00221909193727914,0.09787558103422,0.106574421428354,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPM,Carboxypeptidase M,29584,0.11556631111023,0.00234525572148694,0.110969609896115,0.120163012324344,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRIP2,Cysteine-rich protein 2,29218,0.114361510792581,0.00249608658287462,0.109469181090146,0.119253840495015,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL6,C-X-C motif chemokine 6,29786,0.243186659534707,0.00528560799789419,0.232826867858834,0.253546451210579,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.49078434548572,0.0100847453384856,0.471018244622288,0.510550446349152,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.302971083699877,0.00592325106731434,0.291361511607941,0.314580655791813,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG2,Desmoglein-2,29443,-0.0897109669694418,0.00185062053379308,-0.0933381832156762,-0.0860837507232073,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO3,Beta-enolase,24240,0.167577516290389,0.00416267612387821,0.159418671087587,0.17573636149319,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0683622209154187,0.00172062977079913,0.0649897865646524,0.071734655266185,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0607348808943094,0.00134265528798041,0.0581032765298678,0.063366485258751,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,29301,0.072425377056462,0.00179012290915301,0.0689167361545221,0.0759340179584019,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F7,Coagulation factor VII,29544,0.120913628523491,0.00206417711570382,0.116867841376711,0.12495941567027,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F9,Coagulation factor IX,29545,0.0532926849457048,0.00125613172468116,0.0508306667653298,0.0557547031260799,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF21,Fibroblast growth factor 21,29674,0.331221738408411,0.00821405925252225,0.315122182273468,0.347321294543355,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,29566,0.0615313146936954,0.00153030748227453,0.0585319120284373,0.0645307173589535,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,28797,0.315660599877791,0.00762555546330428,0.300714511169715,0.330606688585868,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.232894693927675,0.00589610708284744,0.221338324045294,0.244451063810056,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FURIN,Furin,29566,0.133743614658029,0.00225480143794437,0.129324203839658,0.1381630254764,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCG,Pro-glucagon,28797,0.495261634494428,0.00837582117092741,0.478845024999411,0.511678243989446,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHR,Growth hormone receptor,24381,0.113364982920042,0.00191719204738628,0.109607286507165,0.117122679332919,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR37,Prosaposin receptor GPR37,28916,0.222964713383133,0.00452980048451818,0.214086304433477,0.231843122332788,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTA1,Glutathione S-transferase A1,29426,0.25771171119258,0.00579850513205667,0.246346641133749,0.269076781251411,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTA3,Glutathione S-transferase A3,28797,0.231896209625704,0.00528361783381859,0.22154031867142,0.242252100579989,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUSB,Beta-glucuronidase,29604,0.187586109284262,0.00411089205367675,0.179528760859056,0.195643457709469,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.305833648768145,0.00508276092384493,0.295871437357409,0.315795860178881,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.114079565671679,0.00234443129336134,0.109484480336691,0.118674651006667,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.373167891875828,0.00840365484332865,-0.389639055368752,-0.356696728382903,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.193657638749455,0.00428673514710243,-0.202059639637776,-0.185255637861134,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,29478,0.0845681574303145,0.00211147096659625,0.0804296743357858,0.0887066405248431,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF9,Protein turtle homolog A,24922,0.322777168804136,0.00554949352934987,0.31190016148661,0.333654176121662,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INHBC,Inhibin beta C chain,29443,0.147093407054993,0.00281338473184846,0.14157917298057,0.152607641129416,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KYNU,Kynureninase,29786,0.132085174273137,0.00313799958042037,0.125934695095513,0.138235653450761,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0585925808848012,0.00135292410887801,0.0559408496314003,0.0612443121382021,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0879751296407466,0.0014843014142858,0.0850658988687465,0.0908843604127468,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LDLR,Low-density lipoprotein receptor,29500,0.439213502380919,0.00274716901134453,0.433829051118683,0.444597953643154,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPL,Lipoprotein lipase,29478,-0.195161217264345,0.00314649832730635,-0.201328353985866,-0.188994080542825,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.128604138292296,0.00329156320684314,0.122152674406883,0.135055602177708,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0558022595636544,0.00142348042971206,0.0530122379214188,0.0585922812058901,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFGE8,Lactadherin,29443,0.246416900695528,0.00277286984716831,0.240982075795078,0.251851725595978,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0904721071451941,0.00210661572732311,-0.0946010739707474,-0.0863431403196408,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCS1,Neuronal calcium sensor 1,29725,0.0798983295039759,0.00198336062875549,0.0760109426716151,0.0837857163363366,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",28774,0.149457236395482,0.00365883062624912,0.142285928368034,0.15662854442293,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.0950131726176925,0.00236565700857593,-0.0996498603545013,-0.0903764848808837,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPY,Pro-neuropeptide Y,29725,0.371899347577035,0.00416006600017741,0.363745618216687,0.380053076937383,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRP1,Neuropilin-1,29628,-0.0922596655135343,0.00190512302429325,-0.095993706641149,-0.0885256243859195,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,P4HB,Protein disulfide-isomerase,29313,0.106759489168755,0.00268677619340663,0.101493407829678,0.112025570507832,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.154186432201364,0.00380968377271869,0.146719452006835,0.161653412395893,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAMR1,Inactive serine protease PAMR1,29443,0.0853382035070131,0.0019005436459859,0.0816131379608807,0.0890632690531454,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.127229871614764,0.00214292177278336,0.123029744940108,0.131429998289419,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAT,Tissue-type plasminogen activator,29736,0.15492405166743,0.00346324907339604,0.148136083483573,0.161712019851286,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLTP,Phospholipid transfer protein,29702,-0.119400913499798,0.00246127886863851,-0.12422502008233,-0.114576806917267,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON3,Serum paraoxonase/lactonase 3,29581,-0.0806176530924527,0.0019639077219825,-0.0844669122275384,-0.076768393957367,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRAP1,Proline-rich acidic protein 1,24938,0.153450111245669,0.00274875720369713,0.148062547126423,0.158837675364915,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0916856048075156,0.00217237677895613,0.0874277463207616,0.0959434632942696,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROC,Vitamin K-dependent protein C,29545,0.0919694360388523,0.00176146634233584,0.088516962007874,0.0954219100698305,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.177280897453735,0.00408676080482514,0.169270846276278,0.185290948631192,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTH,Parathyroid hormone,24195,0.303254747616483,0.00544187903138363,0.292588664714971,0.313920830517995,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,29628,0.187068172432344,0.00317924881507588,0.180836844754795,0.193299500109892,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP5,Retinol-binding protein 5,29349,0.166547572718918,0.00387406263684376,0.158954409950704,0.174140735487132,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA4,Kallistatin,24557,0.0734098253720822,0.00163854559812524,0.0701982759997567,0.0766213747444076,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA5,Plasma serine protease inhibitor,24644,0.100120784797312,0.00218156374766967,0.095844919851879,0.104396649742744,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPIND1,Heparin cofactor 2,24914,0.0797337814927723,0.00194733498983903,0.0759170049126879,0.0835505580728568,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINF1,Pigment epithelium-derived factor,24579,0.0771304675220948,0.00180005208643373,0.0736023654326847,0.0806585696115049,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHBG,Sex hormone-binding globulin,24951,-0.15026782262117,0.00355667170950402,-0.157238899171797,-0.143296746070542,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.199615898755131,0.00504940382703277,0.189719067254147,0.209512730256116,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC39A5,Zinc transporter ZIP5,29434,0.181032325118521,0.00365020563526533,0.173877922073401,0.188186728163641,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.288386929827056,0.00560317857553563,0.277404699819006,0.299369159835106,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.133155977923939,0.00220604190669355,0.128832135786819,0.137479820061058,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNCA,Alpha-synuclein,24381,0.342292402455048,0.00796953772097941,0.326672108521929,0.357912696388168,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.355537099289389,0.00785950988423295,0.340132459916292,0.370941738662486,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.160535291675009,0.0028789750907718,0.154892500497096,0.166178082852922,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.156737308768186,0.00360348420162229,0.149674479733006,0.163800137803365,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFPI,Tissue factor pathway inhibitor,29435,0.098217094096077,0.0021806051002387,0.0939431080996091,0.102491080092545,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS15,Enteropeptidase,29349,0.295854882168927,0.00619341732312836,0.283715784215595,0.307993980122259,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTR,Transthyretin,24707,0.0818804173204757,0.00173343229598145,0.0784828900203521,0.0852779446205994,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPB1,Beta-ureidopropionase,24922,0.267514915523025,0.00630432192671155,0.255158444546671,0.27987138649938,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.216394410491589,0.00467441891928682,0.207232549409787,0.225556271573391,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.264606600018119,0.00544452265285636,0.25393533561852,0.275277864417717,0
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.159493919658827,0.00409900997944231,-0.167527979218534,-0.15145986009912,1.1125369292536e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.187255958362666,0.00480401396639831,0.177840090988526,0.196671825736807,1.11253692925361e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,24229,0.230349213723647,0.00591216694854932,0.21876136650449,0.241937060942804,1.11253692925362e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUMB,Protein numb homolog,24229,0.225460177414983,0.00579071410722392,0.214110377764824,0.236809977065141,1.11253692925366e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAT2,Linker for activation of T-cells family member 2,29349,0.333707246198817,0.00861419432666032,0.316823425318563,0.350591067079071,1.11253692925521e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.182269100667068,0.00471173191751849,0.173034106108732,0.191504095225404,1.11253692927088e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOMO1,Nodal modulator 1,29443,0.0630393550125849,0.00163429435181076,0.0598361380830358,0.066242571942134,1.1125369299481e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRP,Gastrin-releasing peptide,24240,0.144350874679595,0.00374202071458653,0.137016514079006,0.151685235280185,1.11253695618714e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTYMK,Thymidylate kinase,24922,0.182753078752124,0.00474555762206032,0.173451785812886,0.192054371691362,1.11253709180189e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLA,Alpha-galactosidase A,24329,0.100314762692432,0.0026048789614708,0.0952091999279497,0.105420325456915,1.11253719699351e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEG1,Protein HEG homolog 1,24381,0.0724422906733389,0.00188888775226307,0.0687400706789033,0.0761445106677745,1.11261717716565e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F10,Coagulation factor X,24951,0.0730519081500206,0.00190924082465283,0.0693097961337011,0.0767940201663402,1.11381953877254e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,29566,0.0673161237771364,0.00176426704891206,0.0638581603612688,0.0707740871930041,1.11529718346926e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROS1,Vitamin K-dependent protein S,24966,0.0675053313415197,0.00176967813647927,0.0640367621940203,0.0709739004890191,1.19843935445878e-308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAB2,Stabilin-2,24938,0.0741479514209168,0.00195547702602267,0.0703152164499123,0.0779806863919212,6.27875791649304e-306
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM20A,Pseudokinase FAM20A,24922,0.0745396031842976,0.00196788721498349,0.07068254424293,0.0783966621256652,2.67764992771947e-305
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL16,Pro-interleukin-16,29786,0.108357088393835,0.00287470269115422,0.102722671119173,0.113991505668498,8.93600932801399e-304
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKB,Creatine kinase B-type,24938,-0.155266414391419,0.00410995882217065,-0.163321933682873,-0.147210895099965,9.45004906109503e-304
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,29491,0.104170302974536,0.00276959380599357,0.0987418991147887,0.109598706834283,1.94165408879382e-302
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.365314442917357,0.0097071244376484,0.346288479019566,0.384340406815147,1.81315123713409e-301
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPY30,Protein dpy-30 homolog,29604,0.155736734766501,0.00415808917650346,0.147586879980554,0.163886589552448,5.30920400506281e-300
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAPIN,SNARE-associated protein Snapin,24867,0.150814592812725,0.0040178216499433,0.142939662378836,0.158689523246613,5.50679236508575e-300
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATRN,"Attractin, Isoform 2",24966,0.0432527011757043,0.00115381886672526,0.0409912161969228,0.0455141861544858,3.00704359554388e-299
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA1,Ephrin type-A receptor 1,29536,0.086432852701337,0.00231638843623685,0.0818927313663128,0.0909729740363612,8.2606471238981e-298
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTSS1,Protein MTSS 1,24805,0.287398745339694,0.00770754403792726,0.272291959025356,0.302505531654031,3.84172069642012e-296
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORT1,Sortilin,29433,0.0959396993178077,0.00258996759310875,0.0908633628353146,0.101016035800301,1.3178207165634e-293
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCLY,Selenocysteine lyase,29632,0.124849726236685,0.00337208403746626,0.118240441523251,0.131459010950119,2.27845055924195e-293
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GH1,Somatotropin,29433,-0.456591174906552,0.0123473588647045,-0.480791998281373,-0.432390351531731,1.26758305795709e-292
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP29,Synaptosomal-associated protein 29,29566,0.234464323839119,0.0063573642131366,0.222003889981371,0.246924757696867,3.79230772731607e-291
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR5,Cadherin-related family member 5,29478,0.0996516858309432,0.00270760330363305,0.0943447833558224,0.104958588306064,5.84551603080534e-290
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.101259666363602,0.00275621084584154,0.095857493105753,0.106661839621452,6.28153426255151e-289
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFB1,BPI fold-containing family B member 1,29333,-0.160603468179471,0.00438864216140475,-0.169205206815824,-0.152001729543117,9.7195205094928e-287
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYAP1,Synapse-associated protein 1,24381,0.146509819716732,0.00399526894523092,0.138679092584079,0.154340546849384,1.29771330091011e-286
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EEF1D,Elongation factor 1-delta,24922,0.2320494335337,0.00634725095578031,0.219608821660371,0.24449004540703,4.34431907971969e-285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH9,Myosin-9,24938,0.286764480528019,0.00784805973435007,0.271382283448693,0.302146677607345,8.45964897410279e-285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0554800305044478,0.00151922355174349,0.0525023523430305,0.058457708665865,2.55310493734545e-284
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.160670272435331,0.00441624706667458,0.152014428184649,0.169326116686013,2.19904275967402e-283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F11R,Junctional adhesion molecule A,29443,0.142199839831219,0.00391229979504868,0.134531732232924,0.149867947429514,5.38440857158885e-283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.096492558419924,0.00265590127200363,-0.101698124913051,-0.0912869919267968,8.59473300445759e-283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0753717189701604,0.00207557304135324,0.071303595809108,0.0794398421312127,1.59056844461315e-282
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,24381,0.191004753779252,0.00525387454031258,0.18070715968024,0.201302347878265,7.32340577091975e-282
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORD,Sorbitol dehydrogenase,29595,0.171752310948195,0.00474263390391804,0.162456748496516,0.181047873399875,4.98383521804814e-281
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLKB1,Plasma kallikrein,24454,0.0634506077370563,0.00174823325038533,0.060024070566301,0.0668771449078115,5.6906533866561e-281
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.171841254115689,0.00473601715463912,0.162558660492596,0.181123847738782,1.02403850471309e-280
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAA80,N-alpha-acetyltransferase 80,24195,0.304400734595197,0.00840347968429551,0.287929914413977,0.320871554776416,7.81137951927473e-280
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.144360787625822,0.00398653063644201,0.136547187578395,0.152174387673248,1.10715494902762e-279
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMBP,Protein AMBP,29683,0.0504340396297133,0.00140207861068277,0.0476859655527751,0.0531821137066516,2.1926594572995e-277
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELN,Elastin,24922,0.0880234896955785,0.00244431555820757,0.0832326312014917,0.0928143481896654,6.9068538718626e-277
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,29349,0.168958065783013,0.00471574330495802,0.159715208905295,0.178200922660731,3.42964960634105e-275
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YES1,Tyrosine-protein kinase Yes,29349,0.283666680875251,0.00792283784609363,0.268137918696907,0.299195443053594,8.04900931022705e-275
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FYB1,FYN-binding protein 1,29400,0.228580336490517,0.0064078142154018,0.216021020628329,0.241139652352704,7.1445158094612e-273
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCN2,Ficolin-2,29381,0.10176919550599,0.00286007239203711,0.0961634536175977,0.107374937394383,1.52921975699299e-271
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KHK,Ketohexokinase,24240,0.158911740224664,0.00446203892164856,0.150166143938233,0.167657336511095,8.0583616287418e-271
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18R1,Interleukin-18 receptor 1,29786,0.0811981620472926,0.00228784648262251,0.0767139829413525,0.0856823411532327,2.92443778552395e-270
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL13,C-X-C motif chemokine 13,29694,0.150469881114779,0.00424118032571211,0.142157167676383,0.158782594553175,4.70113663326039e-270
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.196817162400361,0.00553815888892361,0.185962370978071,0.207671953822651,7.42014821049505e-270
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.133480193386156,0.00376460525934489,0.12610156707784,0.140858819694472,1.12606451272728e-269
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MLN,Promotilin,29434,0.21916973302261,0.00621016348712518,0.206997812587845,0.231341653457375,2.93455026239987e-267
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLUL1,Clusterin-like protein 1,29435,-0.110827959973057,0.0031449973901069,-0.116992154857667,-0.104663765088448,1.74495946346893e-266
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YTHDF3,YTH domain-containing family protein 3,28931,0.209028315586518,0.005939968045615,0.197385978217113,0.220670652955923,1.14642713341902e-265
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.16157035318484,0.00459211070523135,0.152569816202586,0.170570890167093,1.04182725622665e-264
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.106821206746276,0.00304474809602506,0.100853500478067,0.112788913014485,3.47289601951812e-264
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.218572234028439,0.00623461147209192,0.206352395543139,0.23079207251374,8.95532972631236e-264
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.12089503780416,0.00344378819381813,0.114145212944277,0.127644862664044,2.02638168814492e-263
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPPC,C-type natriuretic peptide,29434,0.116791947396398,0.00334001427875,0.110245519410048,0.123338375382748,1.67643233716249e-262
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.122499298553187,0.00350954485065331,0.115620590645906,0.129378006460467,1.40956609294648e-261
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL22,C-C motif chemokine 22,29169,0.125599186002486,0.00360535824440871,0.118532683843445,0.132665688161527,1.49623449986597e-260
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL17,C-X-C motif chemokine 17,29786,0.10195676650898,0.00293063166736103,0.0962127284409528,0.107700804577008,5.58855936393147e-260
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA3F,Semaphorin-3F,29478,0.0637796636923303,0.00183854642563492,0.0601761126980859,0.0673832146865748,1.76807124040418e-258
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SARG,Specifically androgen-regulated gene protein,24820,0.263857229796858,0.00760941415109311,0.248942778060716,0.278771681533001,2.58428389588505e-257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0670920899741543,0.00193919187147619,0.063291273906061,0.0708929060422477,3.89496172851854e-257
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINF2,Alpha-2-antiplasmin,24515,0.032867610796137,0.000950077801969137,0.0310054583042775,0.0347297632879965,4.37522670798782e-256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MVK,Mevalonate kinase,28931,0.191842065951893,0.00555815870902173,0.18094807488221,0.202736057021575,7.39240803650182e-256
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.202907313397641,0.00589456881861799,0.19135395851315,0.214460668282133,1.46628781460064e-253
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MME,Neprilysin,29349,0.192000507888815,0.00560128044346286,0.181021998219628,0.202979017558002,1.61766262047401e-252
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOST,Sclerostin,29433,0.0924253537603516,0.00270135080339299,0.0871307061857014,0.0977200013350019,1.26946155860419e-251
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.112696447186028,0.00329346732599075,0.106241251227087,0.11915164314497,1.11414682567722e-250
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0703659691912372,0.00206019163593443,0.0663279935848057,0.0744039447976687,6.51795597922185e-250
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.124544098177955,0.00365672591451417,0.117376915385507,0.131711280970403,1.60226811792884e-248
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TJAP1,Tight junction-associated protein 1,29566,0.195117406038581,0.00578425436772409,0.183780267477842,0.20645454459932,8.55171702597797e-245
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0476565026704487,0.00141283747411647,0.0448873412211804,0.050425664119717,9.61095806187911e-245
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTN4R,Reticulon-4 receptor,29725,0.0795677539594525,0.00236328291845896,0.0749357194392729,0.084199788479632,6.50917095400927e-244
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.129402300475481,0.00384433371961643,0.121867406385033,0.13693719456593,1.23623087221245e-243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES3,Carboxylesterase 3,29349,0.163299074854842,0.00487321442632142,0.153747574579252,0.172850575130432,1.26902042227179e-241
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.191346522189496,0.00571959249428929,0.180136120900689,0.202556923478303,6.62052634832336e-241
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXLNA,Alpha-taxilin,29218,0.207118799133388,0.00619065742259281,0.194985110585106,0.21925248768167,7.31368122858512e-241
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HJV,Hemojuvelin,24867,0.103312946660283,0.00308929035143233,0.0972579375714752,0.10936795574909,6.88412272179428e-240
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FN1,Fibronectin,24966,0.0624106047210818,0.00186823118343066,0.0587488716015577,0.0660723378406059,2.08215595291803e-239
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS8,Prostasin,29347,0.0956940179688306,0.00286961919279077,0.0900695643509607,0.101318471586701,2.36923181593874e-239
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD2AP,CD2-associated protein,29478,0.147880038046653,0.00443877516344638,0.139180038726298,0.156580037367008,6.29449816460503e-239
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSD,Cathepsin D,27442,0.0942534577329138,0.00284073146494249,0.0886856240616265,0.0998212914042011,1.02810098559285e-236
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0932851999819016,0.00281642281664724,-0.0988053887025302,-0.087765011261273,3.1553989678697e-236
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0829631051595186,0.00250940691906672,0.0780446675981478,0.0878815427208893,2.12794789655376e-235
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0940663409656666,0.00284103268115924,0.0884979169105944,0.0996347650207387,2.78565271989444e-235
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCXR,L-xylulose reductase,29566,0.123838657312902,0.00375037280901423,0.116487926607234,0.13118938801857,7.73886984070702e-235
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.224611862035366,0.00681698700423947,0.211250567507057,0.237973156563676,7.87352664853496e-234
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.12712536666801,0.00386061667463987,0.119558557985715,0.134692175350304,1.75955404203651e-233
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,29434,0.0987316335216639,0.00300315096795792,0.0928454576244664,0.104617809418861,7.96482201844855e-233
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BECN1,Beclin-1,24240,0.138688738441078,0.00421146379049301,0.130434269411712,0.146943207470444,1.05451542486975e-232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0689026300839501,0.00209372516750548,0.0647989287556393,0.0730063314122608,1.63284489523254e-232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.223413791261515,0.00680428224076819,0.210077398069609,0.236750184453421,3.07486229835663e-232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EZR,Ezrin,29694,0.0551607504747712,0.00168064835592787,0.0518666796971526,0.0584548212523898,4.1835385732422e-232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTD,Biotinidase,24966,0.0475109677163965,0.00144589186095172,0.0446770196689312,0.0503449157638619,7.31570401565106e-232
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.186566467045606,0.00568191151466205,0.175429920476869,0.197703013614344,1.68078961929795e-231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK1,Dickkopf-related protein 1,29694,0.135873066664558,0.00414878399451056,0.127741450035318,0.144004683293799,3.96573352948466e-231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.122428420265611,0.00374038127884789,0.115097272959069,0.129759567572153,8.29144162638747e-231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",29349,0.185297353104001,0.00568192862632067,0.174160772996412,0.196433933211589,3.48829619454221e-229
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGRN,Agrin,29581,0.0784521107330848,0.00240904876679607,0.0737303751501645,0.0831738463160051,1.38579182600615e-228
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAMDC4,Apical endosomal glycoprotein,24793,0.126359801008505,0.00388166899143823,0.118751729785286,0.133967872231724,1.18217133583178e-227
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP20,Centrosomal protein 20,28797,0.169018152467245,0.00520265514321953,0.158820948386535,0.179215356547955,2.10081125633695e-227
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EHBP1,EH domain-binding protein 1,24922,0.169370536191406,0.00522185335380048,0.159135703617957,0.179605368764855,4.44285813707245e-226
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THOP1,Thimet oligopeptidase,29343,0.0698192547947641,0.0021586607291767,0.0655882797655777,0.0740502298239504,1.56543192586765e-225
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREG1,Protein CREG1,29079,0.0862004624542042,0.0026649909368571,0.0809770802179643,0.0914238446904441,1.60886881202965e-225
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD63,CD63 antigen,29169,0.11612736614469,0.00359106152407208,0.109088885557509,0.123165846731871,1.98463423917132e-225
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.254758104714381,0.00787414863027464,0.239324773399043,0.270191436029719,6.81506737190892e-225
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN1,Dynactin subunit 1,29725,0.146592438249808,0.00454135163306849,0.137691389048994,0.155493487450622,1.04102973279725e-224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,24111,0.140891322854193,0.0043593332845866,0.132347029616403,0.149435616091983,2.28586668308726e-224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.187405557051054,0.00579928972739757,0.176038949185355,0.198772164916753,2.31268749577775e-224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.163804638873028,0.00508258468094438,0.153842772898377,0.173766504847679,5.22813879778055e-224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0621193985032285,0.00192443825750408,0.0583474995185205,0.0658912974879365,5.89789019470286e-224
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.219831082752426,0.00681992196174465,0.206464035707406,0.233198129797445,2.35930635630638e-223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAXX,Protein PAXX,24381,0.10309879108886,0.00320023302110507,0.0968263343674944,0.109371247810226,4.99993657666362e-223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGF,Hepatocyte growth factor,29786,0.0774104653121592,0.00240776745620773,0.0726912410979921,0.0821296895263264,5.7228199048878e-223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NHLRC3,NHL repeat-containing protein 3,23825,0.0720010976953045,0.0022418907705285,0.0676069917850687,0.0763952036055404,1.3878470754757e-221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARF6,ADP-ribosylation factor 6,24805,0.239741143102162,0.00747204328062121,0.225095938272144,0.254386347932179,2.38759075383835e-221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPY,Pancreatic prohormone,29400,0.227974684914355,0.00712305764206714,0.214013491935903,0.241935877892807,5.7809411026823e-221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A4,Protein S100-A4,29566,0.127591166670286,0.00398845675364344,0.119773791433145,0.135408541907427,8.78335163682165e-221
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.237611633168697,0.0074296330077471,0.223049552473513,0.252173713863881,1.18680758840511e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPL,N-acetylneuraminate lyase,24922,0.100438750104987,0.00313801342844013,0.0942882437852444,0.10658925642473,2.51467585670189e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STC1,Stanniocalcin-1,29694,0.0971891646007455,0.00304270701072852,0.0912254588597176,0.103152870341773,3.78784192730288e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,24845,0.105811681451168,0.00330736961931085,0.0993292369973185,0.112294125905017,4.04126008220221e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.149172783467324,0.00467180230307076,0.140016050953306,0.158329515981343,6.95681177704633e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0523400153676508,0.00163975079634325,0.049126103806818,0.0555539269284835,7.81097976545358e-220
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,28774,0.176333569484174,0.00552785750682478,0.165498968770798,0.187168170197551,1.8443561301574e-219
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTSS2,Protein MTSS 2,24793,0.221381739503918,0.00694079773256715,0.207777775948086,0.23498570305975,8.11159239270462e-219
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.115160090346565,0.00361620450524603,0.108072329516283,0.122247851176847,9.59347993072227e-219
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.161673763372707,0.00507256199234217,0.151731541867717,0.171615984877698,1.58444422777082e-218
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.158930700769728,0.00500537232376628,0.149120171015146,0.16874123052431,1.69145717724823e-217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AXIN1,Axin-1,29434,0.211395331983803,0.00666087634990281,0.198340014337994,0.224450649629613,2.2440989481603e-217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,29163,0.0524800263910141,0.00165397202611249,0.0492382412198336,0.0557218115621946,3.01994254962237e-217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,29478,-0.087792375409613,0.00277599470118089,-0.0932333250239276,-0.0823514257952984,6.73291094326463e-216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL10,C-X-C motif chemokine 10,29581,0.147647467759567,0.00468017226600866,0.13847433011819,0.156820605400944,7.13664506914253e-215
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.230626836078506,0.00733518067189736,0.216249881961587,0.245003790195425,1.96417142359689e-213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.237802071479874,0.00755533130332699,0.222993622125353,0.252610520834395,2.97516231290659e-213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,29694,0.210839906296764,0.00671740403709087,0.197673794384066,0.224006018209462,9.17741503730543e-213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.159565749193165,0.00507732530276127,0.149614191599753,0.169517306786577,1.58778130443087e-212
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PYY,Peptide YY,24111,0.213202739488077,0.00679849312760524,0.19987769295797,0.226527786018183,1.25696871952472e-211
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP85,Centrosomal protein of 85 kDa,28797,0.140012446467891,0.00448128684182626,0.131229124257911,0.14879576867787,9.02586848295801e-211
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUCB2,Nucleobindin-2,29652,0.0815496170336363,0.00261099275962633,0.0764320712247687,0.0866671628425039,9.90073265154424e-211
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUOM,Fucose mutarotase,24381,0.139101835690339,0.0044575083452591,0.130365119333631,0.147838552047047,1.17050067371299e-209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFC,Platelet-derived growth factor C,28797,0.0627363921974443,0.00202868919341608,0.0587601613783488,0.0667126230165398,1.34601319171381e-206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACE2,Angiotensin-converting enzyme 2,28916,0.111930094005532,0.00362248116497969,0.104830030922171,0.119030157088892,2.83008529265972e-206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLIN1,Perilipin-1,28774,0.0752557204203518,0.00244352251814257,0.0704664162847924,0.0800450245559113,5.95890167197683e-205
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBIN,Erbin,29349,0.220668354722356,0.00717279049520718,0.20660968535175,0.234727024092962,1.39396522093607e-204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNA4,Plexin-A4,29434,0.175906754603409,0.00572044213175478,0.164694688025169,0.187118821181648,2.07792424032392e-204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPB2,Carboxypeptidase B2,24914,0.048698393652707,0.00158258005556962,0.0455965367437906,0.0518002505616235,4.17622199623204e-204
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAB2,Disabled homolog 2,29725,0.237523521255234,0.0077443108812272,0.222344671928029,0.252702370582439,2.08824358265586e-203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELP,P-selectin,29594,0.122069038058359,0.0039806716969453,0.114266921532346,0.129871154584372,2.52171573869703e-203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.234454819395283,0.00763572235636776,0.219488803576802,0.249420835213764,3.18634380662076e-203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0596865532745791,0.00195069481374027,0.0558631914396481,0.06350991510951,1.95977415375215e-202
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KAZN,Kazrin,24805,0.22348774689422,0.00729793265853375,0.209183798883494,0.237791694904947,3.4765872401729e-202
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTBS,Di-N-acetylchitobiase,24653,0.0584767175176436,0.00190993138633875,0.0547332520004196,0.0622201830348675,4.40516608841384e-202
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSP1,Lymphocyte-specific protein 1,29434,0.0860803896700778,0.00281776299557478,0.0805575741987512,0.0916032051414044,8.27444828067637e-202
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.105942227059023,0.00346994267895395,0.0991411394082729,0.112743314709772,1.64009081783421e-201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSO,Cathepsin O,29786,0.0648928912179826,0.00212761619074649,0.0607227634841195,0.0690630189518457,3.24064024504752e-201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEP,Leptin,29478,0.143034009462538,0.00470956912245633,0.133803253982524,0.152264764942552,1.59127408210405e-199
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD6,T-cell differentiation antigen CD6,29760,0.111780247474508,0.00369231828029215,0.104543303645135,0.119017191303881,2.60717330760157e-198
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R9B,Neurabin-2,29786,0.199963729634761,0.00660966419762819,0.18700878780741,0.212918671462112,4.73371194023757e-198
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH2,Cadherin-2,29478,0.0750832476323835,0.00248247303268371,0.0702176004883234,0.0799488947764435,6.40636406635973e-198
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,29581,0.265216867220944,0.00877587076515212,0.248016160521245,0.282417573920642,1.27290824072475e-197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATG16L1,Autophagy-related protein 16-1,24805,0.180886751467263,0.00597796908284104,0.169169932064895,0.192603570869631,1.55528954183664e-197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISM1,Isthmin-1,29434,0.083172427522675,0.00275771099282013,0.0777673139767475,0.0885775410686024,7.91819158102152e-197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.12203193819514,0.00405695970645677,0.114080297170485,0.129983579219795,8.71364393822286e-196
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FETUB,Fetuin-B,29545,0.0696145959318333,0.00231544215373546,0.0650763293105118,0.0741528625531548,1.22776517557234e-195
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCR,Breakpoint cluster region protein,29434,0.192890561816941,0.00642457966416129,0.180298385675185,0.205482737958697,4.22851880311277e-195
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.156573382378693,0.00521106743879648,0.146359690198651,0.166787074558734,9.51043824657389e-195
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0804621947165737,0.00268819374285719,0.0751933349805737,0.0857310544525738,5.75877306177655e-194
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFX1,Transcriptional repressor NF-X1,24111,0.141904672414965,0.00474227641003811,0.13260981065129,0.151199534178639,3.34154265516162e-193
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL17,C-C motif chemokine 17,29414,0.190534774631725,0.00638093813889562,0.17802813587949,0.203041413383961,4.98900599790022e-193
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.21742813444865,0.00728197488858722,0.203155463667019,0.23170080523028,5.20175966584954e-193
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.046881984807093,0.0015718524795005,0.0438011539472721,0.049962815666914,1.46266715028318e-192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD5,Programmed cell death protein 5,29694,0.120974138003225,0.00406022052104557,0.113016105781976,0.128932170224474,3.09090746961203e-192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFC,Vascular endothelial growth factor C,29566,0.116301418348924,0.00390335963627662,0.108650833461821,0.123952003236026,3.15552585465056e-192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,29434,0.133368935925542,0.004477677914524,0.124592687213075,0.14214518463801,4.32816579132371e-192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,24845,0.184621991629751,0.00619866897123074,0.172472600446138,0.196771382813363,1.46551610981665e-191
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.127199024658137,0.00429509344102217,0.118780641513733,0.13561740780254,6.83164047800675e-190
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP23,Synaptosomal-associated protein 23,29478,0.180392099897642,0.00609588387737031,0.168444167497996,0.192340032297287,1.11980047226509e-189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.222456263903472,0.00752540298726766,0.207706474048428,0.237206053758517,8.706253765021e-189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL5,C-X-C motif chemokine 5,29384,0.234852022203697,0.00798125641362674,0.219208759632989,0.250495284774406,1.37655730299866e-187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.153785044774484,0.00522608334486813,0.143541921418543,0.164028168130426,4.91566371412338e-187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCTN3,Tectonic-3,24922,0.0614920796320758,0.0020904453076449,0.0573948068290918,0.0655893524350598,5.43685756498156e-187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRPK2,SRSF protein kinase 2,29434,0.172827997445963,0.00588363416866307,0.161296074475383,0.184359920416542,5.86966195412351e-187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,29349,0.282930416639029,0.00963586469135043,0.264044121843982,0.301816711434076,8.44991966557731e-187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IKBKG,NF-kappa-B essential modulator,29434,0.188776201304974,0.00643226855940076,0.176168954928549,0.2013834476814,1.23522254296012e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.203615316446883,0.00694257661834897,0.190007866274919,0.217222766618847,2.02382993920022e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.142720957282978,0.00487360613883361,0.133168689250864,0.152273225315092,8.47119333143734e-186
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLA2,Src-like-adapter 2,24867,0.215245453712887,0.0073429261604292,0.200853318438446,0.229637588987329,1.01560103862853e-185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.195064986310272,0.0066761588372808,0.181979714989201,0.208150257631342,4.90323998038357e-185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0769415876801001,0.00263126332730124,0.0717843115585897,0.0820988638016106,8.98843180595241e-185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.17275457993473,0.00593068287808527,0.161130441493683,0.184378718375777,6.44313394645049e-184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTUD7B,OTU domain-containing protein 7B,24867,0.129273117602379,0.00443278778190179,0.120584853549851,0.137961381654906,7.15755159453296e-184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.17201765611629,0.00590359683233369,0.160446606324916,0.183588705907664,1.45613648877217e-183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0551636034693806,0.00189595316967186,0.0514475352568238,0.0588796716819375,1.66061461058218e-183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSME1,Proteasome activator complex subunit 1,29192,0.0756976305403826,0.00260392934973451,0.0705939290149029,0.0808013320658622,3.47675152914876e-183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP2B,DNA topoisomerase 2-beta,24229,0.162399560411711,0.00558697102961789,0.15144909719366,0.173350023629762,1.26248736745274e-182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5E,5'-nucleotidase,29566,0.114391795454358,0.0039421695724605,0.106665143092335,0.12211844781638,1.44636533899356e-182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BACH1,Transcription regulator protein BACH1,29434,0.150031827844389,0.00517249793630099,0.13989373188924,0.160169923799539,2.07088530139983e-182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.186885614545659,0.00644644392366126,0.174250584455283,0.199520644636035,3.5267858680894e-182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCK2,Cytoplasmic protein NCK2,29581,0.214770957718179,0.00741138281838584,0.200244647394143,0.229297268042215,4.32977436864368e-182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAT,Linker for activation of T-cells family member 1,29786,0.153874604913519,0.00531128804202528,0.14346448035115,0.164284729475889,5.11121850763317e-182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLSCR3,Phospholipid scramblase 3,24804,0.119751773901476,0.00412811284016898,0.111660672734745,0.127842875068208,5.58424359528429e-182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0477161761160805,0.00164755591830451,0.0444869665162036,0.0509453857159573,7.13044659212414e-182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.167596203242638,0.00580080048023947,0.156226634301369,0.178965772183907,5.80101771290862e-181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.142099496353765,0.00493177526583096,0.132433216832737,0.151765775874794,5.16864965174817e-180
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LBR,Delta(14)-sterol reductase LBR,29694,0.134946502594339,0.0046852356825016,0.125763440656636,0.144129564532042,5.99383828032065e-180
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA5,Integrin alpha-5,29443,0.0506341229315931,0.00175855248609163,0.0471873600588535,0.0540808858043327,8.19050252937576e-180
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0764914751983178,0.0026577782993651,0.0712822297315622,0.0817007206650734,1.17581989671183e-179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,29536,0.105114194079502,0.00365263198113946,0.0979550353964689,0.112273352762536,1.23941452739585e-179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OXT,Oxytocin-neurophysin 1,29694,0.280834095383801,0.00976703393578468,0.261690708869664,0.299977481897939,2.38283602859488e-179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.207720702067056,0.0072131294421295,0.193582968360482,0.22185843577363,2.41342753989201e-179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,29820,0.135263645617106,0.00470586864682168,0.126040143069336,0.144487148164877,3.05006199212585e-179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CMIP,C-Maf-inducing protein,24793,0.167366535097512,0.00582012786908724,0.155959084474101,0.178773985720923,6.51733685739317e-179
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINH1,Serpin H1,24445,0.25946143863079,0.0090276170058433,0.241767309299337,0.277155567962243,1.10719908328137e-178
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.129168464908645,0.00450059669187796,0.120347295392564,0.137989634424726,1.24594769975708e-178
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP5,Fatty acid-binding protein 5,29624,0.136706621617194,0.0047782774829136,0.127341197750683,0.146072045483705,1.32109983373882e-177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0804215940975603,0.00281310713017141,0.0749079041224244,0.0859352840726963,6.98177091482179e-177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MINK1,Misshapen-like kinase 1,24845,0.186198704612513,0.00651552837238138,0.173428269002646,0.198969140222381,9.23990051445296e-177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELE,E-selectin,29820,0.100882504441054,0.00353783673368128,0.0939483444430383,0.107816664439069,1.7794984102465e-176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AAMDC,Mth938 domain-containing protein,24240,0.107106003697236,0.003750721101296,0.0997545903386963,0.114457417055777,1.97149003173335e-176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPD52L2,Tumor protein D54,24381,0.217028292993628,0.00760339991523756,0.202125629159763,0.231930956827494,2.6835132540935e-176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.180977673768382,0.00634434125685623,0.168542764904944,0.19341258263182,3.87991973475994e-176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE4,Ribonuclease 4,24194,0.0551561144220556,0.00193320871304005,0.0513670253444971,0.0589452034996141,4.01198030885673e-176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.154178633692168,0.00540804124647389,0.143578872849079,0.164778394535257,6.03557817286613e-176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0406383722479353,0.00142778321745057,0.0378399171417321,0.0434368273541384,8.38431872351095e-176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN2,CCN family member 2,29478,0.114100500561711,0.00400895313950301,0.106242952408285,0.121958048715137,8.45220555723907e-176
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.138541495849349,0.0048645277994165,0.129007021362493,0.148075970336206,1.37913904810018e-175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0788705065357545,0.0027747020395126,0.0734320905383098,0.0843089225331992,2.18983945208363e-175
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL5,C-C motif chemokine 5,29594,0.200019416220899,0.00705120103538601,0.186199062191542,0.213839770250255,1.13977044124066e-174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,29349,0.0713607245033904,0.00252138052863591,0.0664188186672641,0.0763026303395168,7.06657230960623e-174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOK2,Docking protein 2,29478,0.241764007560294,0.00854458829503072,0.225016614502034,0.258511400618554,8.57228560674519e-174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.226904411634315,0.00800946894291479,0.211205852506202,0.242602970762428,8.80609348538397e-174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.126717920025202,0.00447406016028141,0.11794876211105,0.135487077939353,1.02542745928486e-173
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0516099706974133,0.00182848559214685,0.0480261389368055,0.0551938024580211,5.41622604343996e-173
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXO1,Forkhead box protein O1,29434,0.169247536736377,0.00600746739702337,0.157472900638211,0.181022172834543,2.45085019666845e-172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1R2,Interleukin-1 receptor type 2,29404,0.0394153356833144,0.00139957629270384,0.0366721661496149,0.0421585052170139,3.2895957115109e-172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK11,Serine/threonine-protein kinase STK11,28916,0.144320036229627,0.00512565613021018,0.134273750214415,0.154366322244839,4.22466744065677e-172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGFR,Opioid growth factor receptor,29349,0.0646017562562403,0.00229598291538563,0.0601016297420845,0.0691018827703962,6.6826100608398e-172
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAO1,Hydroxyacid oxidase 1,29725,0.25285530946976,0.00899660662999424,0.235221960474971,0.270488658464548,1.47415027924319e-171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.189312704113692,0.00673590058380803,0.176110338969428,0.202515069257956,1.72752520200411e-171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.186825369833934,0.00665277786854112,0.173785925211594,0.199864814456275,3.04972353481983e-171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.221596505046509,0.00789146449960618,0.206129234627281,0.237063775465737,3.08320241805085e-171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP43,Centrosomal protein 43,28705,0.137356064698115,0.0048911996120915,0.127769313458415,0.146942815937814,3.34606980515984e-171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0984766641796356,0.00351179661242458,0.0915935428192834,0.105359785539988,8.35860803331378e-171
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLK1,Protein delta homolog 1,29820,0.109540216956964,0.0039169519090514,0.101862991215223,0.117217442698705,6.66594537912456e-170
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0865626953273256,0.0030956876154376,0.0804951476010679,0.0926302430535833,7.90570291335446e-170
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0550191027834063,0.00197351554085611,0.0511510123233283,0.0588871932434843,7.54113936548529e-169
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.1313291094417,0.00471234142312127,0.122092920252382,0.140565298631017,1.10362146139441e-168
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCBP2,Poly(rC)-binding protein 2,24867,0.14152724434707,0.00508167168277857,0.131567167848824,0.151487320845316,4.04970307233081e-168
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.108661224644851,0.00390788047950202,0.101001778905027,0.116320670384675,5.21494655803669e-168
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USO1,General vesicular transport factor p115,29349,0.175265393194543,0.00631094080852311,0.162895949209838,0.187634837179249,1.40910371665038e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL13,C-C motif chemokine 13,29732,0.134535660727615,0.00485161132313766,0.125026502534266,0.144044818920965,4.07854738908108e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS9,Galectin-9,29453,0.0621762878595599,0.00224302721755422,0.0577799545131536,0.0665726212059662,5.63938499440677e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.21156536715473,0.00762460138984469,0.196621148430634,0.226509585878825,6.59017278732239e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F13B,Coagulation factor XIII B chain,24833,0.0503806640868159,0.00181628650088041,0.0468207425450903,0.0539405856285415,8.44561074820999e-167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NIT2,Omega-amidase NIT2,24813,0.144917816638018,0.00523242103410373,0.134662271411174,0.155173361864861,2.63881067964148e-166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.149094062342053,0.00539087364284739,0.138527950002072,0.159660174682034,3.15214357252185e-166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGLN1,Egl nine homolog 1,29434,0.105324507454424,0.00382115859116056,0.097835036615749,0.112813978293098,3.8363078998563e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEXIM1,Protein HEXIM1,29434,0.157389659820846,0.00571044661393048,0.146197184457543,0.16858213518415,4.02591346777879e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,29443,0.103074580802225,0.0037428955996188,0.0957385054269723,0.110410656177478,7.45814287313413e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.122246988697021,0.00443555014153834,0.113553310419605,0.130940666974436,9.91978105804526e-165
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,24867,0.220611471507376,0.00801420675602584,0.204903626265565,0.236319316749187,2.39876167939957e-164
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.133837768350326,0.00487799213995264,0.124276903756019,0.143398632944634,3.0991113972019e-163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP3B1,AP-3 complex subunit beta-1,24805,0.147521073638386,0.00538637163050328,0.1369637852426,0.158078362034173,1.01161817004389e-162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0560257505055356,0.00205008568975797,0.0520075825536099,0.0600439184574612,1.96317326207524e-162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QDPR,Dihydropteridine reductase,29345,0.0828256033366575,0.00303250696533245,0.0768818896846059,0.0887693169887091,3.2298066389104e-162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,24381,0.150019815233629,0.00548565684218529,0.139267927822946,0.160771702644312,3.23868174998141e-162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOLM2,Protein GOLM2,29694,0.0433721550053317,0.0015895984964855,0.0402565419522201,0.0464877680584432,6.38894501531685e-162
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP2,Methionine aminopeptidase 2,29674,0.110124840875608,0.0040398750682605,0.102206685741817,0.118042996009398,1.26438667300231e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0628704358728368,0.00230679531338798,0.0583491170585964,0.0673917546870773,1.46062365074579e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0805875845879065,0.00296435687752593,0.0747774451079557,0.0863977240678574,9.03555755871527e-161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BID,BH3-interacting domain death agonist,29434,0.127302890658234,0.00468900093116833,0.118112448833144,0.136493332483324,2.45320560296084e-160
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.213021468482794,0.00785320044733043,0.197629195606026,0.228413741359561,4.8088042831707e-160
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PXN,Paxillin,28774,0.098230985746018,0.00362194438660479,0.0911319747482726,0.105329996743763,5.73776775772406e-160
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.161509712943786,0.00596051592559918,0.149827101729612,0.173192324157961,2.5993760828406e-159
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAG1,Dystroglycan,29581,0.0902221394298397,0.00333633260655063,0.0836829275210004,0.0967613513386789,4.07139956628759e-159
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.147235970922355,0.00544526890981026,0.136563243859127,0.157908697985583,1.01193397639093e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC13,Mucin-13,28774,0.0977742655886145,0.00362165834809847,0.0906758152263415,0.104872715950888,1.51813396957371e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMPR,GMP reductase 1,29786,0.0942118831133994,0.00349135315970528,0.087368830920377,0.101054935306422,1.82501408063528e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,24209,0.108096747601067,0.00400250762003354,0.100251832665801,0.115941662536333,2.69980169706146e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.194633007017126,0.00721101084434082,0.180499425762218,0.208766588272034,3.63444699071203e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NSFL1C,NSFL1 cofactor p47,29694,0.123191715787106,0.00457217705596605,0.114230248757413,0.1321531828168,5.38829727559947e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.171974373783887,0.00637738716989021,0.159474694930902,0.184474052636872,6.96995853555013e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEC31A,Protein transport protein Sec31A,24240,0.145918366954975,0.00541091405264323,0.135312975411794,0.156523758498156,7.62655867995169e-158
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC27,Cell division cycle protein 27 homolog,28797,0.115184175003301,0.00428216093812622,0.106791139564574,0.123577210442028,2.02104458739506e-157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDUA,Alpha-L-iduronidase,29725,0.0870573218383056,0.00324378641545428,0.0806995004640152,0.093415143212596,8.61153619906025e-157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.136371934674858,0.00507673153346331,0.12642154086927,0.146322328480446,1.06764772620185e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,29581,0.161627685952524,0.00602530490328398,0.149818088342087,0.17343728356296,1.24823363722924e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0619224071560852,0.00230855148145798,0.0573976462524276,0.0664471680597429,1.34687710617005e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNMBP,Dynamin-binding protein,29218,0.115321147444915,0.00429942528100013,0.106894273894155,0.123748020995675,1.3998709099013e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGF,Placenta growth factor,29786,0.0494858433850865,0.00184633497147732,0.0458670268409909,0.053104659929182,2.19303547534266e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYN,Tyrosine-protein kinase Lyn,29349,0.158826545507838,0.00593202167185776,0.147199783030997,0.170453307984679,4.830688889495e-156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST3,Cystatin-C,29530,0.0533301740971468,0.00199482419857145,0.0494203186679468,0.0572400295263469,1.34572668024402e-155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYTL4,Synaptotagmin-like protein 4,24922,0.137298165100023,0.00513044379034904,0.127242495270939,0.147353834929108,1.43945488228021e-155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.196451230683881,0.00735020546442123,-0.210857633394147,-0.182044827973616,1.62625207392939e-155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,29349,0.111781204182544,0.00418574354865017,0.103577146827189,0.119985261537898,2.94982284897506e-155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.1001117638435,0.00374675369504395,0.0927681266012139,0.107455401085786,4.71285446297316e-155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAMBP,STAM-binding protein,29163,0.119920685788008,0.00449685768742458,0.111106844720656,0.12873452685536,8.07152400857771e-155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0524642175839957,0.0019678168029427,0.048607296650228,0.0563211385177633,1.01306666600041e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0941140574045519,0.00352940871461458,0.0871964163239074,0.101031698485196,2.03785413264462e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBPL,FK506-binding protein-like,24805,0.110942002160225,0.00416277090854909,0.102782971179469,0.119101033140981,2.60295483836201e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EREG,Proepiregulin,29163,0.15020903295487,0.00564495498949897,0.139144921175452,0.161273144734288,3.67764069365079e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.111566431032955,0.00419282924389706,0.103348485714916,0.119784376350993,7.75992862222949e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0690143023802752,0.00259440604134766,0.0639292665392337,0.0740993382213166,9.39146294640975e-154
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTDH,Protein LYRIC,24229,0.174276419856613,0.00655181467165956,0.161434863100161,0.187117976613066,1.10438348494848e-153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX15,Sorting nexin-15,24381,0.100780010892143,0.00380505021356735,0.0933221124735513,0.108237909310735,2.02795534943651e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0832325972896357,0.00314752679062069,0.0770634447800192,0.0894017497992523,2.63041036067465e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,29434,0.106343126267403,0.00402227466852955,0.0984594679170851,0.114226784617721,2.97830289724521e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH2B3,SH2B adapter protein 3,28797,0.182350500329018,0.00690244753746203,0.168821703155593,0.195879297502444,5.50460747867987e-152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,24922,0.168349750473811,0.00637453552355269,0.155855660847648,0.180843840099975,1.29655546203008e-151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0814925137515512,0.00308999396144181,0.0754361255871252,0.0875489019159771,1.73455475845445e-151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0649617053736148,0.0024636153131955,-0.069790391387478,-0.0601330193597516,1.82143521791209e-151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,24229,0.18055595787123,0.00685133223694698,0.167127346686814,0.193984569055646,6.30324314088666e-151
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,29443,0.0946598101670107,0.00360309362571394,0.0875977466606113,0.10172187367341,2.19068601334977e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.190469933489394,0.00725058688280876,0.176258783199088,0.204681083779699,2.26941615321584e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.192556689950504,0.00733291903753018,0.178184168636944,0.206929211264063,2.97352468611939e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNST,Consortin,29478,0.200050400903403,0.00762055465523039,0.185114113779151,0.214986688027654,3.68250002561955e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,28916,0.0640725222503866,0.00244376938820769,0.0592827342494995,0.0688623102512737,9.19630317058478e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASAH2,Neutral ceramidase,29218,0.0976875739837561,0.00372641430691295,0.0903838019422067,0.104991346025305,9.73674375609422e-150
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMN,Protein amnionless,28931,0.0875908734012629,0.00334151124746867,0.0810415113562244,0.0941402354463015,1.0642326858561e-149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARSB,Arylsulfatase B,29349,0.101699459497278,0.00388043784804315,0.0940938013151138,0.109305117679443,1.1348172640654e-149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CES2,Cocaine esterase,29349,0.100757684426287,0.00384694125895879,0.0932176795587274,0.108297689293846,1.73717005141075e-149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGCC,Regulator of cell cycle RGCC,24867,0.139336463027787,0.00532099759132673,0.128907307748786,0.149765618306787,4.02927693293666e-149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.131989856228412,0.00504402699399095,0.12210356332019,0.141876149136635,7.09237070254018e-149
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.106417342339575,0.00407898230454533,0.0984225370226661,0.114412147656484,2.31039418800548e-148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM5,Tripartite motif-containing protein 5,29434,0.157600046273772,0.00604573146716386,0.145750412598131,0.169449679949413,4.05790074949585e-148
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFA,Vascular endothelial growth factor A,29683,0.105776019065765,0.00406472006684565,0.0978091677347474,0.113742870396782,1.23914860517074e-147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNB3,Plexin-B3,29383,0.0866003538869847,0.00333261367786276,0.0800684310783737,0.0931322766955957,3.32260024118813e-147
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTBDN,Retbindin,29349,0.0541088888369386,0.00208726541285555,0.0500178486277417,0.0581999290461355,1.62826558949485e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.115493471348414,0.00445871485415724,0.106754390234266,0.124232552462563,2.94068197499205e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3GLB2,Endophilin-B2,24845,0.121242689754546,0.00468108731409229,0.112067758618925,0.130417620890167,5.70356712927391e-146
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.170078560600319,0.00658115842018649,0.157179490096753,0.182977631103884,1.30983446803059e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYDGF,Myeloid-derived growth factor,24922,0.181918963114313,0.0070348002685509,0.168130754587954,0.195707171640673,1.5709303791513e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD5,T-cell surface glycoprotein CD5,29683,0.0625623238624567,0.00242261224068819,0.0578140038707078,0.0673106438542055,1.9190915713564e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0475224979878485,0.0018391360211571,0.0439177913863806,0.0511272045893165,2.95936107904204e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP10,Stromelysin-2,29439,-0.107364561952217,0.0041606585736499,-0.115519452756571,-0.0992096711478631,3.24827142983056e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AZI2,5-azacytidine-induced protein 2,24867,0.100455078694238,0.00389102863766484,0.0928286625644147,0.108081494824061,4.65930892458277e-145
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COCH,Cochlin,24922,0.0837711654460675,0.0032590504208254,0.0773834266212497,0.0901589042708853,7.88385473399095e-144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.110613212931204,0.00431133685302315,0.102162992699279,0.119063433163129,1.36767931341348e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.155579839831702,0.00607340605033662,0.143675963973042,0.167483715690362,3.66600921393594e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.138690769188521,0.00541421076507015,0.128078916088984,0.149302622288059,3.75899983993294e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAX1BP1,Tax1-binding protein 1,24845,0.113966229720741,0.00444595609329157,0.10525215577789,0.122680303663593,4.66669902113194e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.144379815464598,0.005633863875306,0.133337442268999,0.155422188660198,5.47596969782643e-143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIAE,Sialate O-acetylesterase,29495,0.0839187733488757,0.00328278747981159,0.077484509888445,0.0903530368093065,1.4020017289084e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANG,Angiogenin,29435,0.0606553972252536,0.0023750954307584,0.0560002101809671,0.06531058426954,2.65228961417235e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.181759344961778,0.0071177585828318,0.167808538139428,0.195710151784128,2.79233768456484e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MITD1,MIT domain-containing protein 1,29218,0.17359236100971,0.0068004354033739,0.160263507619097,0.186921214400323,3.62406539010782e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VNN1,Pantetheinase,24951,0.130883753437276,0.00512455315635771,0.120839629250815,0.140927877623737,4.69401923628481e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,24805,0.172258770591142,0.00674966106753383,0.159029434898776,0.185488106283509,7.80293851024311e-142
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,24867,0.136490771127298,0.00535320327096654,0.125998492716204,0.146983049538393,1.40617442016018e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,29820,0.0399418226000031,0.00156962748888235,0.0368653527217937,0.0430182924782125,2.48710688901544e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEP1A,Meprin A subunit alpha,24805,0.129211749328794,0.00507442869099321,0.119265869094448,0.139157629563141,3.28600312752878e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TALDO1,Transaldolase,24888,0.0797886571741587,0.00313606346830734,0.0736419727762763,0.0859353415720411,5.46316220266192e-141
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,24951,0.0481518196711132,0.00189450688596535,0.0444385861746211,0.0518650531676053,1.02471013775643e-140
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRAP,BRCA1-associated protein,24565,0.196286703568486,0.00772579887647076,0.181144137770603,0.211429269366369,1.39574911977051e-140
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA1,GDNF family receptor alpha-1,29674,0.0505868426445711,0.00199384574080431,0.0466789049925947,0.0544947802965476,1.64585806738708e-140
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.10077277412712,0.00397236474816707,0.0929869392207121,0.108558609033527,1.82477044534667e-140
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELOA,Elongin-A,29349,0.0933127167441684,0.00368078237178975,0.0860983832954605,0.100527050192876,2.82134392319946e-140
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRKL,Crk-like protein,29491,0.188864952522018,0.00746982206914528,0.174224101266494,0.203505803777543,1.48543409810795e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLB1,Beta-galactosidase,29218,0.0744029544878701,0.00294890168380114,0.0686231071876198,0.0801828017881203,5.69283943652964e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GASK1A,Golgi-associated kinase 1A,24111,0.0766157733209173,0.00303449342407648,0.0706681662097274,0.0825633804321072,7.54805822289201e-139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0839386059942739,0.00332967266903658,0.0774124475629622,0.0904647644255856,1.76069296526337e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM13A,Protein FAM13A,24805,0.119940797889206,0.00475996115756276,0.110611274020383,0.129270321758029,2.33180595728302e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA2,Apolipoprotein A-II,24951,-0.0858248192613431,0.00340814848939407,-0.0925047903005555,-0.0791448482221307,3.34554288017663e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCC,Tubulin-specific chaperone C,29218,0.143226368421276,0.00569394347287739,0.132066239214436,0.154386497628116,3.77211114763766e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,29725,0.065471976817691,0.0026034167890676,0.0603692799111185,0.0705746737242635,4.09884744495864e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.157841138972167,0.00627058854138064,0.145550785431061,0.170131492513273,4.4405555904921e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,29581,0.230177005941386,0.00915467040128859,0.21223385195486,0.248120159927911,4.75310291612085e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.116680895399064,0.00463684351401273,0.107592682111599,0.125769108686529,5.32653642112231e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL11,Eotaxin,29786,0.0666740599031274,0.00265416116498475,0.0614719040197573,0.0718762157864975,8.09977383787231e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPHN1,Oligophrenin-1,24845,0.190434279405128,0.00757295117774346,0.175591295096751,0.205277263713505,8.16053964484529e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0903120539857885,0.00359533131703332,0.0832652046044032,0.0973589033671738,9.35906419498738e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS8,Galectin-8,29694,0.107299156550679,0.0042726189705644,0.0989248233683728,0.115673489732985,9.81133709100521e-138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST13,Hsc70-interacting protein,24381,0.0988032144345796,0.00393436680514311,0.0910918554964991,0.10651457337266,2.01324858087899e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0904493565690428,0.00360273108792187,0.083388003636716,0.0975107095013697,2.23870053657011e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0793729135597305,0.00316570410357749,-0.0855776936027424,-0.0731681335167186,4.98055472369715e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.159230768280077,0.00635665758036452,0.146771719422563,0.171689817137592,9.75000052188714e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.137342721678169,0.00548865723840677,0.126584953490892,0.148100489865446,9.96411018084454e-137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IST1,IST1 homolog,24636,0.175290538551365,0.0070028944981797,0.161564865334932,0.189016211767797,1.42893746475233e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMMD1,COMM domain-containing protein 1,24240,0.108158595696906,0.0043208813996561,0.0996896681535798,0.116627523240232,1.50551244921885e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,28916,0.133387853107299,0.00533491781885354,0.122931414182346,0.143844292032252,1.61356778853509e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0879746634927254,0.0035190323568877,0.0810773600732255,0.0948719669122253,1.64019223204183e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NIT1,Deaminated glutathione amidase,24240,0.0834932805893498,0.00333677256527422,0.0769532063614123,0.0900333548172872,1.89599673707344e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0810910505755754,0.0032466681176047,0.0747275810650702,0.0874545200860806,2.88351942776818e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNLR1,Interferon lambda receptor 1,29434,0.0652643647649227,0.00261303050557443,0.0601428249739968,0.0703859045558486,2.90020572634313e-136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,24229,0.155223596863028,0.00622252458800295,0.143027448670542,0.167419745055514,1.23460911181483e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0582633738702117,0.0023354014135388,0.0536859870996757,0.0628407606407478,1.23649685964699e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.185914254097861,0.00745603095235401,0.171300433431247,0.200528074764475,1.54783286153583e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDRKH,Tudor and KH domain-containing protein,28774,0.149186728184542,0.00598915166402339,0.137447990923056,0.160925465446028,1.60782483185079e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1S,Complement C1s subcomponent,24966,0.036751236003668,0.00147428370239483,0.0338616399469741,0.0396408320603618,1.67580108443304e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0555901553639624,0.00223243185161612,0.0512145889347948,0.05996572179313,3.62020505073838e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASHC3,WASH complex subunit 3,24845,0.132124536260553,0.0053125746027214,0.121711890039219,0.142537182481887,7.00734019919342e-135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,29386,0.113296160582649,0.00456461214464487,0.104349520779145,0.122242800386153,1.31503585470636e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,A1BG,Alpha-1B-glycoprotein,24966,0.029926971730969,0.00120486560821692,0.0275654351388638,0.0322885083230742,1.48708615113884e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,24229,0.0866700490731291,0.00349158678313278,0.0798265389781888,0.0935135591680693,2.44712940511803e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBNL,Drebrin-like protein,29581,0.161568058952279,0.0065169398946568,0.148794856758752,0.174341261145807,2.579338703128e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUS,RNA-binding protein FUS,28765,0.0691280855915524,0.0027884800772297,0.0636626646401822,0.0745935065429226,2.9166088732112e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.118051572886006,0.00475910375937931,0.108723729517622,0.127379416254389,3.3616082625177e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.131973873028399,0.00532899392818675,0.121529044929153,0.142418701127645,5.09316867745698e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNCG,Gamma-synuclein,29218,0.116643199757428,0.00471006470450833,0.107411472936592,0.125874926578265,5.21175331706684e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDHD2,Phospholipase DDHD2,24867,0.115720387301245,0.00467064198797856,0.106565929004807,0.124874845597683,6.83756821567983e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD36,Platelet glycoprotein 4,24229,0.079171303677008,0.00319512700600904,0.0729088547452302,0.0854337526087857,7.06634951245428e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOLGA3,Golgin subfamily A member 3,24867,0.136091448082119,0.00549540592808657,0.125320452463069,0.146862443701169,9.04062286534222e-134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB27B,Ras-related protein Rab-27B,24922,0.14297791987753,0.005791141724768,0.131627282096985,0.154328557658075,5.5647084751223e-133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.20190231938829,0.00819487300337722,0.185840368301671,0.217964270474909,1.1169830430686e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,24381,0.143587942266539,0.00582247861458486,0.132175884181952,0.155000000351125,1.18770371152212e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",28774,0.088457580639431,0.00359157613532328,0.0814180914141974,0.0954970698646646,1.45682931692893e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.190835251498807,0.00775239879214894,0.175640549866195,0.206029953131419,1.82712861382703e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,24867,0.105342490038043,0.00427756732692414,0.0969584580772718,0.113726521998814,2.52161994850935e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.185782162080731,0.00754684689660373,0.170990342163388,0.200573981998075,3.17260568166567e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL3,C-X-C motif chemokine 3,29453,0.16293644024038,0.00663429519396668,0.149933221660205,0.175939658820555,7.24968043346316e-132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17RB,Interleukin-17 receptor B,29034,-0.0928730314467149,0.00378750217736539,-0.100296535714351,-0.0854495271790787,1.92773733049458e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D23,TBC1 domain family member 23,29349,0.154722100795787,0.00632568592486041,0.14232375638306,0.167120445208513,8.19890780060315e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.253191150083484,0.0103426155363372,0.232919623632264,0.273462676534705,8.54369921601964e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBKS,Ribokinase,28795,0.0857969564838149,0.00350813386125171,0.0789210141157615,0.0926728988518683,9.27722895246847e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,24846,0.034532612941582,0.00141101231359317,0.0317670288069394,0.0372981970762246,9.98041896727438e-131
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAT2,Signal transducer and activator of transcription 2,24229,0.133868899857072,0.00546978127247389,0.123148128563023,0.144589671151121,1.07518278745914e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.143293338175743,0.00585841985628758,0.131810835257419,0.154775841094066,1.41451630494912e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.124644018638522,0.00510386861643545,0.114640436150309,0.134647601126736,2.01626307011934e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEFTY2,Left-right determination factor 2,29674,0.0893545730303636,0.00365984410532849,0.0821812785839198,0.0965278674768074,2.30735617254891e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.100006455927597,0.00409524750094609,0.0919797708257424,0.108033141029451,3.83507494192526e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.107153826424031,0.00438984982522795,0.098549720766584,0.115757932081478,5.14808699766135e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.209687389838445,0.00860151823632976,0.192828414095239,0.226546365581651,6.27170789867523e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PENK,Proenkephalin-A,24381,0.0531487933785712,0.00217960980552105,0.0488767581597499,0.0574208285973924,8.96323558479778e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGA,Protein O-GlcNAcase,24805,0.121529892257601,0.00498534047747353,0.111758624921753,0.131301159593449,9.99447812794744e-130
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0479601274034326,0.00196959309197908,0.0440997249431536,0.0518205298637116,1.11851933417549e-129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS1BP3,HCLS1-binding protein 3,24240,0.155104108721996,0.00636656869696862,0.142625634075937,0.167582583368054,1.55536108342735e-129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGKA,Diacylglycerol kinase alpha,24229,0.0936985137929999,0.00386212893876153,0.0861287410730273,0.101268286512973,1.73668850862197e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SULT2A1,Bile salt sulfotransferase,29434,0.0956468125942872,0.00395098288816156,0.0879028861334905,0.103390739055084,3.26917557336254e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,28931,0.067117273935466,0.00277465657424338,0.061678947049949,0.0725556008209831,5.39042543193749e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD1,Sushi domain-containing protein 1,28916,0.083522451111672,0.00345328569042259,0.0767540111584438,0.0902908910649003,5.80088792221985e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,29566,0.057287646670035,0.00236893687498396,0.0526445303950665,0.0619307629450036,5.91818359675712e-128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,24867,0.201654351526007,0.0083489127952435,0.18529048244733,0.218018220604684,2.02643963039869e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THPO,Thrombopoietin,28916,0.0656039529619975,0.00272223243487989,0.0602683773896329,0.0709395285343621,4.56790297116147e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASC3,Protein CASC3,24195,0.0713545660172683,0.00296088012572487,0.0655512409708476,0.0771578910636891,7.99890329343622e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF2,TNF receptor-associated factor 2,29434,0.119470948497894,0.00496438929884528,0.109740745472157,0.12920115152363,9.64919198204838e-127
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.122625305132705,0.00510249341608056,0.112624418037187,0.132626192228223,2.08621882681024e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.114893888874808,0.00478162324598464,0.105521907312678,0.124265870436938,2.27696171289506e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMPR2,GMP reductase 2,24381,0.113890357672328,0.00473977529978043,0.104600398084759,0.123180317259898,4.09600224425618e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RWDD1,RWD domain-containing protein 1,29694,0.107408876776277,0.00447592079637283,0.0986360720153866,0.116181681537168,4.75114593339634e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0950694105485349,0.00396529179469522,0.0872974386309323,0.102841382466138,8.2749734880237e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMA,Granzyme A,29786,0.0586139661493011,0.00244551790289825,0.0538207510596205,0.0634071812389816,9.36062378627779e-126
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.075360461879565,0.00314505510439096,0.0691961538749587,0.0815247698841712,1.19285669404756e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0815306992591543,0.00340071948923902,0.0748652890602458,0.0881961094580628,1.3815439736252e-125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.144410196750922,0.00604688352788231,0.132558305036273,0.156262088465572,1.2910404469065e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINC1,Antithrombin-III,24914,0.0248868091707988,0.00104305946628494,0.0228424126168803,0.0269312057247173,2.01533292175168e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C19orf12,Protein C19orf12,28774,0.108265169780231,0.00454904532078385,0.0993490409514948,0.117181298608968,5.34882974561882e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.118964614252289,0.0050015024819037,0.109161669387758,0.12876755911682,6.87773589261774e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TWF2,Twinfilin-2,24938,0.140816001352121,0.00591720121733272,0.129218286966149,0.152413715738093,8.47961977220661e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0951307846387543,0.00400127108028991,0.0872882933213861,0.102973275956123,8.89185092450071e-124
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GTPBP2,GTP-binding protein 2,24195,0.135675730555791,0.00570617339771611,0.124491630696267,0.146859830415314,1.51283044307555e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNPY4,Protein canopy homolog 4,29349,0.125509232072499,0.00528401219799316,0.115152568164433,0.135865895980566,1.51698279188035e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0447665404223199,0.0018857153612987,0.0410705383141745,0.0484625425304653,2.01908261385441e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAS6,Growth arrest-specific protein 6,29639,-0.042573742066826,0.00179784026675175,-0.0460975089896594,-0.0390499751439925,7.94785150647825e-123
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL7,C-C motif chemokine 7,29434,0.0980471798345272,0.00414249651569605,0.089927886663763,0.106166473005291,1.06682999502457e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMOX2,Heme oxygenase 2,28774,0.0778861603870078,0.00329435299550454,0.0714292285158189,0.0843430922581967,2.0872574426136e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCAM,Cell surface glycoprotein MUC18,29594,-0.0554823469568774,0.00234705460470121,-0.0600825739820918,-0.050882119931663,2.08806984051021e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.147190288863213,0.00622752822712645,0.134984333538045,0.159396244188381,2.32573923945143e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBXN1,UBX domain-containing protein 1,24381,0.114988188849109,0.00486753842419969,0.105447813537678,0.124528564160541,5.20624578532662e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0950274181138749,0.00402310922068253,0.0871421240413371,0.102912712186413,5.30969632918509e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD99L2,CD99 antigen-like protein 2,29443,0.0403279968387946,0.0017090079122962,0.0369783413306941,0.0436776523468951,5.58813239737803e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,29478,0.132804048375833,0.00563248818835396,0.121764371526659,0.143843725225007,8.67467021778011e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPC5,Glypican-5,29218,0.0935456142832259,0.00396821107909792,0.085767920568194,0.101323307998258,9.84418750156079e-122
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPART,Spartin,24381,0.128761142845095,0.00546160988517915,0.118056387470144,0.139465898220046,1.57171064355213e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18,Interleukin-18,29335,0.0764296693589053,0.00324622111929453,0.070067075965088,0.0827922627527226,1.9318795914975e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSZ,Cathepsin Z,29487,0.0524281338505785,0.00222859053938014,0.0480600963933935,0.0567961713077636,2.95619441100612e-121
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAX,Protein max,28774,0.174086601080388,0.00742357089272923,0.159536402130639,0.188636800030138,1.76739662480938e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0990171510845931,0.00422419146870181,0.0907377358059376,0.107296566363249,2.19582653107525e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS1,Galectin-1,29478,0.0566677755971147,0.00241784057292274,0.0519288080741861,0.0614067431200432,2.25169901599103e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL3,C-C motif chemokine 3,29434,0.10008217979014,0.00427124969767243,0.0917105303827017,0.108453829197578,2.58090168680293e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.14011519520826,0.00598974193479867,0.128375301016054,0.151855089400465,6.70452520637167e-120
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN3,Ataxin-3,24845,0.101636709651456,0.0043596903877983,0.0930917164913717,0.110181702811541,6.22799603376439e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",28916,0.15267651138387,0.00655727337621094,0.139824255566497,0.165528767201244,8.09177930119351e-119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.113309286744935,0.00487210890424925,0.103759953292606,0.122858620197263,2.42170185851944e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.141656733748289,0.00610111342320705,0.129698551438804,0.153614916057775,5.42776185982239e-118
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0785396125613212,0.00339342755060428,0.0718884945621368,0.0851907305605055,2.8646664165553e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICA1,Islet cell autoantigen 1,28931,0.129833531105928,0.00561687905027219,0.118824448167395,0.140842614044462,3.79053290847433e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADD1,Alpha-adducin,24381,0.114323639716199,0.0049424917590147,0.104636355868531,0.124010923563868,4.14912454299779e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0498138555429765,0.00215675697042519,0.0455866118809431,0.0540410992050099,5.47846730031735e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD22,B-cell receptor CD22,29786,0.0681617183027644,0.0029540176411519,0.0623718437261067,0.0739515928794222,8.90808317218499e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.109661246512797,0.0047481855342194,0.100354802865727,0.118967690159867,9.24744924891744e-117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0512053477157083,0.00221892071988213,0.0468562631047394,0.0555544323266773,1.3393703054152e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.129890887773863,0.00563835976389612,0.118839702636626,0.140942072911099,3.53453447406615e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AP2B1,AP-2 complex subunit beta,24195,0.0793537891485984,0.00344468242205634,0.072602211601368,0.0861053666958289,3.57196353511122e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,28797,0.148949000363308,0.0064790276165554,0.136250106234859,0.161647894491757,6.59744665511341e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS2,Trypsin-2,29594,0.0868204552146816,0.00377810232585595,0.079415374656004,0.0942255357733593,7.67099190132792e-116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA11,Annexin A11,29373,0.108302311462035,0.00471536409849245,0.0990601978289896,0.11754442509508,1.02264335377923e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.134928874802095,0.0058751157008839,0.123413648028362,0.146444101575827,1.05630866957603e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPACT,Protein IMPACT,24845,0.0904062825796886,0.00393351855972899,0.0826965862026198,0.0981159789567574,1.09789078944532e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.169202814909834,0.00736907153158658,0.154759434707925,0.183646195111744,1.18551591845661e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FMNL1,Formin-like protein 1,28774,0.0995337926124937,0.00433549554868852,0.0910362213370643,0.108031363887923,1.34788738151812e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YJU2,Splicing factor YJU2,24793,0.0525707160123717,0.00229338366879237,0.0480756840215387,0.0570657480032048,4.34070752465609e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOD,Apolipoprotein D,23787,-0.0704551209092147,0.00307622670260065,-0.076484525246312,-0.0644257165721174,7.57591492440217e-115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOK1,Docking protein 1,24845,0.22050126272728,0.0096459967994879,0.201595109000284,0.239407416454276,1.79355041069609e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C3,Complement C3,23779,0.075075938557887,0.00328640788694331,0.0686345790994781,0.0815172980162959,2.82945785736437e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.131966729267737,0.00578692205679665,-0.143309096499058,-0.120624362036415,4.03184425532024e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,29218,0.12769616307315,0.00559984244191653,0.116720471886993,0.138671854259306,4.20426150544375e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.126111091927456,0.00553235591402215,0.115267674335972,0.136954509518939,5.06968941658472e-114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,29434,0.0533622611975012,0.00234912222868832,0.0487579816292721,0.0579665407657303,2.95075137189386e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RILPL2,RILP-like protein 2,24922,0.157193236573909,0.00691523345205785,0.143639379007876,0.170747094139943,3.1111641614523e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.1258406289364,0.00554514097462899,0.114972152626127,0.136709105246673,5.06848071269407e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDC4,Syndecan-4,29478,0.0741791389049123,0.00327093442761814,0.0677681074267808,0.0805901703830439,6.80858806360987e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CETN3,Centrin-3,24805,0.124347132960471,0.00547904867547797,0.113608197556534,0.135086068364408,7.09424004396261e-113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0566617560926408,0.00250334809949392,0.0517551938176328,0.0615683183676489,1.82189642411908e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0460919392397333,0.00203553643159086,0.0421022878338152,0.0500815906456514,2.32862520032109e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDC,Nuclear migration protein nudC,29786,0.101115804779785,0.0044718335834702,0.0923510109561835,0.109880598603387,2.93720036555928e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRY2,Protein sprouty homolog 2,28931,0.147504006218421,0.00652501260274717,0.134714981517037,0.160293030919806,3.55978009809326e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA4D,Semaphorin-4D,29694,0.0478225679790257,0.00211575193847042,0.0436756941796237,0.0519694417784277,3.58122005123905e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL4,C-C motif chemokine 4,29498,0.104053740654203,0.00460969084581814,0.0950187465963992,0.113088734712006,7.12604733675282e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0616913379208486,0.00273378415287174,0.05633312098122,0.0670495548604772,8.19216864949129e-112
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSNL1,Visinin-like protein 1,24845,0.0608950900269058,0.00269778241213348,0.0556074364991242,0.0661827435546875,1.08029310903628e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH9,Protocadherin-9,24805,0.0539918504459543,0.00239254001317304,0.0493024720201352,0.0586812288717735,1.22608272337122e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.115280869874785,0.00510912979945533,0.105266975467853,0.125294764281718,1.39904940904942e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0973390329965207,0.00432040948428431,0.0888710304073234,0.105807035585718,1.83381971216956e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.125955851096877,0.00559252715164814,0.114994497879646,0.136917204314107,3.26819314070355e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53,Cellular tumor antigen p53,28797,0.0694442896050924,0.00308665696014625,0.0633944419632058,0.0754941372469791,3.93174325316489e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,23906,0.0848549476043563,0.00377158811930622,0.0774626348905161,0.0922472603181965,6.10716537326026e-111
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.152294337751337,0.00678407788454724,0.138997545097625,0.16559113040505,1.12021120513249e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLG4,Disks large homolog 4,24845,0.112566260553054,0.00501224013328727,0.102742269891811,0.122390251214297,1.34317491987343e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN2L,Ataxin-2-like protein,24867,0.0763521959385913,0.00340045272359029,0.0696873086003543,0.0830170832768282,1.48772038534668e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESM1,Endothelial cell-specific molecule 1,29454,-0.0542829218217442,0.00242075160497047,-0.0590275949674863,-0.0495382486760021,1.93500988863488e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESYT2,Extended synaptotagmin-2,24845,0.130456087876918,0.00581331100668315,0.119061998303819,0.141850177450017,1.96888895525112e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,29518,0.0563464582245771,0.00251525567275286,0.0514165571059815,0.0612763593431727,3.13882605850766e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0922159348633131,0.00411874361230454,0.0841431973831962,0.10028867234343,4.38152157077836e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM17,Splicing factor 45,24867,0.121048626567391,0.00540294671337412,0.110458851009178,0.131638402125604,4.41204025407876e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0614864934057093,0.00274638620567083,0.0561035764425945,0.0668694103688241,6.59595669066001e-110
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPP,Lipoma-preferred partner,24111,0.105110213476547,0.00470258502757843,0.0958931468224931,0.114327280130601,1.51431688587874e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.0517250017017743,0.00231663736533417,0.0471843924657193,0.0562656109378293,1.60684258187975e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UROD,Uroporphyrinogen decarboxylase,24381,0.109238619670306,0.00488901661790827,0.099656147099206,0.118821092241406,1.75124557784428e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRADD,Death domain-containing protein CRADD,29163,0.119427112238054,0.00535028063205371,0.108940562199229,0.12991366227688,1.8852298255453e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0852471160388233,0.00381938052252068,0.0777611302146828,0.0927331018629638,1.94557689354357e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,24396,0.102616204884354,0.00459496400679298,0.0936100754310401,0.111622334337669,2.24330627489333e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.121452266013512,0.00544899880257608,0.110772228360463,0.132132303666561,3.7951710446742e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OCLN,Occludin,24867,0.0692110651468349,0.00310319172278496,0.0631288093701764,0.0752933209234935,4.05268751095285e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.135982795031659,0.00610880766406162,0.124009532010098,0.147956058053219,7.5872667652218e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUB1,NEDD8 ultimate buster 1,29434,0.131630540761168,0.00591509827827673,0.120036948135746,0.143224133386591,8.29478573998183e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD207,C-type lectin domain family 4 member K,28835,0.0607478732619575,0.00273019428295027,0.055396692467375,0.0660990540565401,9.22908723186427e-109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0908340425255627,0.0040883855300068,0.0828208068867493,0.098847278164376,2.80675289918863e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRAP2,GRB2-related adapter protein 2,29478,0.200328389148996,0.00902706608915347,0.182635339614256,0.218021438683737,3.16903185920491e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,29786,0.105499533079764,0.00475742366293437,0.0961749827004123,0.114824083459115,4.4228611138814e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0690315749333205,0.00311303960883948,0.0629300172999951,0.0751331325666459,4.67839782455131e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.13377109807368,0.00602855312441682,0.121955133949823,0.145587062197537,5.08967413116417e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXJ3,Forkhead box protein J3,24229,0.0695407646217978,0.00313582699233944,0.0633945437168125,0.0756869855267831,6.91593088669161e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK10,Kallikrein-10,29466,0.0625787849247973,0.00282578743452406,0.0570402415531302,0.0681173282964645,8.7338782862064e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEXN,Nexilin,24951,0.107858248587195,0.0048676093868313,0.0983177341890054,0.117398762985384,9.50646866499825e-108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.119392217204104,0.00539351692107866,0.108820924038789,0.129963510369418,1.12241246722688e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0689735967372138,0.00311391736300396,0.0628703187057261,0.0750768747687016,1.19673873391715e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRAS,Ras-related protein R-Ras,24195,0.204355938036214,0.00924387579203087,0.186237941483833,0.222473934588594,3.1144091584292e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPB1,Carboxypeptidase B,29820,0.0920035562178012,0.00417096447959106,0.0838284658378027,0.1001786465978,5.74077283433493e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMOT,Angiomotin,24381,0.062851834123732,0.00284822918767536,0.0572693049158883,0.0684343633315758,7.31201122939495e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0892690765756816,0.0040499354485171,0.081331203096588,0.0972069500547751,8.33463331521284e-107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0690939788631937,0.00313346500274872,0.0629523874578062,0.0752355702685812,1.01429732445836e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RFC4,Replication factor C subunit 4,24793,0.0331386046604934,0.00150343215165883,0.0301918776432421,0.0360853316777447,1.20876065997826e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0973551132701712,0.00441962633007885,0.0886926456632166,0.106017580877126,1.62777997697405e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F2,Prothrombin,24966,0.0230446018899376,0.00104682077897932,0.0209928331631381,0.025096370616737,2.18433694655328e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,24381,0.195237696197713,0.00887536081500602,0.177841989000301,0.212633403395125,3.27496114710849e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0823735247100201,0.00374508554544379,0.0750331570409503,0.08971389237909,3.32933458089179e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHRL,Appetite-regulating hormone,29478,0.125191910770005,0.00570541442673372,0.114009298493607,0.136374523046403,7.18300203155878e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.0874183054078781,0.0039843592934361,0.0796089611927434,0.0952276496230129,7.61101972729156e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0887781499945577,0.00404644842035745,0.0808471110906571,0.0967091888984583,8.00208436984594e-106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF19,Fibroblast growth factor 19,29581,0.119330475614865,0.00544502680474976,0.108658223077555,0.130002728152174,1.28337133580847e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YWHAQ,14-3-3 protein theta,24381,0.114542347253884,0.00522374032643305,0.104303816214075,0.124780878293693,1.49800469937154e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0442959678340493,0.00202391287398089,0.0403290986010468,0.0482628370670519,2.37949656554662e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MGLL,Monoglyceride lipase,29536,0.133883474825478,0.00612757172286576,0.121873434248661,0.145893515402294,5.36395397310347e-105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD226,CD226 antigen,24229,0.0650484201714345,0.00298037226798392,0.059206890526186,0.070889949816683,1.35201908793396e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIFBP,KIF-binding protein,29349,0.126576930881061,0.00581905320724139,0.115171586594868,0.137982275167254,4.38782647801548e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PF4,Platelet factor 4,24822,0.149523568599652,0.0068730257856642,0.13605243805975,0.162994699139554,5.79347482851604e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD72,B-cell differentiation antigen CD72,24381,0.0658750322037111,0.00302818892753227,0.0599397819057479,0.0718102825016744,6.18564307010913e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0554299402328388,0.00255019687781305,0.0504315543523253,0.0604283261133524,6.21268354941747e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPARC,SPARC,29566,0.10799348868053,0.00496893134945238,0.0982543832356033,0.117732594125457,6.42249777698584e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD69,Early activation antigen CD69,29344,0.134660837115787,0.0061975391128778,0.122513660454547,0.146808013777028,7.34882262799681e-104
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,29820,0.110043738152187,0.0050731892211159,0.1001002872788,0.119987189025574,1.57139676169351e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIP,Gastric inhibitory polypeptide,24240,0.0785545947803865,0.00361912299844345,0.0714611137034374,0.0856480758573357,1.76644072373183e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0729610825347326,0.00336322356610771,0.0663691643451614,0.0795530007243037,2.1291455238234e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CETN2,Centrin-2,28774,0.103445572984061,0.00477297093111673,0.0940905499590721,0.11280059600905,2.46904180388684e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDT,D-dopachrome decarboxylase,24938,0.0626136346373775,0.00288746841071346,0.0569541965523791,0.0682730727223759,2.58622780131212e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0821311978252342,0.00378777494443897,0.0747071589341338,0.0895552367163346,2.79914030025286e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0935145820403094,0.00431764663916233,0.0850519946275512,0.101977169453068,3.22732095069028e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOF,Apolipoprotein F,24951,-0.0383282301708776,0.00176839637565188,-0.0417942870671553,-0.0348621732746,3.23906176416561e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APPL2,DCC-interacting protein 13-beta,24381,0.171759261888632,0.0079249011923719,0.156226455551583,0.187292068225681,3.4542981075491e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP10,Caspase-10,28774,0.109434280442213,0.00505352455113091,0.0995293723219969,0.11933918856243,3.63941888860027e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0758671132421709,0.00350100454638643,0.0690051443312536,0.0827290821530883,3.68171391559803e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2,Microtubule-associated protein 2,24845,0.0707950496305518,0.00326827140805812,0.0643892376707579,0.0772008615903457,4.28444516332171e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.149462742017607,0.00690043809563191,0.135937883350169,0.162987600685046,4.41614835182267e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGF,Pro-epidermal growth factor,29379,0.157779868912132,0.00729608080615465,0.143479550532069,0.172080187292195,6.60710433825341e-103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNMT,Histamine N-methyltransferase,29082,0.0719140806150417,0.00332905224591858,0.0653891382130413,0.0784390230170421,1.10675924808733e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM2,Paralemmin-2,24845,0.0577401590539949,0.00267824459916135,0.0524907996396387,0.0629895184683511,3.77400386382277e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK24,Serine/threonine-protein kinase 24,28774,0.0942213097280096,0.00437510052519682,0.0856461126986239,0.102796506757395,4.61133831519514e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0994609237328512,0.00462304076634447,0.0903997638308161,0.108522083634886,6.89537841366912e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNM3,Dynamin-3,24867,0.0835397504435075,0.00388080625357174,0.0759333701865069,0.0911461307005082,7.51146350484199e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATOX1,Copper transport protein ATOX1,29566,0.108481336246572,0.00504512538296687,0.0985928904959567,0.118369781997187,8.95825931285381e-102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.116576817371974,0.00541872781588448,0.105956110852841,0.127197523891108,1.03812859735718e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED8,Protein TMED8,24805,0.156423452886981,0.00727292256495902,0.142168524659662,0.170678381114301,1.12287554962757e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.101152725331793,0.0047054608434937,0.0919300220785454,0.110375428585041,1.45464346794713e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINE2,Glia-derived nexin,24922,0.0978620856302475,0.00455466216301451,0.088934947790739,0.106789223469756,1.75236004812787e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0456498583197447,0.00212671045509933,0.04148150582775,0.0498182108117394,2.02366320588647e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0934687582623721,0.00436248087881441,0.0849182957398958,0.102019220784848,6.29048907706226e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA1,Carboxypeptidase A1,29820,0.0920158281981444,0.00429797091794575,0.0835918051989707,0.100439851197318,6.33261266254134e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.148665292843545,0.00694812034908151,0.135046976959345,0.162283608727745,8.79809670550817e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6AP2,Renin receptor,28797,0.0614215613518423,0.00287094179400477,0.055794515435593,0.0670486072680917,9.22716078409975e-101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.128960913716432,0.00602985797979236,0.117142392076039,0.140779435356825,1.42316027176616e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0826537060904388,0.00386783499441343,0.0750727495013885,0.0902346626794891,1.54143366648367e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,24805,0.0883199289519027,0.00413095015819571,0.0802232666418391,0.0964165912619663,1.65769913270006e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPBP,Platelet basic protein,24816,0.12777585330068,0.005980346283461,0.116054374585097,0.139497332016264,2.22743500463083e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MENT,Protein MENT,24381,-0.034248397171353,0.00160402988547993,-0.0373922957468937,-0.0311044985958124,3.13333616963802e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLG,Plasminogen,24421,0.0334314375680585,0.00156724206738626,0.0303596431159815,0.0365032320201356,4.76112898686451e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP5,Microfibrillar-associated protein 5,29820,0.0614514336260578,0.00288716444065974,0.0557925913223647,0.0671102759297509,8.77876255179062e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0703650183033347,0.00330637895936859,0.0638845155429723,0.0768455210636972,9.37003805039162e-100
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0689195468615416,0.00324049596598219,-0.0752709189548667,-0.0625681747682165,1.24116502754821e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD244,Natural killer cell receptor 2B4,29786,0.0406859351541674,0.0019130944549349,0.036936270022495,0.0444356002858398,1.26427030690006e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPI,Glucose-6-phosphate isomerase,24951,0.0711082877578164,0.00334209044009147,0.0645577904952372,0.0776587850203957,1.43710937809885e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.140499304122372,0.00660610477599077,0.12755133876143,0.153447269483314,1.72837437956357e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0863651467248222,0.00406866020189917,0.0783905727290999,0.0943397207205446,3.03263953091668e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.127404765594599,0.0060049241776127,0.115635114206478,0.13917441698272,3.85072907078775e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RILP,Rab-interacting lysosomal protein,29632,0.0890634451134379,0.00420275739125498,0.0808260406265782,0.0973008496002977,6.19486656574462e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.101159484651144,0.00477613005895024,0.0917982697356018,0.110520699566687,7.94020941963774e-99
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0688388876033466,0.00325108695061601,0.0624667571801392,0.075211018026554,1.2959436034213e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0567474572958716,0.00268505838777197,0.0514847428558385,0.0620101717359047,2.82393198008815e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL8,C-C motif chemokine 8,29683,0.0902406026670245,0.00427688891194546,0.0818579003996114,0.0986233049344376,4.22362036609434e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCB,Tubulin-folding cofactor B,29218,0.149870501311642,0.0071053444819162,0.135944026127086,0.163796976496197,5.01048727185309e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.11011017764795,0.00522477416912872,0.0998696202764581,0.120350735019443,7.47943023673924e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMPER,BMP-binding endothelial regulator protein,24381,0.0340762825573252,0.00161591315241195,0.0309090927785978,0.0372434723360526,7.68761425361134e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTF1,Cardiotrophin-1,28916,0.125828771118268,0.0059725644754207,0.114122544746444,0.137534997490093,8.55043008804998e-98
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,24381,0.177242012242587,0.00841073102356622,0.160756979436397,0.193727045048777,1.04128416808888e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0525003081832636,0.00249245320276274,0.0476150999058486,0.0573855164606786,1.22973956915745e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX4,Syntaxin-4,29349,0.0882293107957328,0.00419317405169287,0.0800106896544147,0.0964479319370508,1.45065835674462e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPSE,Heparanase,24688,0.139872857994078,0.00664548658539756,0.126847704286699,0.152898011701457,1.72449538861711e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPT1,Angiopoietin-1,29322,0.125004069484905,0.00595055633376458,0.113340979070726,0.136667159899083,2.94587267370867e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0762393866113551,0.00363051902681662,0.0691235693187945,0.0833552039039157,4.64037240318116e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMT,Catechol O-methyltransferase,28591,0.125058868284828,0.00595886243310891,0.113379497915935,0.136738238653721,4.65765218825849e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACYBP,Calcyclin-binding protein,24329,0.15287909381471,0.00728088724594306,0.138608554812661,0.167149632816758,5.04490763275206e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JAM3,Junctional adhesion molecule C,24381,0.0752159665078039,0.00358430769391779,0.068190723427725,0.0822412095878828,6.507304576476e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TADA3,Transcriptional adapter 3,24793,0.0587603875718356,0.0028003846250544,0.0532716337067289,0.0642491414369422,6.54173238224735e-97
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKD2,Polycystin-2,24111,0.0875597027954744,0.00417777545368464,0.0793712629062525,0.0957481426846963,1.14571166756769e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,24195,0.118855830623739,0.00567515164283833,0.107732533403776,0.129979127843702,1.55856422032891e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EHD3,EH domain-containing protein 3,24240,0.174098402423677,0.00831329639334633,0.157804341492718,0.190392463354636,1.58647758987001e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMG3,Proteasome assembly chaperone 3,29434,0.0745899210189044,0.00356465859239025,0.0676031901778195,0.0815766518599892,1.60822548262271e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCG2,Secretogranin-2,29559,0.0482353303875592,0.00230676839279021,0.0437140643376904,0.052756596437428,2.15500006690065e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP7,Caspase-7,24845,0.124348027835939,0.00594299345356799,0.112699760666946,0.135996295004932,2.22442726328322e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARK7,Parkinson disease protein 7,29443,0.0771553006286121,0.00369196670819285,0.0699190458805541,0.08439155537667,2.78921374346469e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0886546712067434,0.0042422911789517,0.0803397804959981,0.0969695619174887,2.9106221892852e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MIF,Macrophage migration inhibitory factor,29386,0.100408759195101,0.00480915694589906,0.090982811581139,0.109834706809063,4.18308465403428e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FIS1,Mitochondrial fission 1 protein,29453,0.113739533274917,0.00545151699628756,0.103054559962194,0.124424506587641,5.65827543180073e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSC22D1,TSC22 domain family protein 1,24867,0.0984017772572083,0.00471509097253029,0.0891601989510489,0.107643355563368,6.73816572316472e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F12,Coagulation factor XII,24966,0.0613184761471907,0.0029401302360451,0.0555558208845423,0.067081131409839,8.88859538132191e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,24793,0.081341514195053,0.00390097100627421,0.0736956110227556,0.0889874173673505,9.79477135829597e-96
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX8,Syntaxin-8,29434,0.0712272203279966,0.00341959926481075,0.0645248057689675,0.0779296348870257,1.1576754604236e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.153542560218067,0.00736752354770428,0.139102214064566,0.167982906371567,1.27097928849459e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0906813464031318,0.00435115803991638,0.0821530766448957,0.0992096161613679,1.27771394234007e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0934228274835149,0.00449155057762245,0.0846193883513748,0.102226266615655,2.93231705074842e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.143135273639252,0.00688215480685297,0.129646250217821,0.156624297060684,3.06662470598444e-95
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0587142690366214,0.00283463590286249,0.0531583826670109,0.0642701554062319,1.65999400900036e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,24951,0.106365775253103,0.00513578714066531,0.0962996324573985,0.116431918048807,1.73272986567354e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTNB,Dystrobrevin beta,24752,0.0636994634700217,0.00307613865991392,0.0576702316965904,0.069728695243453,1.87299002618673e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPI,Mannose-6-phosphate isomerase,29349,0.12508899623809,0.0060454866965528,0.113239842312846,0.136938150163333,1.96296013292793e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0767846784799539,0.00371103897998084,0.0695110420791914,0.0840583148807163,2.73958259357142e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LACTB2,Endoribonuclease LACTB2,29478,0.0962884721875661,0.00466303712005868,0.0871489194322511,0.105428024942881,4.59708566728819e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0475613588003245,0.00230357204252328,0.0430463575969788,0.0520763600036701,4.87188986485529e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATG4A,Cysteine protease ATG4A,28797,0.0859176490905491,0.00416733307021485,0.077749676272928,0.0940856219081702,9.21656980173755e-94
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THTPA,Thiamine-triphosphatase,24755,0.128513652931834,0.00623925515361938,0.11628471283074,0.140742593032928,1.75666361594821e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL32,Interleukin-32,29434,-0.0634304549504314,0.00308275411814775,-0.069472653022001,-0.0573882568788618,2.0544782695671e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIAPIN1,Anamorsin,29566,0.0911545400457604,0.00443066412034629,0.0824704383698817,0.0998386417216391,2.1403301309428e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2,Complement C2,29545,0.033920180772039,0.00165164533816123,0.030682955909243,0.037157405634835,4.48398357018762e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.150298133378325,0.00731591943440665,0.135958931286888,0.164637335469762,5.1897145231009e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.144270790563703,0.00702868489898592,0.130494568161691,0.158047012965715,7.86194847331155e-93
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL18,C-C motif chemokine 18,29166,0.101903800015485,0.00497202920501566,0.0921586227736539,0.111648977257315,1.06655177060161e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,24904,0.0695708921124562,0.00339354285078424,0.0629195481249191,0.0762222360999933,1.23042789500515e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,28797,0.0656769619775573,0.00320685638946894,0.0593915234541981,0.0719624005009164,1.48013603549637e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0821548240911143,0.00401338336914055,0.0742885926875988,0.0900210554946297,1.72986409652242e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,29354,0.129064445392011,0.0063080457370889,0.116700675747317,0.141428215036705,2.15048904727536e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERMAP,Erythroid membrane-associated protein,24229,0.064779738061916,0.00316397956274403,0.0585783381189377,0.0709811380048943,2.22001831728685e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASSF2,Ras association domain-containing protein 2,28797,0.0809297186443009,0.00395591494403027,0.0731761253540015,0.0886833119346002,2.32207497221531e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0481111939433428,0.00235280561029172,0.043499694947171,0.0527226929395145,2.73349469150362e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.060910272746801,0.00297790334490058,0.0550735821907959,0.0667469633028062,3.19459619155066e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.131284453377666,0.00642180526262848,0.118697715062914,0.143871191692418,4.11308687458792e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB6,Serpin B6,29623,0.0854524686308059,0.00418602152501632,0.0772478664417739,0.0936570708198379,5.43096406056633e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.12953061009879,0.00634232125994222,0.117099660429303,0.141961559768277,5.89626938254632e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,24805,0.120289559022642,0.00588993814310132,0.108745280262164,0.131833837783121,5.98360317433688e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,29581,0.041939931767378,0.00205525797494717,0.0379116261364815,0.0459682373982744,6.34429240030973e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0908581272670209,0.00445325922992421,0.0821297391763695,0.0995865153576724,6.78151880429321e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.136939044114494,0.00671417766374179,0.12377925589356,0.150098832335428,7.9097169630199e-92
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0926709047342437,0.00454557426266289,0.0837615791794245,0.101580230289063,1.23016618674987e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRG1,Scrapie-responsive protein 1,24922,0.0396583717649362,0.00194746758835956,0.0358413352917515,0.043475408238121,1.93663362197965e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WDR46,WD repeat-containing protein 46,24793,0.0519246251757847,0.00255078235084427,0.04692509176813,0.0569241585834395,2.28131384060803e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0498829917989393,0.00245376793342372,0.0450736066494288,0.0546923769484498,2.97532854030313e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0547535903074693,0.00269332131621974,0.0494746805276787,0.06003250008726,3.00999422522711e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0900827382493395,0.00443175228057231,0.0813965037794177,0.0987689727192612,3.12251933682661e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMVK,Phosphomevalonate kinase,28757,0.157744106510197,0.00776337364836706,0.142527894159397,0.172960318860996,3.81888101802182e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK13,Kallikrein-13,28845,0.0633877509096718,0.00312045655050265,0.0572716560706866,0.069503845748657,4.23732397537039e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BIN2,Bridging integrator 2,29443,0.129138146824088,0.0063669509741198,0.116658922914813,0.141617370733363,7.66932741799319e-91
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.127072030700312,0.0062664709241532,0.114789747688972,0.139354313711652,1.08477689322451e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG6,Large proline-rich protein BAG6,28916,0.0521996344348165,0.00257572608918598,0.047151211300012,0.0572480575696211,1.09727313008313e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0467735934122588,0.00230884035400262,0.0422482663184136,0.0512989205061039,1.2257676679267e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.160194571976885,0.00790775677145815,0.144695368704827,0.175693775248943,1.24957380993925e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPB1,Heat shock protein beta-1,29039,0.0985608889566856,0.00486625428843329,0.0890230305513563,0.108098747362015,1.38781625905707e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.105294070320013,0.00520116009061306,0.095099796542411,0.115488344097614,2.23048800247504e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL2,C-C motif chemokine 2,29169,0.0748920925496627,0.00371325485114373,0.067614113041421,0.0821700720579044,7.55129825112935e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.097664958240202,0.00484063820045607,0.0881773073673081,0.107152609113096,8.77459123712541e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0952563111118345,0.00472132014350624,0.0860025236305623,0.104510098593107,8.82203506131807e-90
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.067480458877547,0.00334689607111192,0.0609205425781676,0.0740403751769263,1.10002914012109e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.159408855142697,0.00791738463052386,0.14389078126687,0.174926929018524,1.54038822893494e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0921591401996288,0.00457623953014641,0.0831897107205418,0.101128569678716,1.76145999129339e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",29395,0.15579452129529,0.00774475827818198,0.140614795070053,0.170974247520526,2.13520087251181e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA4,Protein disulfide-isomerase A4,24938,0.086524679167916,0.0043026149138498,0.0780915539367704,0.0949578043990617,3.0947960000455e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0663464185320348,0.0033039272263763,0.0598707211683373,0.0728221158957324,5.50087284508766e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F11,Coagulation factor XI,24606,0.0440793675494285,0.00219519151679861,0.0397767921765032,0.0483819429223537,5.71217242031201e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APP,Amyloid-beta precursor protein,29395,0.0944978728273605,0.00470969291454486,0.0852668747148526,0.103728870939868,5.94868955952429e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.108311937388603,0.00540005008103604,0.0977278392297721,0.118896035547433,6.78673184864516e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0682499981694294,0.00340170428130789,0.061582657778066,0.0749173385607929,8.11385346977008e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.130777528827143,0.00652133169061125,0.117995718713545,0.143559338940741,9.82309617517829e-89
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0580327320835569,0.00289661445978971,0.0523553677423691,0.0637100964247448,1.08889469803387e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CERT,Ceramide transfer protein,28774,0.0870728538886644,0.00434612601846596,0.0785544468924711,0.0955912608848577,1.10943503417007e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MESD,LRP chaperone MESD,29443,0.171871000043768,0.00858457377093803,0.155045235452729,0.188696764634806,1.40967167493551e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP2,Caspase-2,29434,0.096157717703711,0.00480364707874339,0.086742569429374,0.105572865978048,1.50440489517484e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL7,Interleukin-7,29434,0.091182599425781,0.00456012691929329,0.0822447506639661,0.100120448187596,2.3259426365714e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REEP4,Receptor expression-enhancing protein 4,24867,0.088043194777136,0.00440067546237379,0.0794178708708834,0.0966685186833886,2.3886425869615e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.104122461926506,0.00520995907039996,0.0939109421485222,0.11433398170449,3.63580712296148e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM106A,Transmembrane protein 106A,24793,0.0999855616527812,0.00500828452828387,0.0901693239773448,0.109801799328218,5.57128061238415e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARA5,Scavenger receptor class A member 5,29694,0.0424814738825886,0.00212955174567487,0.0383075524610659,0.0466553953041114,5.82651883997487e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0853397396886313,0.00427505735683301,0.0769606272692386,0.093718852108024,5.92699330723786e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFB2,BPI fold-containing family B member 2,24852,0.0917234370902568,0.00459579519077012,0.0827156785163474,0.100731195664166,6.23594064446337e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.103973347618113,0.00521222297093941,0.0937573905950716,0.114189304641154,7.81461325196069e-88
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.140719235417443,0.0070745020177064,0.126853211462738,0.154585259372147,1.83051756272809e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB33A,Ras-related protein Rab-33A,24111,0.093719857871612,0.00470889052386534,0.0844904324448359,0.102949283298388,1.94351039236541e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSS,Cathepsin S,23389,0.0344441179641594,0.00173116256957003,0.0310510393278022,0.0378371966005167,2.30713881614145e-87
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOXO3,Forkhead box protein O3,28797,0.135206029406344,0.00682884715844052,0.121821488975801,0.148590569836887,1.14198507812951e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.1317700291063,0.00666335462892335,0.11870985403361,0.14483020417899,1.7895527450595e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L1,Bcl-2-like protein 1,24845,0.139596670359398,0.00705506517108778,0.125768742624066,0.15342459809473,1.79801404917869e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.105014678824244,0.0053155799942174,0.0945961420355783,0.11543321561291,3.25893865956435e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.09135685918916,0.0046280926239669,0.0822857976461849,0.100427920732135,3.66353770246141e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POSTN,Periostin,24938,-0.0529959426037785,0.0026859565766365,-0.058260417493986,-0.047731467713571,5.32701695807344e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEMIP2,Cell surface hyaluronidase,24229,0.0462993515956819,0.00234736461105193,0.0416985169580201,0.0509001862333437,6.35085809488741e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL16,C-X-C motif chemokine 16,29786,0.032851876037078,0.0016675031716403,0.029583569820663,0.036120182253493,7.42260573882896e-86
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0399988909416532,0.00203206261912401,0.0360160482081701,0.0439817336751362,1.05612639785096e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBI,Acyl-CoA-binding protein,29329,0.109144576408553,0.00554851191487969,0.0982694930553887,0.120019659761717,1.36497139383276e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0524310909049067,0.00266780706755122,0.0472021890525063,0.0576599927573071,1.96137296781289e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.131284424508882,0.00668624092493804,0.118179392296003,0.14438945672176,3.4526571346101e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0740121487766727,0.00377205997346299,0.0666189112286853,0.0814053863246602,4.502853561877e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCA,Calcitonin,29163,0.0861392164955106,0.00439815362423615,0.0775188353920077,0.0947595975990134,7.25599804011666e-85
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D5,TBC1 domain family member 5,29434,0.108135055997744,0.00552947540403267,0.0972972842058398,0.118972827789648,1.26277878408332e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0845157473196346,0.00432741957553192,0.076034004951592,0.0929974896876771,2.08110201826585e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0875893019335246,0.00448556573251043,0.0787975930978041,0.096381010769245,2.21683192224305e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LARP1,La-related protein 1,24793,0.0869471843209632,0.00445053307312336,0.0782241394976414,0.095670229144285,2.3264745851281e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP3R1,Calcineurin subunit B type 1,29218,0.0565678802293159,0.00289766050305474,0.0508884656433286,0.0622472948153032,2.46880981803035e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0442624002608276,0.00226809081356932,0.0398169422662317,0.0487078582554234,2.77680190001863e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYO9B,Unconventional myosin-IXb,28931,0.0912896451403445,0.00467783004558171,0.0821210982510043,0.100458192029685,2.83511082037074e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUGT1,Protein SGT1 homolog,28797,0.111410013886829,0.00571233713286449,0.100213833106415,0.122606194667244,3.59348123669124e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.129794159400091,0.00666037919834207,0.11673981617134,0.142848502628841,4.77108744015459e-84
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F2R,Proteinase-activated receptor 1,29536,0.0789001310368427,0.00405838634139121,0.070945693807716,0.0868545682659695,1.15416429870536e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFASC,Neurofascin,29786,0.0390073088058952,0.0020066116941486,0.0350743498853639,0.0429402677264265,1.18441796401101e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0928743331813377,0.00478150410440662,0.0835025851367008,0.102246081225975,1.66926928098611e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12A_IL12B,Interleukin-12,29349,0.106621036857426,0.00549517575341683,0.0958504923807291,0.117391581334123,2.44250247460407e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,24805,0.120426029142473,0.00620993481973011,0.108254556895802,0.132597501389144,3.69352432877333e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIF1,Allograft inflammatory factor 1,28797,0.0720414649097546,0.00371799497494385,0.0647541947588646,0.0793287350606445,4.13435076734457e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGXT,Serine--pyruvate aminotransferase,29478,0.10569205523403,0.00545651661854546,0.0949972826616812,0.116386827806379,4.55866472294474e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0670864786712404,0.00346485445102469,0.060295363947232,0.0738775933952488,6.84351274244948e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GMFG,Glia maturation factor gamma,24922,0.0984115248845163,0.00508404665891954,0.088446793433034,0.108376256335999,7.2451907702081e-83
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB9,Serpin B9,29218,0.0453724974683118,0.00234975348778534,0.0407669806322525,0.0499780143043711,1.46444399268798e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA3,Annexin A3,29640,0.0951796054307715,0.00493254253059666,0.0855118220708021,0.104847388790741,1.85392566302197e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.134090070964622,0.00694602108706424,0.120475869633976,0.147704272295268,1.96842636076713e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0791373031444018,0.00410537271139634,0.071090772630065,0.0871838336587386,2.79533421788016e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0574976568314848,0.00298548859541064,0.05164609918448,0.0633492144784897,4.83076062596201e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MICALL2,MICAL-like protein 2,24195,0.0933235467217696,0.00484562572442011,0.0838261203019061,0.102820973141633,4.85544820473745e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPON2,Spondin-2,29311,-0.047487905575403,0.00246793668634552,-0.0523250614806403,-0.0426507496701658,5.29344910643489e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STXBP1,Syntaxin-binding protein 1,24867,0.105737791548981,0.00549400478169019,0.0949695421768682,0.116506040921094,6.02128878667822e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.139453376761241,0.00724701917004505,0.125249219187953,0.153657534334529,6.62456695980257e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.146887624965425,0.0076383379290838,0.131916482624421,0.161858767306429,8.15090431327671e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0502928961480286,0.00261571220912451,0.0451661002181445,0.0554196920779126,8.84360281961302e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DXO,Decapping and exoribonuclease protein,24845,0.0620595560575593,0.00322823453128623,0.0557322163762382,0.0683868957388803,9.16449576322612e-82
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD164,Sialomucin core protein 24,29443,0.0364193663808888,0.00189674404447078,0.0327017480537261,0.0401369847080516,1.14825420545899e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0545326869566172,0.00283866996266907,0.0489688938297858,0.0600964800834486,1.17580734469556e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGL1,Fibrinogen-like protein 1,24951,-0.0868098562481793,0.00451953550739944,-0.0956681458426822,-0.0779515666536764,1.24164019103034e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACYP1,Acylphosphatase-1,24297,0.0893138102768156,0.00465056594089234,0.0801987010326666,0.0984289195209646,1.35666145959606e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAP3,Cytosol aminopeptidase,28931,0.0658214836905219,0.00344413669577327,0.0590709757668063,0.0725719916142375,6.43736786709729e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,24769,0.118510577933654,0.00619933517579366,0.106359880989098,0.130661274878209,7.02807150417349e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.103305486237382,0.0054069693581633,0.0927078262953824,0.113903146179383,8.58080266467966e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0551653019229038,0.00288953092106492,0.0495018213176166,0.0608287825281911,9.11911689074112e-81
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRB1,Chymotrypsinogen B,29443,0.075200951330941,0.00394178521256699,0.0674750523143097,0.0829268503475724,1.18420487738209e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYBB1,Beta-crystallin B1,24922,0.0883546127661706,0.00462878882838897,0.0792821866625283,0.097427038869813,1.19601281049033e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBCA,Tubulin-specific chaperone A,24381,0.115818473226161,0.00607080190921124,0.103919701484107,0.127717244968215,1.48999199768778e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP3,Caspase-3,29820,0.118589280294219,0.00622786942016386,0.106382656230697,0.13079590435774,2.31214817091807e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.123696789401411,0.00649606144789198,0.110964508963543,0.136429069839279,2.34089288104281e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.117778577220118,0.00618379223796255,0.105658344433711,0.129898810006525,2.70269778885463e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMSB10,Thymosin beta-10,29443,0.102037966650167,0.00537275790257673,0.0915073611611166,0.112568572139217,6.01132862094984e-80
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARB2,Lysosome membrane protein 2,28762,0.0427392653837879,0.00225355844963371,0.0383222908225059,0.04715623994507,1.01505153867031e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,29173,0.0381508925674242,0.00201190462345831,0.0342075595054459,0.0420942256294025,1.05044844073471e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GET3,ATPase GET3,24922,0.0740826541218147,0.00390695428079613,0.0664250237314543,0.0817402845121751,1.28629074757756e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0407986108266008,0.00215171813683332,0.0365812432784075,0.0450159783747941,1.32064436193195e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.109698934011499,0.00579004131111126,0.0983504530417205,0.121047414981277,1.41636813110336e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFB,Complement factor B,24538,0.0441254013936544,0.00232789715394447,0.0395627229719232,0.0486880798153855,1.48766361748952e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSTN,Growth/differentiation factor 8,28916,0.0705896860173936,0.00372661905293866,0.0632855126736338,0.0778938593611534,1.56025845668856e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTF2,Transcription termination factor 2,24195,0.0658430149288016,0.00348074357647859,0.0590207575189036,0.0726652723386996,3.12489854299786e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDCP1,CUB domain-containing protein 1,29218,0.0696768891587817,0.00368654027022977,0.0624512702291313,0.076902508088432,3.36877553057896e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0645796014360127,0.00341876828535056,0.0578788155967256,0.0712803872752998,4.17034299102685e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KITLG,Kit ligand,29478,-0.0498872635447563,0.00264165036568157,-0.0550648982614921,-0.0447096288280204,4.45679092962959e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARF1,Scavenger receptor class F member 1,29820,0.0566399762418867,0.00300091276577615,0.0507581872209655,0.062521765262808,5.37172583982542e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0731244926153163,0.00387286507541475,0.0655336770675034,0.0807153081631292,6.00732800910924e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NBN,Nibrin,28931,0.0701283376042651,0.00371782218342297,0.0628414061247561,0.0774152690837742,6.87941834946954e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTD,Deoxycytidylate deaminase,24381,0.126962896118754,0.0067288751387461,0.113774300846812,0.140151491390697,7.5806354970639e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLMH,Bleomycin hydrolase,29820,0.0424392514485539,0.00225248000167856,0.038024390645264,0.0468541122518439,9.97627838210228e-79
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.132731924541541,0.00704342609594345,0.118926809393492,0.14653703968959,1.1472726030189e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0661112960744514,0.00351193348770396,0.0592279064385516,0.0729946857103512,1.7696210854936e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,24240,0.0753153536806049,0.00400623781737971,0.0674631275585406,0.0831675798026691,2.7511268992827e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0407259131633456,0.00216782265879226,0.0364769807521128,0.0449748455745785,2.77558652748964e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP1,Guanylate-binding protein 1,24816,0.0860160424835139,0.00457924126523096,0.0770407296036612,0.0949913553633665,3.57008949359399e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0802372301082341,0.00428622759377202,0.0718362240244409,0.0886382361920272,9.70453687122837e-78
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,29566,0.110724835305154,0.00592034390771071,0.0991209612460411,0.122328709364267,1.32851329836399e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRGN,Neurogranin,24951,0.121027670116205,0.00646939866602489,0.108347648730796,0.133707691501614,1.45602589026518e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.106122988394944,0.00567789684730464,0.094994310574227,0.117251666215661,2.07351114948748e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.167500379106557,0.00896300665451215,0.149932886063713,0.185067872149401,2.10636383313157e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XCL1,Lymphotactin,29725,0.0733118206167631,0.00392966345809858,0.0656096802388899,0.0810139609946363,3.12112646780524e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAP18,Chromatin complexes subunit BAP18,24845,0.0877426781066451,0.00470083965790515,0.078529032377151,0.0969563238361392,3.20381661160732e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RP2,Protein XRP2,29349,0.0552918368516026,0.00296456493785923,0.0494812895733985,0.0611023841298067,3.47398601641258e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PQBP1,Polyglutamine-binding protein 1,28797,0.073632433237226,0.00395052988425589,0.0658893946640845,0.0813754718103676,4.44561915218659e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNRD2,Protein ZNRD2,24805,0.0908165273571885,0.00487155196369652,0.0812682855083433,0.100364769206034,4.91606562548922e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0879904071334732,0.00472275782320152,0.0787338017999982,0.0972470124669482,6.24035717347667e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0807300407946981,0.0043344330731366,0.0722345519713503,0.0892255296180458,6.92269647099757e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSNAX,Translin-associated protein X,24111,0.0519773090280572,0.00279198144912112,0.0465050253877798,0.0574495926683346,8.15164696951241e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0412171612335425,0.00221652023628393,-0.045561540896659,-0.036872781570426,9.60256302211589e-77
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.157210718562898,0.00845794306130898,0.140633150162732,0.173788286963064,1.11389209339176e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL1,Growth-regulated alpha protein,29420,0.125193654083175,0.00674691526542673,0.111969700162939,0.138417608003412,2.00599428580712e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD274,Programmed cell death 1 ligand 1,29218,0.0450174241817048,0.00242621965153298,0.0402620336647001,0.0497728146987094,2.06244770091753e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0498941574064222,0.00269048114420551,0.0446208143637794,0.055167500449065,2.42542292968076e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.141954982772266,0.00765517072064721,0.126950848159798,0.156959117384735,3.1933375248119e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.100334043649698,0.00541375939951147,0.0897230752266559,0.110945012072741,3.65103899064979e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0374206047879227,0.00202019085099716,0.0334610307199683,0.0413801788558772,4.3496711767021e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEPR,Leptin receptor,29478,-0.0406904601211613,0.00220027413355906,-0.0450029974229371,-0.0363779228193855,6.28896731938756e-76
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0637629889651992,0.00345483287067856,0.0569915165386692,0.0705344613917292,1.48889154660111e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0583052618982682,0.00316973901501309,0.0520925734288426,0.0645179503676939,4.73593033681514e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREH,Trehalase,24938,0.0977131388001548,0.0053127887296221,0.0873000728900955,0.108126204710214,4.77531100526271e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,29694,0.0597598698621399,0.00325337542304797,0.0533832540329659,0.0661364856913139,6.10791121925158e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.144438072400857,0.00786719562327932,0.129018368979229,0.159857775822484,7.3867632287238e-75
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF6,SLAM family member 6,28797,0.0497117450469682,0.00271275270531639,0.0443947497445481,0.0550287403493883,1.38466694705266e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BGLAP,Osteocalcin,24938,0.114734697226927,0.00628462843707225,0.102416825490265,0.127052568963588,5.5899469841289e-74
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0879857073597365,0.00483015747588143,0.0785185987070089,0.0974528160124641,1.20057299576636e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA1,Apolipoprotein A-I,24966,-0.0354657552427981,0.00194854900710764,-0.0392849112967291,-0.0316465991888671,1.51400990548494e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSL,Cathepsin L1,29478,0.0313484575513915,0.00172463062273819,0.0279681815308247,0.0347287335719584,1.98311075114369e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.10266162937168,0.00564813791375391,0.0915912790607225,0.113731979682638,2.38381656680285e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0891629460281247,0.0049113325954134,0.0795367341411145,0.098789157915135,3.63664362953913e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0741310066473928,0.00408597025140936,0.0661225049546305,0.0821395083401552,3.76133088806227e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRD1,Natural killer cells antigen CD94,29786,0.059577241824607,0.00328682700012216,0.0531350609043676,0.0660194227448464,4.90738710321665e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL11,C-X-C motif chemokine 11,29694,0.101148850815525,0.00558025784002151,0.0902115454490833,0.112086156181968,4.90949645263813e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0719576739789441,0.00397403740403773,0.0641685606670302,0.0797467872908581,8.49482712271268e-73
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0909483670391484,0.00502603165522895,0.0810973449948997,0.100799389083397,1.01218471982617e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPT,Dermatopontin,29820,0.0337590818437534,0.00186754285822777,0.030098697841627,0.0374194658458798,1.18887889678867e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP7,Matrilysin,28870,0.0639983466456716,0.00354022321433045,0.0570595091455839,0.0709371841457593,1.20775582658745e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM1,Intercellular adhesion molecule 1,29391,0.0368843315679255,0.0020432709707678,0.0328795204652206,0.0408891426706304,1.88939618901896e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,24938,0.0421008661120599,0.0023324333992913,0.0375292966494489,0.0466724355746708,2.27391258373213e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS3BP,Galectin-3-binding protein,24966,0.0387986823810356,0.00215273114604397,0.0345793293347894,0.0430180354272818,3.69074889556275e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLNK,B-cell linker protein,24229,0.0510017715307026,0.0028304661443755,0.0454540578877266,0.0565494851736786,4.10239376743455e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",24240,0.111091380193766,0.00617832376210165,0.0989818656200472,0.123200894767486,8.07416904399066e-72
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,29581,0.11127214303273,0.00620128577591527,0.0991176229119356,0.123426663153524,1.29727048852287e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0551299410079903,0.00307253248196835,0.0491077773433323,0.0611521046726482,1.58979570101035e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP5,Platelet glycoprotein V,24381,0.0459798481342316,0.00256580431435878,0.0409508716780884,0.0510088245903748,2.35489302062347e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMMT,MICOS complex subunit MIC60,24793,0.0565199011565523,0.00315581302076047,0.0503345076358618,0.0627052946772429,2.78677454169666e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP170,Centrosomal protein of 170 kDa,24240,0.0980318642306271,0.00547536298604573,0.0873001527779775,0.108763575683277,3.15053027747884e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0402973830127711,0.00225622651729929,-0.0447195869866777,-0.0358751790388644,5.61655279469028e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN9,Septin-9,29349,0.0359341538163482,0.00201250216057829,0.0319896495816148,0.0398786580510816,6.22762921589976e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARSA,Arylsulfatase A,29443,0.0566218265732866,0.00317450071772863,0.0503998051665384,0.0628438479800347,8.69647208622589e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NID1,Nidogen-1,29518,0.0479292375123752,0.00268800889011945,0.0426607400877411,0.0531977349370093,9.59745272651028e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0680209631415742,0.00381488965171289,0.060543779424217,0.0754981468589315,9.86833722175354e-71
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.114502059437618,0.006421836747769,0.101915259411991,0.127088859463246,1.16841873116894e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FEN1,Flap endonuclease 1,28797,0.0795609301988928,0.00446638691334182,0.0708068118487428,0.0883150485490428,1.3358115930706e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABHD14B,Protein ABHD14B,29121,0.0723466469813997,0.00406212187058611,0.064384888115051,0.0803084058477485,1.39998676940608e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.0553296395810007,0.00311157900378238,0.0492309447335873,0.0614283344284142,2.31446691590347e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0378400227767892,0.00213304550748468,0.0336592535821192,0.0420207919714592,4.78168464785573e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.066668813908828,0.00375809925653732,0.0593029393660148,0.0740346884516411,5.70587958791367e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0401339109836787,0.00226339404087747,0.0356976586635588,0.0445701633037985,6.50182486817754e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,28797,0.0497972506549173,0.00280987412825189,0.0442898973635435,0.055304603946291,6.64859496084988e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.054832203888157,0.00309286472005538,0.0487701890368484,0.0608942187394655,6.97330427443681e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMTN,Smoothelin,24776,0.118758080140235,0.00670326901298471,0.105619672874785,0.131896487405685,8.44802568008075e-70
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0450375834932972,0.00254613230115091,0.0400471641830414,0.050028002803553,1.40896305770292e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TST,Thiosulfate sulfurtransferase,28706,0.0947410584246804,0.00536220003398101,0.0842311463580776,0.105250970491283,1.71821133892011e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0522872030083091,0.00295866057928214,0.0464882282729161,0.0580861777437021,1.81718023167182e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLF4,Krueppel-like factor 4,24101,0.0498272784387946,0.002822058181996,0.0442960444020824,0.0553585124755067,2.48744751312968e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3BP1,SH3 domain-binding protein 1,24805,0.0599132684070501,0.0033994588227163,0.0532503291145261,0.066576207699574,4.23040004876826e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0746184212104942,0.00423902464754309,0.0663099329013098,0.0829269095196787,5.40075695064818e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB10,Ras-related protein Rab-10,24922,0.0668586622898855,0.00379696823482919,0.0594166045496203,0.0743007200301507,5.56048470948384e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0567551722181617,0.00322389075273042,0.0504363463428101,0.0630739980935133,6.11139071769274e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0667154407179022,0.00379312644627468,0.0592809128832038,0.0741499685526005,6.81705734313965e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0648061580009826,0.00368740380688948,0.0575788465394792,0.072033469462486,8.60358561755196e-69
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0315132946837432,0.00179486635948961,0.0279953566191436,0.0350312327483429,1.35150136403666e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD83,CD83 antigen,29434,0.0423180257535202,0.00241164425647491,0.0375912030108294,0.047044848496211,1.39369166486816e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.052353791729843,0.00298421991473692,0.0465047206969587,0.0582028627627274,1.48345848451708e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOC1,Apolipoprotein C-I,24914,0.0466040216058944,0.00265582869809261,0.0413985973576329,0.0518094458541559,1.59853220656567e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ING1,Inhibitor of growth protein 1,28719,0.0571232873274074,0.00326130639298209,0.0507311267971625,0.0635154478576523,2.47741742850997e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,24805,0.122046208836165,0.0069672387652677,0.108390420856241,0.13570199681609,2.73489411853906e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0254156461104355,0.00145212011785819,-0.0282618015414375,-0.0225694906794334,3.03397614823259e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCS,Copper chaperone for superoxide dismutase,29218,0.058843758698673,0.00336231092243973,0.0522536292906911,0.0654338881066549,3.14221595691682e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,24922,0.0341861642517481,0.00195423123231573,0.0303558710364093,0.0380164574670869,4.11102495224889e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNA4,Ephrin-A4,29169,0.0380924056737103,0.00218048756265353,0.0338186500509093,0.0423661612965112,5.4187709368191e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3C,Protein FAM3C,29433,0.0371414108057545,0.00212644675105418,0.0329735751736883,0.0413092464378207,5.6927606220677e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.148868271443775,0.0085285400729693,0.132152332900755,0.165584209986795,6.90236796913985e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP6,Platelet glycoprotein VI,29400,0.108728100212993,0.00623578585359691,0.0965059599399427,0.120950240486043,9.62724225922596e-68
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSTB,Cystatin-B,29030,0.0525184608371053,0.00301636454739163,0.0466063863242177,0.0584305353499929,1.49776921116662e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP6,Bone morphogenetic protein 6,28884,0.0509241494529188,0.00292539819227686,0.0451903689960561,0.0566579299097814,1.59979213441133e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BDNF,Brain-derived neurotrophic factor,24938,0.102613236902982,0.00589825837616128,0.0910526504857061,0.114173823320258,2.16813737462124e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC3B,Tetranectin,24381,0.0263743607994827,0.00151946681671787,0.0233962058387157,0.0293525157602497,4.37572335535341e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPPK1,Epiplakin,24240,0.090869037344043,0.00523512656826776,0.0806081892702382,0.101129885417848,4.40527107325994e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNF,Tumor necrosis factor,28868,0.0470090896768498,0.00271219835263925,0.0416931809056769,0.0523249984480227,5.84766057221829e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12B,Interleukin-12 subunit beta,29786,0.0668380650260362,0.0038602784280559,0.0592719193070466,0.0744042107450258,7.80297100795731e-67
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGH,Gamma-glutamyl hydrolase,28984,0.0418199202369662,0.00241763270926268,0.0370813601268114,0.0465584803471211,1.05661126970736e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0390368702881969,0.00225668834408318,0.0346137611337938,0.0434599794425999,1.1919762104693e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0785494601637258,0.00454408436742214,0.0696430548035784,0.0874558655238732,1.30092875299756e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0828071008589105,0.00479112467412931,0.0734164964976171,0.092197705220204,1.58010083973692e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1R,Complement C1r subcomponent,24966,0.0237897230386951,0.00137668180027246,0.0210914267101611,0.0264880193672291,1.61078367151747e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBN1,Drebrin,24229,0.0629431846197986,0.00364397998896386,0.0558009838414294,0.0700853853981677,1.87455945680688e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0860584152709864,0.00498380421395772,0.0762901590116293,0.0958266715303435,2.02234735130751e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDHB,Succinate dehydrogenase,24805,0.0842051307421537,0.00488158652176515,0.074637221159494,0.0937730403248133,2.7512070790145e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCOF1,Treacle protein,24922,0.0382979588090574,0.00222094450077788,0.0339449075875328,0.0426510100305821,3.01232640507533e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.148088718659306,0.00860261296389832,0.131227597250065,0.164949840068547,4.36840100535347e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPLAH,5-oxoprolinase,24240,0.0838787969295453,0.00487215141056465,0.0743293801648386,0.093428213694252,4.98364807451805e-66
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FADD,FAS-associated death domain protein,29478,0.0927614120365172,0.00540721736596052,0.0821632659992346,0.1033595580738,1.20040375590993e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0368942589206664,0.00216210055520286,0.0326565418324688,0.041131976008864,5.66674536797298e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0471377742517081,0.00276320817651399,0.0417218862257406,0.0525536622776755,7.16678302587324e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0341532394343238,0.00200229740895547,0.0302287365127711,0.0380777423558765,7.41252516766643e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SWAP70,Switch-associated protein 70,24805,0.0433453837607848,0.0025428682421381,0.0383613620061941,0.0483294055153755,8.78280125096969e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0295206125682073,0.00173277322489929,0.0261243770474047,0.0329168480890099,8.99868339616366e-65
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL24,C-C motif chemokine 24,29536,0.0999821709959033,0.00587247404754255,0.0884721218627199,0.111492220129087,1.08159007297988e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FST,Follistatin,29536,0.0609935814879771,0.0035827720906443,0.0539713481903142,0.0680158147856399,1.10809272817458e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLO1,Lactoylglutathione lyase,28916,0.0698620839535518,0.00410747411273494,0.0618114346925913,0.0779127332145123,1.46462043064395e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0818243434036131,0.00481147119132843,0.0723938598686094,0.0912548269386168,1.4942885505077e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0673842702602321,0.00396201304524199,0.0596187246915578,0.0751498158289064,1.69261052577909e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NADK,NAD kinase,29478,0.0649230246858371,0.00383254626527619,0.0574112340058957,0.0724348153657784,4.59574803330028e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALB2,Calretinin,28774,0.0366306292688338,0.00216682792283469,0.0323836465400778,0.0408776119975898,8.38235558946588e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREML2,Trem-like transcript 2 protein,29443,0.0406739417152341,0.00240637339489573,0.0359574498612385,0.0453904335692298,8.61675434737499e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTX3,Pentraxin-related protein PTX3,29434,-0.0592741689606868,0.00350774534033294,-0.0661493498277394,-0.0523989880936343,9.29637958254302e-64
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFP,Alpha-fetoprotein,29132,0.0813500755842624,0.00482477806349747,0.0718935105798074,0.0908066405887175,1.74712263828163e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0610145353902309,0.00362009685130002,0.0539191455616828,0.0681099252187789,1.9299000010019e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0272490138909033,0.00161698867892036,0.0240797160802194,0.0304183117015872,2.02004249607495e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,29169,0.04789829852277,0.00284285264361631,0.042326307341282,0.053470289704258,2.1421145101728e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.104882196245371,0.00622288613430417,0.0926853394221348,0.117079053068607,2.20130241880944e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",24845,0.126801509719749,0.00752920215073713,0.112044273504304,0.141558745935194,2.73088779392485e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0560466498937566,0.00333243939045355,0.0495150686884677,0.0625782310990456,3.57989921949215e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX9,Sorting nexin-9,29478,0.0813882767165181,0.00484139435336703,0.0718991437839188,0.0908774096491175,3.99962394980755e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0419786904854973,0.0024973648109918,0.0370838554559534,0.0468735255150412,4.11639244534696e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0782420325837019,0.00465655441781764,0.0691151859247794,0.0873688792426245,4.65774467259962e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAL,Integrin alpha-L,24229,0.0520628880536522,0.00309722103766011,0.0459923348198384,0.058133441287466,4.73448381895062e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCN1,Ficolin-1,24919,0.0668043238553584,0.00397589955260761,0.0590115607322475,0.0745970869784693,5.22169121533249e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADM,Pro-adrenomedullin,29725,0.0316389429979879,0.00188450031034805,0.0279453223897057,0.0353325636062701,5.73173760435366e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRN1,Secernin-1,29434,0.0664903252041245,0.00396115768247681,0.05872645614647,0.074254194261779,6.11213027848169e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRMD4B,FERM domain-containing protein 4B,24111,0.0837663578070037,0.00498944932882716,0.0739870371225025,0.0935456784915049,6.72824052260124e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MIA,Melanoma-derived growth regulatory protein,29566,0.0439431294060368,0.00261922207730259,0.0388094541345237,0.0490768046775499,7.01172659733348e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0476901669465612,0.00284129535548788,0.042121228049805,0.0532591058433175,7.0249236932814e-63
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0286936029491234,0.00171449687385167,0.0253331890763742,0.0320540168218727,1.40178586837953e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.102574347135014,0.00613271408724885,0.0905542275240062,0.114594466746022,1.87012790570037e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSR,"Glutathione reductase, mitochondrial",24867,0.0269022391605592,0.00160859998674001,0.0237493831865488,0.0300550951345696,1.92419776965595e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLRX,Glutaredoxin-1,29291,0.066392127816334,0.00397886492062394,0.0585935525719111,0.0741907030607569,3.20360011941157e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA2,Carboxypeptidase A2,29577,0.07720509460774,0.00462702297444751,0.0681361295778229,0.0862740596376571,3.2099259566141e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPXM1,Probable carboxypeptidase X1,29566,0.081186611463759,0.00486823965411919,0.0716448617416853,0.0907283611858326,3.72167759809995e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.141057822153397,0.00846953926809827,0.124457525187924,0.15765811911887,5.36950285251124e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0423196890665385,0.00254148757322247,0.0373383734230225,0.0473010047100546,5.75321030774012e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA2,Annexin A2,23907,0.0840118262376665,0.0050430452387895,0.0741274575696391,0.0938961949056939,5.83069393918679e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF23,Fibroblast growth factor 23,29693,0.0670673216585918,0.00402863120345625,0.0591712044998176,0.0749634388173661,6.01240177439483e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0973972549296915,0.00585067907089002,0.0859299239507471,0.108864585908636,6.09668182214612e-62
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,24229,0.101819768730244,0.00613560350281894,0.0897939858647193,0.11384555159577,1.65944474744462e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UMOD,Uromodulin,29750,-0.0634800682610152,0.00382870924593869,-0.0709843383830551,-0.0559757981389754,1.83607236286627e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB2B,Ras-related protein Rab-2B,24793,0.0727241169278566,0.00438609598117439,0.0641273688047548,0.0813208650509584,2.06329582733905e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN4,CCN family member 4,29725,0.0471205736612113,0.0028434343870598,0.0415474422625741,0.0526937050598485,2.10661720232128e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA13,Carbonic anhydrase 13,29114,0.122385637810766,0.00739455027441826,0.107892319272907,0.136878956348626,3.01274981281696e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100P,Protein S100-P,28916,0.0628685325300197,0.00380063357125195,0.0554192907303659,0.0703177743296736,3.5202113209511e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0373593304550883,0.0022589886377246,0.0329317127251481,0.0417869481850285,3.6575383471415e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0602065002004347,0.00364028701020819,0.0530715376604267,0.0673414627404428,3.68868187752848e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0450251569298927,0.00272286093618741,0.0396883494949654,0.05036196436482,4.2871452505087e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLB,Beta-klotho,28774,-0.0868818962379478,0.00525750331680924,-0.0971866027388939,-0.0765771897370016,4.61480390719934e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0517123106138292,0.00313093489198451,0.0455756782255395,0.0578489430021188,5.26316033227065e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPP1,Tripeptidyl-peptidase 1,29286,0.0537526075584935,0.00325537155264647,0.0473720793153064,0.0601331358016806,5.68102247900043e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.088470369914716,0.00536166059405882,0.0779615151503608,0.0989792246790713,6.92586012229919e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA9,Serpin A9,29227,0.0845410696181522,0.00512977925233703,0.0744867022835716,0.0945954369527328,9.54008018968419e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0842282620392331,0.0051112029552612,0.0742103042469211,0.094246219831545,9.80888720623507e-61
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGR1,Prostaglandin reductase 1,24922,0.0953314099888626,0.00579556527740884,0.0839721020451413,0.106690717932584,1.77720554668603e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.054980497772553,0.00334651091525114,0.0484213363786607,0.0615396591664452,2.46475174874761e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.102272148647164,0.0062278873903938,0.0900654893619917,0.114478807932335,2.48902858579274e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFRP4,Secreted frizzled-related protein 4,24381,0.0482524223036352,0.00293772496563675,0.0424944813709872,0.0540103632362832,2.6689045323555e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD40LG,CD40 ligand,29786,0.090437825495794,0.00551082804191454,0.0796366025336415,0.101239048457946,2.93953717258052e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0746594182265554,0.00454770298998978,0.0657459203661755,0.0835729160869354,3.06113382301493e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGR,Tyrosine-protein kinase Fgr,28774,0.0661016081775328,0.00403056925948494,0.0582016924289423,0.0740015239261232,3.5852200328975e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0519970202922653,0.00317081716592491,0.0457822186470525,0.0582118219374782,4.12768318066918e-60
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0779160003164528,0.00476967138365419,0.0685674444044906,0.087264556228415,1.02190503270252e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0802819549266287,0.0049174900599663,0.0706436744090948,0.0899202354441627,1.18612462296716e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0444619589370464,0.0027258663356174,0.0391192609192362,0.0498046569548565,1.67801607897392e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MATN2,Matrilin-2,29497,0.0344036472143437,0.00211079626893557,0.03026648652723,0.0385408079014575,1.82984066861794e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0686396366091766,0.00421258668766053,0.0603829667013619,0.0768963065169912,2.25580659342727e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP4,Dipeptidyl peptidase 4,28990,0.0346159481978288,0.0021278118899559,0.0304454368935153,0.0387864595021424,3.03338831556444e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STXBP3,Syntaxin-binding protein 3,28797,0.0505985853393944,0.00311025060991364,0.0445024941439637,0.0566946765348251,3.04566682228539e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKN3,Serine/threonine-protein kinase N3,24445,0.0872343260884122,0.00536022556587539,0.0767282839792964,0.0977403681975279,3.07651188725093e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0360302220697775,0.00221490114824551,-0.0403714283203387,-0.0316890158192163,3.3130887229982e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN6,Dynactin subunit 6,28774,0.0822897292526638,0.00506185240192889,0.0723684985448832,0.0922109599604445,3.669477067235e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAP,Prolyl endopeptidase FAP,29820,0.0316714304308043,0.00194985209911436,0.0278497203165401,0.0354931405450684,4.49405704850162e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS3,Galectin-3,29544,0.0343287658580696,0.00211403473620494,0.0301852577751079,0.0384722739410313,4.85815201923465e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0503213142301434,0.00309789133722393,0.0442494472091845,0.0563931812511023,4.99595632426784e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNC79,Protein unc-79 homolog,24016,0.064745064783976,0.00398713070225933,0.0569302886075477,0.0725598409604043,5.55886603612029e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF2,Fibroblast growth factor 2,29434,0.0776688424362642,0.0047873168628353,0.0682857013851071,0.0870519834874214,6.16610455127307e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASS1,Argininosuccinate synthase,24111,0.0913654314560659,0.00563447995075433,0.0803218507525874,0.102409012159544,8.04199263322005e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASAH1,Acid ceramidase,24732,0.0536463858670109,0.00330888280788099,0.0471609755635642,0.0601317961704577,8.23386081642666e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEPH,Hephaestin,24922,0.0304228560151983,0.00187685372159563,0.0267442227208709,0.0341014893095258,8.64317972617929e-59
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PARD3,Partitioning defective 3 homolog,24445,0.0852333465941509,0.00526439690945518,0.0749151286516187,0.095551564536683,1.1887192224581e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1RL,Complement C1r subcomponent-like protein,24925,0.0224045502796704,0.00138510713627929,0.019689740292563,0.0251193602667778,1.49756465784959e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNAP25,Synaptosomal-associated protein 25,24101,0.054260228336385,0.00336419846117018,0.0476663993524915,0.0608540573202786,3.23674022648855e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRK5,G protein-coupled receptor kinase 5,28916,0.0595108264469588,0.0036916277737925,0.0522752360103255,0.0667464168835921,3.2883258232543e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0417896167609525,0.00259261610112899,0.0367080892027397,0.0468711443191654,3.79881644071965e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3B,Protein FAM3B,29349,0.0406972495552851,0.0025285503693416,0.0357412908313755,0.0456532082791946,4.89773973443851e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL26,C-C motif chemokine 26,29434,0.101592679726339,0.00632632767719434,0.0891930774790382,0.11399228197364,8.75054600671437e-58
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PVR,Poliovirus receptor,29694,0.0421504233368875,0.00262733835018152,0.0370008401705318,0.0473000065032433,1.11894874325932e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,28797,0.0598527224126343,0.0037331282268916,0.0525357910879268,0.0671696537373418,1.33873228414308e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0319225644561739,0.00199023994482271,0.0280216941643214,0.0358234347480264,1.34459931547423e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.111185269712443,0.00695817167798658,0.0975472532235893,0.124823286201297,3.12789608247337e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0582140143463565,0.00364380950837669,0.0510721477099382,0.0653558809827748,3.24369392665949e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNAS,Neuroendocrine secretory protein 55,24867,0.100192493836234,0.00628114743520536,0.0878814448632314,0.112503542809236,5.35479156610617e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,24867,0.0404705164470041,0.00253816414711128,0.035495714718666,0.0454453181753422,5.93633578484755e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADA,Adenosine deaminase,29786,0.0393254947685278,0.00246938894228375,0.0344854924416516,0.0441654970954039,7.28015031428433e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1F,Protein phosphatase 1F,24922,0.0596327414954067,0.00374468455274111,0.0522931597720342,0.0669723232187793,8.15751424507221e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACRBP,Acrosin-binding protein,24793,0.0438515563935963,0.00275386531716584,0.0384539803719513,0.0492491324152414,8.31511718431017e-57
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.103348941765217,0.00649947750404955,0.0906099658572795,0.116087917673154,1.18500265501187e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0293806188983868,0.00184941076853192,-0.0330054640047094,-0.0257557737920642,1.48953422151965e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G15,Phospholipase A2 group XV,29566,0.029893506731768,0.00188286698951545,0.0262030874323178,0.0335839260312183,1.57752079933616e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0756330873115704,0.00476346107651655,0.0662967036015979,0.0849694710215428,1.71356388965598e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSAP,Prosaposin,24761,0.032081723311865,0.002021036172384,0.0281204924139924,0.0360429542097377,1.82614514320725e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLN4,Cerebellin-4,29725,0.0357567764554007,0.00225376030038051,0.0313394062666549,0.0401741466441465,1.87762279692755e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0417237588283388,0.00263208062869046,0.0365648807961055,0.0468826368605721,2.60448573127254e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0430268426549627,0.00271858801931973,0.037698410137096,0.0483552751728294,3.50575668790078e-56
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0795148475471654,0.00504886420480528,0.069619073705747,0.0894106213885837,1.18190325284344e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.107297691025054,0.00681748388115352,0.0939354226179935,0.120659959432115,1.39363681839602e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGS10,Regulator of G-protein signaling 10,24867,0.0666758589206761,0.00423792473183398,0.0583695264462815,0.0749821913950707,1.66198858937128e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0649582193154331,0.00413335457037245,0.0568568443575031,0.0730595942733631,1.99544999147049e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD46,Membrane cofactor protein,29331,0.0319403590643281,0.00203289004519563,0.0279558945757447,0.0359248235529116,2.11405726330075e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0815541237478689,0.00519297432647846,0.0713758940679711,0.0917323534277667,2.369196315665e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTC,Probetacellulin,28797,0.0829541466947549,0.00528282394071997,0.0725998117709438,0.093308481618566,2.46410567070583e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSE,Cathepsin E,24381,0.0582965956841766,0.00371150508554418,0.0510220457165101,0.0655711456518432,2.53126519173318e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MARCO,Macrophage receptor MARCO,29478,0.0293086524196584,0.00186756948949771,0.0256482162202429,0.0329690886190739,2.80817912812716e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C4BPB,C4b-binding protein beta chain,29566,0.0446572267800897,0.00284609540350801,0.039078879789214,0.0502355737709654,2.92811412849909e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BPIFA2,BPI fold-containing family A member 2,23405,-0.123659201587767,0.00787930807547845,-0.139102645415705,-0.108215757759829,3.1730871806474e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGRN,Neugrin,24845,0.0247047865393418,0.00157460684916622,0.0216185571149761,0.0277910159637076,3.28786827583295e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA6,Integrin alpha-6,29434,0.0579267240399493,0.00369864332412133,0.0506773831246715,0.0651760649552271,4.62115386579082e-55
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CORO1A,Coronin-1A,28847,0.0988911908216095,0.00633977582274122,0.0864652302090368,0.111317151434182,1.24621480400874e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0218534369033914,0.00140195604660043,-0.0246012707547282,-0.0191056030520545,1.45891629409712e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEP1B,Meprin A subunit beta,29478,0.129101685497137,0.00829159783712986,0.112850153736363,0.145353217257912,1.91388299029102e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO2,Gamma-enolase,29694,0.072319465096569,0.00464691530343202,0.0632115111018423,0.0814274190912958,2.1349697751597e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGMN,Legumain,29581,0.0395861596971731,0.00254383961806405,0.0346002340457676,0.0445720853485787,2.18316488655802e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFRP1,Secreted frizzled-related protein 1,29120,0.0476664061587932,0.00307512084127896,0.0416391693098864,0.0536936430077,5.64518376299057e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POMC,Pro-opiomelanocortin,24240,0.0778204616189536,0.00502505533616026,0.0679713531600795,0.0876695700778277,7.75734653389289e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0968760331858634,0.00626286822302438,0.0846008114687356,0.109151254902991,9.32831465829018e-54
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0534927030734233,0.00346092555039468,0.0467092889946497,0.0602761171521969,1.22037137498146e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD84,SLAM family member 5,29434,0.0342637106910009,0.00221883054033979,0.0299148028319349,0.0386126185500669,1.38159714148682e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.062329389437228,0.00404236521179653,0.0544063536221068,0.0702524252523492,1.99456150643264e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTN2,Dynactin subunit 2,29349,0.103113205444783,0.0066901887759968,0.0900004354438297,0.116225975445737,2.18166879759217e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX16,Syntaxin-16,28797,0.063535997795107,0.00412559500598439,0.0554498315833776,0.0716221640068365,2.65331417176592e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARFIP1,Arfaptin-1,24867,0.0752391402706426,0.00489079204623737,0.0656531878600174,0.0848250926812679,3.69545503698656e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL1,Fc receptor-like protein 1,29478,0.0494583015455678,0.00322405108832523,0.0431391614124504,0.0557774416786853,6.5773707451222e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FXN,"Frataxin, mitochondrial",29725,0.0797554858761779,0.00520344147972637,0.0695567405759143,0.0899542311764416,7.98780377403568e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,29594,0.0499373327236872,0.00326043366778803,0.0435468827348227,0.0563277827125517,9.50922903639299e-53
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.035173252491478,0.00229696978325566,0.030671191716297,0.0396753132666591,1.0903186239019e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLTA,Clathrin light chain A,28916,0.0511185544762667,0.00334142429827491,0.0445693628516479,0.0576677461008855,1.25976077065429e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BST2,Bone marrow stromal antigen 2,29694,0.056899404504381,0.00372612639074931,0.0495961967785124,0.0642026122302497,1.90712197423173e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA2,Integrin alpha-2,24381,0.0372007057841795,0.00243835587968707,0.0324215282599928,0.0419798833083661,2.60257050997414e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0304445417569016,0.0019983313778985,0.0265278122562206,0.0343612712575827,3.26872294661159e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DMD,Dystrophin,24240,0.0560036711000915,0.00367472911863076,0.0488012020275753,0.0632061401726078,3.34093545937975e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SF3B4,Splicing factor 3B subunit 4,29349,0.0785943143904868,0.00517095623154347,0.0684592401766616,0.088729388604312,5.6512090618836e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0412803805856625,0.00271688269276573,0.0359552905078417,0.0466054706634834,6.10163252453016e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0642473635039855,0.00422760995734392,0.0559612479875914,0.0725334790203796,6.32283585316421e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH7,Protocadherin-7,24805,0.0376031457662081,0.00247473432819341,0.032752666482949,0.0424536250494672,6.55986248262543e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NID2,Nidogen-2,29443,0.0790448934680368,0.00520432153858448,0.0688444232524112,0.0892453636836624,6.65203098544153e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOL1,Apolipoprotein L1,24951,0.0647753999526548,0.0042661059734784,0.0564138322446371,0.0731369676606724,7.73286647301892e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK4,Dickkopf-related protein 4,29169,0.0493973539168734,0.0032573644056395,0.04301291968182,0.0557817881519268,9.53030310980163e-52
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.123456825883562,0.00814897688285837,-0.139428820573965,-0.10748483119316,1.19164791560877e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.072811214476509,0.00480907637882045,0.0633854247740209,0.0822370041789971,1.50370605095665e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDK,Midkine,29455,0.0545297115183228,0.0036093185792354,0.0474554471030214,0.0616039759336242,2.23470804692858e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPPB,Natriuretic peptides B,28916,-0.143603008128024,0.00951570120822854,-0.162253782496152,-0.124952233759896,2.90431399296665e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0953665292515118,0.00632121687964064,0.0829769441674162,0.107756114335607,3.37352563029992e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0434387999099559,0.00287939135239817,0.0377951928592555,0.0490824069606564,3.42589544325836e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMB1,Laminin subunit beta-1,24240,0.0326278787080537,0.00216341430759473,0.028387586665168,0.0368681707509394,3.6518204776563e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.045367049467474,0.00301841354422148,0.0394509589207999,0.0512831400141481,7.26085861016203e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0243323007829038,0.00162037701096279,0.0211563618414167,0.0275082397243909,9.5561184412589e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0231809181435253,0.00154443935927468,0.0201538169993469,0.0262080192877037,9.8543535459707e-51
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTGES2,Prostaglandin E synthase 2,24037,0.0587496674083019,0.00391486203705169,0.0510765378156806,0.0664227970009232,1.12443152266256e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPING1,Plasma protease C1 inhibitor,24914,0.0200256066553826,0.00133498624315897,0.017409033618791,0.0226421796919742,1.21125085054044e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSME2,Proteasome activator complex subunit 2,29081,0.0385462298025025,0.00257139121899257,0.0335063030132771,0.043586156591728,1.31160664518442e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD302,CD302 antigen,29349,0.0324578410407244,0.00216671213482854,0.0282110852564605,0.0367045968249883,1.52121349917048e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMOTL2,Angiomotin-like protein 2,24711,0.0515097911257311,0.00343755897120962,0.0447721755421603,0.058247406709302,1.54892575785502e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERI1,3'-5' exoribonuclease 1,24445,0.0361169488028484,0.0024117202146367,0.0313899771821605,0.0408439204235364,1.77623192601476e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0411977723759903,0.00275577428300346,0.0357964547813035,0.046599089970677,2.38663032052291e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR3,Toll-like receptor 3,29786,0.064825756848368,0.00433772985088398,0.0563238063406354,0.0733277073561006,2.57087526134714e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL19,C-C motif chemokine 19,29694,0.129886838912943,0.0087261349296216,0.112783614450885,0.146990063375001,6.26544690521321e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN2,Nectin-2,29433,0.031429135070999,0.00211561251997536,0.0272825345318473,0.0355757356101507,9.66620783837429e-50
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCRIB,Protein scribble homolog,24240,0.0955982753190594,0.0064336564532843,0.0829883086706221,0.108208241967497,1.00609852916888e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDZD2,PDZ domain-containing protein 2,24111,0.0635397039319044,0.00427994060117007,0.055151020353611,0.0719283875101977,1.22542894219373e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0618344441606447,0.00417745229569547,0.0536466376610816,0.0700222506602078,2.30981277970978e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0733102554276007,0.00495491676043871,0.0635986185771408,0.0830218922780605,2.5741860646428e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAEP,Glycodelin,29218,-0.138282698558277,0.00935806790865804,-0.156624511659247,-0.119940885457308,3.11302226542609e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLIT2,Slit homolog 2 protein,28774,0.0545978225963341,0.00369717594906774,0.0473513577361614,0.0618442874565069,3.59798851687215e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL15,C-C motif chemokine 15,29820,0.0461292583572902,0.00312560383161689,0.0400030748473211,0.0522554418672593,4.04438824401082e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPCAL1,Hippocalcin-like protein 1,29786,0.0768527974858021,0.0052082583070505,0.0666446112039831,0.087060983767621,4.20165275556901e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0638968587681088,0.00432876720770942,-0.0723812424952192,-0.0554124750409983,4.27381607432186e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0369382131732581,0.00250283796597,-0.0418437755865593,-0.0320326507599569,4.43057209521109e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AK1,Adenylate kinase isoenzyme 1,29478,0.0657397599896376,0.0044631736092376,0.0569919397155319,0.0744875802637433,6.23585349100802e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX7,Syntaxin-7,24229,0.0520537973149716,0.00353281806420908,0.0451294739091218,0.0589781207208214,6.31987004585296e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP1,Interstitial collagenase,28424,0.0956893139501692,0.00650137649463086,0.0829466160206927,0.108432011879646,7.44441285722524e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.123208536315101,0.00837828051244304,0.106787106510712,0.139629966119489,9.51044261546491e-49
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0289895112388151,0.00197300724754124,0.0251224170336343,0.032856605443996,1.15850251780419e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPR,Nucleoprotein TPR,24111,0.0498543224588923,0.00339472360863409,0.0432006641859695,0.0565079807318151,1.28948158258646e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPMT,Thiopurine S-methyltransferase,28797,0.075896212568828,0.00517289731806038,0.0657573338254296,0.0860350913122263,1.4618506737086e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0533223713129702,0.00364275111501721,0.0461825791275365,0.060462163498404,2.3804649467796e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0711904229210471,0.00487208945717055,0.0616411275849928,0.0807397182571014,3.7717281220712e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL14,C-C motif chemokine 14,29435,0.0410014018211009,0.00281216727167741,0.0354895539686132,0.0465132496735887,5.53732872876999e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPA1,Inositol monophosphatase 1,29218,0.0631118082635349,0.00432935614327571,0.0546262702227145,0.0715973463043552,5.74685758068274e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.040465159763234,0.00278002192273408,-0.0459140027317928,-0.0350163167946752,7.88271867024031e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPAG1,Sperm-associated antigen 1,24867,0.0598953371982854,0.00411473860902507,0.0518304495245962,0.0679602248719745,8.38194266905846e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDF2,Growth/differentiation factor 2,29478,0.0368044848496531,0.00253054332488926,0.0318446199328702,0.0417643497664361,9.3220165978064e-48
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPL14,60S ribosomal protein L14,24240,0.0415055567381832,0.00286465322027912,0.0358908364264361,0.0471202770499303,2.24918702002092e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0846930377880612,0.00584639494680693,0.0732341036923196,0.0961519718838028,2.30748150622938e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDA,Cytidine deaminase,24890,0.0480378198687425,0.00332070482708597,0.041529238407654,0.054546401329831,3.08406137820289e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DENR,Density-regulated protein,24229,0.0591035627747888,0.00408622501637872,0.0510945617426865,0.0671125638068911,3.21497317957475e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0641516899155689,0.00443841715276747,0.0554523922961447,0.0728509875349932,3.68527893326834e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL25,C-C motif chemokine 25,29786,0.0503982602134346,0.00349047860413513,0.0435569221493297,0.0572395982775394,4.25710010397388e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0540721699135855,0.00374373784841088,0.0467344437307002,0.0614098960964709,4.28380648109749e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB8,Serpin B8,29786,0.0576445416216185,0.00399810085962509,0.0498082639367533,0.0654808193064837,5.74340147678001e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOE,Apolipoprotein E,24966,0.0744272937808299,0.00516659149743392,0.0643007744458595,0.0845538131158004,7.37026306337345e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF22,Kinesin-like protein KIF22,24111,0.125910558260921,0.00874228399484336,0.108775681631028,0.143045434890814,7.81449745205488e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0573462563058801,0.00398374143118479,0.049538123100758,0.0651543895110023,8.61797372427825e-47
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOLA1,BolA-like protein 1,24101,0.0558923337049488,0.00388648861515166,0.0482748160192516,0.0635098513906461,1.06055680168106e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP8,Caspase-8,29632,0.0627423119395226,0.00437116034839702,0.0541748376566644,0.0713097862223807,1.44788923324232e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAGED1,Melanoma-associated antigen D1,28797,0.0493289509637596,0.00343760188415524,0.0425912512708153,0.0560666506567038,1.54664881030355e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL20,C-C motif chemokine 20,29786,0.0893850939849769,0.00623104206666373,0.077172251534316,0.101597936435638,1.63388853181438e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APLP1,Amyloid-like protein 1,29478,-0.0523796851357677,0.00365304041679781,-0.0595396443526914,-0.045219725918844,1.79915402840679e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0306813524426953,0.00214120076712794,0.0264845989391245,0.0348781059462661,2.20390705022381e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.042029942519117,0.00293554491066886,0.0362762744942061,0.047783610544028,2.44821487453957e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0397679493597999,0.00277967504148285,0.0343197862784935,0.0452161124411062,2.8326370532859e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOM,Apolipoprotein M,29545,0.0281351821495447,0.00196862071263396,0.0242766855527822,0.0319936787463073,3.50953178032329e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_E,,29434,0.0293821915276816,0.00206148516777885,0.025341680598835,0.0334227024565281,6.11584965740057e-46
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFA,Protransforming growth factor alpha,29434,0.0471403336631117,0.00331993820591881,0.0406332547795108,0.0536474125467125,1.31211489658298e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNM1,Dynamin-1,24805,0.115434070942973,0.00812952187600782,0.0995002080659979,0.131367933819949,1.39541347180343e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRZB,Secreted frizzled-related protein 3,29123,0.0259407252268947,0.00182941074727553,0.0223550801622346,0.0295263702915547,1.731753686563e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTN,Pleiotrophin,28916,0.0503467629556883,0.00355459561725749,0.0433797555458636,0.057313770365513,2.17614871448709e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STK4,Serine/threonine-protein kinase 4,29478,0.0869556964566547,0.00614334773100843,0.0749147349038782,0.0989966580094312,2.46897510058652e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0412659004842309,0.00291561442004878,0.0355512962209353,0.0469805047475266,2.67313611474338e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C7orf50,Uncharacterized protein C7orf50,24845,0.0224329676270089,0.00158626225809598,0.0193238936011408,0.025542041652877,3.13462912638297e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0407497568898654,0.00288216961488101,0.0351007044446986,0.0463988093350322,3.32511388427684e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENAH,Protein enabled homolog,28931,0.0478697937641543,0.00338743631075406,0.0412304185950763,0.0545091689332322,3.43213264952467e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COLEC12,Collectin-12,29454,0.0264627328295119,0.00187302809454117,0.0227915977642112,0.0301338678948126,3.5713673610648e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS27,Serine protease 27,29395,0.0404035239578226,0.00285990631173899,0.0347981075868142,0.046008940328831,3.61164091232288e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTA,Lymphotoxin-alpha,29434,0.0402375781853381,0.00284913253401615,0.0346532784186665,0.0458218779520098,3.86399158650839e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA4,Annexin A4,29341,0.0721935532987505,0.00511436821134976,0.062169391604505,0.082217714992996,4.26421236907395e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0339394258673767,0.00240790493905287,0.0292199321868331,0.0386589195479203,5.71609283043232e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,24240,0.0525652976669349,0.00372906383289391,0.0452563325544628,0.0598742627794069,6.0423197254722e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0462317130571898,0.00328170407137333,0.039799573077298,0.0526638530370815,6.37489900404063e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,28719,0.0663095533019545,0.0047108173190692,0.0570763513565788,0.0755427552473301,7.52097039948082e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRG2,Bone marrow proteoglycan,24938,-0.0518899871854639,0.00368660904469287,-0.0591157409130619,-0.0446642334578659,8.00604450980172e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0355199028866527,0.00252647229271491,0.0305680171929315,0.0404717885803739,9.48362769627614e-45
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNGR2,Interferon gamma receptor 2,29218,0.0519869133224244,0.00369987890774834,0.0447351506632376,0.0592386759816111,1.06270846735945e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0536797340727576,0.00382513472620293,0.0461824700093999,0.0611769981361154,1.35150571232921e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXNB2,Plexin-B2,29701,0.0237573938335585,0.00169572540942261,0.0204337720310901,0.0270810156360268,1.87213777690911e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BGN,Biglycan,28750,-0.119149557063762,0.00851667179331197,-0.135842233778653,-0.102456880348871,2.50300749665641e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,24445,0.0701262300214133,0.00502235837946928,0.0602824075976535,0.079970052445173,3.8858000923588e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,24445,0.0346957728855298,0.00248795253927115,0.0298193859085584,0.0395721598625013,4.94311527169925e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDGF,Hepatoma-derived growth factor,29688,0.0924155280066665,0.00664126618562408,0.0793986462828433,0.10543240973049,7.02292772505393e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,28931,0.066166887414355,0.00475803144272101,0.0568411457866219,0.0754926290420882,8.0230912850573e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL8,Interleukin-8,29218,0.0669702435460654,0.00481751889207027,0.0575279065176076,0.0764125805745231,8.56779266182448e-44
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0426033218116382,0.00306999711165718,0.0365861274727901,0.0486205161504862,1.26644615928102e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0553966529244945,0.00399514356026266,0.0475661715463797,0.0632271343026093,1.48891756269937e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.0322888844363943,0.00233235630319471,0.0277174660821327,0.036860302790656,1.90037850811424e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRG,Histidine-rich glycoprotein,24833,0.0308508956607611,0.00223159176057874,0.0264769758100268,0.0352248155114954,2.62124498767433e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0483607307054969,0.0035115744958613,0.0414780446936087,0.055243416717385,5.10937978478897e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0583981607630279,0.00424336575186606,0.0500811638893704,0.0667151576366854,5.87570009882551e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0896565047990984,0.00651290539745702,0.0768912102200827,0.102421799378114,5.92658361770215e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPB6,Heat shock protein beta-6,29725,0.0375716246894378,0.0027304242649614,0.0322199931301135,0.0429232562487622,5.97843467397582e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0495514128226805,0.00360156870636842,0.0424923381581984,0.0566104874871626,6.21160704569264e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0948928307207419,0.00691297573538646,0.0813433982793844,0.108442263162099,9.51005194957028e-43
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APRT,Adenine phosphoribosyltransferase,29192,0.0465465386693448,0.00339274461681803,0.0398967592203814,0.0531963181183081,1.05415142498393e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAM2,Neural cell adhesion molecule 2,29443,-0.0262825344764594,0.00191576119025365,-0.0300374264093566,-0.0225276425435623,1.05614141552332e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.110965027108924,0.00808812139571204,0.0951123091733282,0.126817745044519,1.11132077551853e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA2,Carbonic anhydrase 2,29368,0.0668359864167873,0.00487824069785796,0.0572746346489856,0.0763973381845889,1.35742086432667e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0329313116938298,0.00240785446536147,0.0282119169417214,0.0376507064459383,1.88782657279747e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0425427415539879,0.0031151195444148,0.0364371072469349,0.0486483758610409,2.49039584142797e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.022425820640793,0.001645139162955,0.0192013478814012,0.0256502934001848,3.47927162164078e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0843460928871988,0.00619283754332077,0.0722081313022901,0.0964840544721075,4.3433001161852e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0376317384841087,0.00276502468875357,0.0322122900941517,0.0430511868740657,4.69948081531441e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0528297725454386,0.00388922009604977,0.045206901157181,0.0604526439336961,6.70577999851437e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,29566,0.0234351450525118,0.00172693814094434,0.0200503462962609,0.0268199438087627,8.01422732698116e-42
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP3,Stromelysin-1,29443,-0.0472319116897288,0.00348622920087041,-0.0540649209234348,-0.0403989024560228,1.08403056631819e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN3,Calsyntenin-3,24845,0.0294221114010238,0.00217137313751361,0.0251662200514971,0.0336780027505505,1.11466749152296e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCF2,Neutrophil cytosol factor 2,29395,0.0794925789327525,0.00589932088578957,0.0679299099966049,0.0910552478689,2.91634375872645e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBD,Thrombomodulin,29478,0.027432004469587,0.00203582348800032,0.0234417904331063,0.0314222185060676,2.92274513261719e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,24938,0.0253724259884106,0.00188368564530785,0.0216804021236072,0.029064449853214,3.29343324284868e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD80,T-lymphocyte activation antigen CD80,24922,0.0326957988522731,0.00243331766549822,0.0279264962278966,0.0374651014766496,5.12059587826042e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO2,Roundabout homolog 2,29694,0.0220608169864387,0.00164533025218801,0.0188359696921502,0.0252856642807272,7.12711467940884e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHPS,Deoxyhypusine synthase,24793,0.0388747138949704,0.00289930515422163,0.033192075792696,0.0445573519972448,7.50748433659404e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXN,Thioredoxin,24647,0.0417836706457051,0.00311654143648323,0.0356752494301979,0.0478920918612122,7.64610007828586e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0454837330106278,0.00339629257540915,0.0388269995628258,0.0521404664584297,9.3072072154334e-41
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XRCC4,DNA repair protein XRCC4,28774,0.0351973618603392,0.00263266556394148,0.0300373373550139,0.0403573863656644,1.20602096680735e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMA4,Laminin subunit alpha-4,29581,0.031749319610551,0.00237527245477192,0.027093785599198,0.0364048536219039,1.24377256423687e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0401819616177425,0.00300566341906881,0.0342908613163676,0.0460730619191174,1.28289542116458e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX6,Syntaxin-6,28797,0.0638217023866598,0.00478406510028441,0.0544449347901023,0.0731984699832172,1.77565749501843e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX6,Peroxiredoxin-6,29725,-0.0566802654519666,0.00425064815579524,-0.0650115358373253,-0.0483489950666079,1.90640851742051e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTRK3,NT-3 growth factor receptor,29694,-0.0204615051574938,0.00153943562848626,-0.0234787989893269,-0.0174442113256607,3.3766888734577e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0339098756786518,0.00255524093731725,0.02890160344151,0.0389181479157936,4.72460901096361e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0688566876102817,0.00519993770253871,0.0586648097133058,0.0790485655072576,6.54298576380982e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMS,Spermine synthase,24101,0.0602706000374357,0.00455516819880875,0.0513424703677705,0.0691987297071008,7.97647377494681e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0705338999378647,0.00533740290779406,0.0600725902385883,0.080995209637141,9.83902201664293e-40
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRSF1,G-rich sequence factor 1,23862,0.0759107880801882,0.00574830512113173,0.06464411004277,0.0871774661176064,1.12014758472295e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPL,Periplakin,24229,0.0307167095883349,0.00232857772469426,0.0261526972479341,0.0352807219287356,1.35088010343308e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0313923791870916,0.00238099802201442,0.0267256230639433,0.0360591353102398,1.40296449265712e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA6,Carbonic anhydrase 6,29372,-0.0592029322960955,0.00449207952046226,-0.0680074081562015,-0.0503984564359895,1.49361275427797e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CIT,Citron Rho-interacting kinase,24195,0.042516299450719,0.00322646210763324,0.0361924337197578,0.0488401651816801,1.62103346326037e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TF,Serotransferrin,24966,0.020244561985205,0.00153713749068492,0.0172317725034626,0.0232573514669475,1.76207599377181e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0535348444139219,0.00406807036898937,0.0455614264907028,0.0615082623371411,1.94225288063886e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0226924233191903,0.00172725302317508,0.0193070073937672,0.0260778392446135,2.57805344239824e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,29820,0.0326652419093999,0.00248695021165939,0.0277908194945475,0.0375396643242523,2.68045675277636e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSHB,Follitropin subunit beta,24240,0.0605214919274189,0.00460770407148009,0.0514903919473179,0.0695525919075199,2.8325380233111e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPME1,Protein phosphatase methylesterase 1,29349,0.0556574234136515,0.00424686347713812,0.0473335709984608,0.0639812758288422,3.94342755319703e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C5,Complement C5,24966,0.0141339986150965,0.00107831618204794,0.0120204988982825,0.0162474983319104,4.01892003630826e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL2A1,Collagen alpha-1(II) chain,24240,0.0752474107352605,0.00574812914923109,0.0639810776027675,0.0865137438677534,5.04522791759814e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMIGO2,Amphoterin-induced protein 2,29349,0.021265284973105,0.00163083338198775,0.0180688515444091,0.024461718401801,9.34658754838327e-39
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRR3,Small proline-rich protein 3,24845,0.0630237187194432,0.00483410777906905,0.0535488674724679,0.0724985699664185,1.00618645325025e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0349503943113357,0.00268673744335609,0.0296843889223578,0.0402163997003137,1.40676920697282e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0498092207805132,0.00382913109936459,0.0423041238257586,0.0573143177352678,1.48517137329548e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.034723105405753,0.00267104193010671,0.0294878632227438,0.0399583475887621,1.56585477661657e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0502859227314993,0.00386709638126215,0.0427064138242255,0.0578654316387731,1.57073491937016e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASET2,Ribonuclease T2,29697,0.0244981717275672,0.00188796520034688,0.0207977599348874,0.0281985835202471,2.13047273480549e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0611008214432947,0.00471106687807707,0.0518671303622636,0.0703345125243257,2.42287834291674e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDF1,Endothelial differentiation-related factor 1,24867,0.0626978344001546,0.00484109526919292,0.0532092876725365,0.0721863811277727,3.07747010638481e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBS,Cystathionine beta-synthase,24240,0.0469667499021892,0.00364787247428533,0.0398169198525899,0.0541165799517884,8.27046475369659e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0554068767270351,0.00430407759705845,0.0469708846368006,0.0638428688172697,8.44238106293042e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMM2,Phosphomannomutase 2,24111,0.0550738852993399,0.00428047666108772,0.046684151043608,0.0634636195550718,9.27667315514225e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.0899130548483896,0.00699294810325662,0.0762068765660067,0.103619233130773,9.83322610135797e-38
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0577662145521318,0.0044926292970078,0.0489606611299965,0.0665717679742671,1.02224379912977e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,24805,0.0234217258197503,0.00182411056983163,0.0198464691028803,0.0269969825366203,1.28876094432514e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIGR,Polymeric immunoglobulin receptor,29115,0.0329979530566211,0.00257106619279658,0.0279586633187398,0.0380372427945024,1.33184129151466e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAA10,N-alpha-acetyltransferase 10,24111,0.0464611852532087,0.00362585450605221,0.0393545104213464,0.053567860085071,1.81788464431972e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0562349838261972,0.00439720486631374,0.0476164622882222,0.0648535053641721,2.50471642472416e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0562960404297979,0.0044098499929672,0.0476527344435822,0.0649393464160136,3.34900377099032e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0431286533565383,0.00337942095248862,0.0365049882896606,0.049752318423416,3.49075547354589e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO1,Roundabout homolog 1,29497,0.0218225713561937,0.00171298942446146,0.0184651120842493,0.0251800306281382,4.46979986158042e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PER3,Period circadian protein homolog 3,24229,0.108737619497749,0.00854570514292426,0.0919880374176174,0.125487201577881,5.6965149172526e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,24951,0.0236037235542992,0.00185544975032683,0.0199670420436586,0.0272404050649398,5.86774409695239e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELOB,Elongin-B,24111,0.035832838370022,0.00282261698919772,0.0303005090711945,0.0413651676688496,8.28046260544561e-37
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAT,Catalase,24587,0.0482832733452762,0.00380892141056907,0.0408177873805608,0.0557487593099916,1.04197142310149e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0441194827158257,0.00348244190563741,0.0372938965807764,0.050945068850875,1.0932412198207e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSNK1D,Casein kinase I isoform delta,24229,0.0576322446940776,0.0045494003487859,0.0487154200104572,0.0665490693776979,1.16151049874523e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK7,Kallikrein-7,23801,0.0353037620538335,0.00278685959881073,0.0298415172401644,0.0407660068675025,1.16946482976028e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BSG,Basigin,29760,0.0184781364563031,0.00145989831103651,0.0156167357666716,0.0213395371459347,1.26987941517799e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAPK2,Death-associated protein kinase 2,24229,0.0481153368895843,0.00382098789698619,0.0406262006114914,0.0556044731676772,3.02119025655144e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL5,Insulin-like peptide INSL5,24805,0.0874220825051167,0.00695436116346088,0.0737915346247333,0.1010526303855,3.93820362895905e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0267894456151723,0.00213578533021023,0.0226033063679602,0.0309755848623843,5.36153937232384e-36
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.0309828741971441,0.0024809762265824,0.0261201607930425,0.0358455876012456,1.06772957361973e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIMAP8,GTPase IMAP family member 8,24016,0.0452932169485669,0.00363004397066209,0.0381783307660692,0.0524081031310646,1.2805542178888e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TREML1,Trem-like transcript 1 protein,24951,0.0468035138507861,0.00375524632545637,0.0394432310528917,0.0541637966486806,1.5070162804037e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA14,Carbonic anhydrase 14,29725,-0.0314755467467757,0.00252957674287947,-0.0364335171628194,-0.0265175763307319,1.87111104888878e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRN,Progranulin,29313,0.0218297805483318,0.00175462089537878,0.0183907235933894,0.0252688375032742,1.91662199227758e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEK,Angiopoietin-1 receptor,29566,0.0193000619910284,0.00155319108574893,0.0162558074629605,0.0223443165190963,2.31287333133734e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM,Paralemmin-1,24657,0.0264452567793253,0.00212815820559879,0.0222740666963517,0.030616446862299,2.39959518366429e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0603668135047686,0.00486808295266778,0.0508253709175397,0.0699082560919974,3.30235130806421e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,29433,0.065429153420973,0.00529342072811054,0.0550540487938763,0.0758042580480696,5.22483780947696e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A12,Protein S100-A12,29023,0.0657839725673049,0.0053333989847855,0.0553305105571253,0.0762374345774844,7.23696365713023e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0320378655077271,0.00259776035060509,0.0269462552205411,0.0371294757949131,7.38055583012359e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHCHD6,MICOS complex subunit MIC25,24793,0.0254504242790084,0.00206489320288985,0.0214032336013443,0.0294976149566725,8.37290986655367e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY75,Lymphocyte antigen 75,29434,0.0340361010816316,0.00276354932985563,0.0286195443951146,0.0394526577681487,9.04094644438786e-35
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGMB,RGM domain family member B,29694,0.0235343758134666,0.00191479939161726,0.0197813690058968,0.0272873826210365,1.23271047982948e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAST,Gastrin,24845,0.11362871814597,0.00927064134162756,0.0954582611163805,0.131799175175561,1.9421421024423e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX5,Sorting nexin-5,24240,0.0260445634279037,0.00212649308210267,0.0218766369869824,0.0302124898688249,2.1857352072612e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0319490364530585,0.00261361752519942,0.0268263461036676,0.0370717268024493,2.90112873145693e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYM,Ketimine reductase mu-crystallin,24101,0.0664405422979129,0.00543597460483299,0.0557860320724402,0.0770950525233856,2.9823840547439e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CR1,Complement receptor type 1,24903,0.0312519340973742,0.00255802819972954,0.0262381988259043,0.0362656693688441,3.15372639479798e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0431066582987363,0.00353045419885672,0.0361869680689771,0.0500263485284955,3.46713732619066e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP2,Retinol-binding protein 2,29349,-0.0665842471031593,0.00546182685932595,-0.0772894277474381,-0.0558790664588804,4.20656287974364e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD101,Immunoglobulin superfamily member 2,24805,0.0371563271887562,0.00304952384230212,0.031179260457844,0.0431333939196684,4.71634712542521e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300A,CMRF35-like molecule 8,24381,0.0259391864465422,0.00213489980308498,0.0217547828324956,0.0301235900605887,7.18273428839295e-34
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0631424495289125,0.00521071502301355,0.0529294480838059,0.073355450974019,1.02719431623098e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VGF,Neurosecretory protein VGF,24867,0.0261605212510652,0.00216062851941404,0.0219256893530137,0.0303953531491167,1.19418136421955e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0355970324821473,0.00294161950975054,0.0298314582430362,0.0413626067212584,1.30340640585041e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWC2,Brorin,29114,0.0343087392846811,0.00283645393855388,0.0287492895651155,0.0398681890042467,1.34099964341582e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0458591384216988,0.00379991328698497,0.0384113083792082,0.0533069684641893,1.92164990448946e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C7,Complement component C7,24374,-0.0277610053158131,0.00231355924642782,-0.0322955814388116,-0.0232264291928146,4.44396616731298e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0263607902735475,0.00219828103843335,0.0220521594382182,0.0306694211088769,4.88109547309758e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0372646253337384,0.00310792105614417,0.0311731000636958,0.0433561506037809,4.96054750079813e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP9,Caspase-9,24229,0.0537494771273646,0.00448633483003113,0.0449562608605036,0.0625426933942256,5.55933899319706e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.028891707522886,0.00241427467794792,0.0241597291541081,0.0336236858916639,6.29403199774158e-33
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0565889538394632,0.00475008146954131,0.0472787941591622,0.0658991135197642,1.19853157239421e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0272546064670774,0.00229193582411118,0.0227624122518194,0.0317468006823353,1.55285011626359e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0319926530933868,0.00269109327316275,0.0267181102779878,0.0372671959087858,1.62023558453639e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0459159725535935,0.00386389859130095,0.0383427313146436,0.0534892137925433,1.77067334859794e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0322033835624481,0.00271283012326729,0.0268862365208442,0.037520530604052,2.06177299610519e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LBP,Lipopolysaccharide-binding protein,29594,-0.0492119354057575,0.00414975093072279,-0.0573454472299741,-0.0410784235815408,2.2882788231113e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0277025564214863,0.00233918680219616,0.0231177502891819,0.0322873625537908,2.77157252590256e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0289386047958786,0.00244484878004757,0.0241467011869854,0.0337305084047718,2.99142281197971e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2orf69,UPF0565 protein C2orf69,24195,0.0502507858683578,0.00424537144022893,0.0419298578455091,0.0585717138912065,3.09921844830516e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSDE1,Cold shock domain-containing protein E1,24111,0.0997111994463931,0.00843350407636319,0.0831815314567213,0.116240867436065,3.63412247993346e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0378603340434288,0.00321243282813356,-0.0441567023865705,-0.031563965700287,5.46533112520134e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA4,Carbonic anhydrase 4,29820,-0.0199260565670248,0.00169108568346237,-0.0232405845066111,-0.0166115286274386,5.62483104706019e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS7_LGALS7B,Galectin-7,29320,0.0351446486011558,0.00298350799666803,0.0292969729276864,0.0409923242746251,5.86858792011897e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGKZ,Diacylglycerol kinase zeta,28931,0.0296598140473042,0.00252578818677389,0.0247092692012274,0.034610358893381,9.08098687937316e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0358168653098459,0.0030498663053318,0.0298391273513955,0.0417946032682962,9.23064990811897e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0654766771470397,0.00557866395162547,-0.0764108584922256,-0.0545424958018538,9.69418617534721e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA3,Protein disulfide-isomerase A3,24381,0.0209582650671484,0.00178546784110033,0.0174587480985917,0.024457782035705,9.88058890963486e-32
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPG,Macrophage-capping protein,29174,0.0486333486593765,0.00414703255568654,0.0405051648502309,0.0567615324685221,1.08862154859506e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0422982591979786,0.00360857512853412,0.0352254519460517,0.0493710664499054,1.16189001113891e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEL1L,Protein sel-1 homolog 1,24240,0.0266711827985063,0.00227627448440453,0.0222096848090735,0.0311326807879392,1.26909809830297e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0450635651415501,0.00385034222555507,0.0375168943794622,0.0526102359036381,1.43295383565504e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0398866365069533,0.00341106056583259,0.0332009577979214,0.0465723152159852,1.62565879813193e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP6,Gastrotropin,28872,0.0467863504318872,0.00400180774633944,0.0389428072490619,0.0546298936147125,1.66316303515412e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,29349,0.0301045478281058,0.00257593702940034,0.0250557112504811,0.0351533844057305,1.74796489264137e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QA,Complement C1q subcomponent subunit A,29646,-0.0188288778603008,0.00161454999198751,-0.0219933958445964,-0.0156643598760053,2.33393338676758e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0541927981604647,0.00464724247023902,0.0450842029187962,0.0633013934021332,2.35696150602515e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0309103391029376,0.00265257001277422,0.0257113018779002,0.0361093763279751,2.68577642091252e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHCY,Adenosylhomocysteinase,29478,0.0559048300986483,0.00480113342156029,0.0464946085923901,0.0653150516049065,2.87967618647323e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS22,Brain-specific serine protease 4,24229,0.0290117202197485,0.00249333232814134,0.0241247888565915,0.0338986515829056,3.28487656028985e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.0130956677402635,0.00112747193702647,0.0108858227436916,0.0153055127368354,4.03200923532333e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZBP1,Z-DNA-binding protein 1,24229,0.0335340015278989,0.00289939879259391,0.0278511798944148,0.039216823161383,7.3990755707266e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.034997083655621,0.00302769875693837,0.0290627940920218,0.0409313732192203,7.75153960857046e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRDT,Bromodomain testis-specific protein,24111,0.0303257409216852,0.00262576208667242,0.0251792472318073,0.0354722346115632,8.96864845833419e-31
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINI2,Serpin I2,24805,0.0466240720945837,0.00404306472440998,0.0386996652347401,0.0545484789544272,1.09164968154362e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPOCK1,Testican-1,29218,0.0210032095955225,0.00183123676909802,0.0174139855280904,0.0245924336629546,2.18330082166678e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0545251994126513,0.00475514313203136,0.0452051188738699,0.0638452799514328,2.25279077538645e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSC,Dipeptidyl peptidase 1,29446,0.0353618474881965,0.00308531578171448,0.0293146285560362,0.0414090664203569,2.39296340844713e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0418278612414166,0.00365087219589791,0.0346721517374567,0.0489835707453765,2.59785223844037e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0520181760974701,0.00454285012630296,0.0431141898499163,0.0609221623450239,2.71781729199841e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0473089094916661,0.00413541914929175,0.0392034879590542,0.0554143310242779,3.05972627796697e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0352343365108635,0.00308432490266233,0.0291890597016453,0.0412796133200817,3.68706610263361e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SBSN,Suprabasin,24905,-0.0279912674347207,0.00245590232545882,-0.03280483599262,-0.0231776988768214,5.10510151888546e-30
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.020066996856204,0.00177090532053498,0.0165960224279555,0.0235379712844526,1.05734532008047e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0208536987709083,0.00184326553441202,0.0172408983234607,0.0244664992183558,1.32914221000163e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0381466084448905,0.00337420200138281,0.0315331725221802,0.0447600443676008,1.42501279174118e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0406318022896734,0.00359534989459057,0.0335849164962759,0.0476786880830709,1.52732920768624e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPQ,Carboxypeptidase Q,24920,0.0295253405893127,0.00262711238885984,0.0243762003071475,0.034674480871478,3.09542366210535e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.041866625552933,0.00373125297829515,-0.0491798813903915,-0.0345533697154746,3.70588577107201e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCAM1,Vascular cell adhesion protein 1,29545,-0.0217590887355301,0.00194305146581994,-0.0255674696085371,-0.017950707862523,4.75049335923168e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0447271424262174,0.00399547393884036,-0.0525582713463445,-0.0368960135060903,4.969090275443e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL2,Fc receptor-like protein 2,29645,0.0392433330331575,0.00350651363956823,0.0323705662996038,0.0461160997667113,5.12867169314943e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD276,CD276 antigen,29454,-0.0286054608154762,0.00255836293555966,-0.0336198521691731,-0.0235910694617793,5.76849875706831e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.0335109190409946,0.00300282070096683,-0.0393964476148895,-0.0276253904670996,7.33154364872606e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD248,Endosialin,24938,-0.0319747584928945,0.00286578916955093,-0.0375917052652143,-0.0263578117205747,7.71224309905597e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0340217740562755,0.00305289149363928,0.0280381067287425,0.0400054413838085,8.73026433014593e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR5,Complement factor H-related protein 5,24623,0.0331451490547177,0.00297680545991716,0.0273106103532801,0.0389796877561553,9.98557842194056e-29
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE6,Ribonuclease K6,24828,0.0243515322153689,0.00218891234798583,0.0200612640133167,0.0286418004174211,1.10910721357795e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,24240,0.0190298387803428,0.00171220199102169,0.0156739228779403,0.0223857546827453,1.25436116161546e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR2,TGF-beta receptor type-2,29566,0.0258704867397683,0.00233075335240447,0.0213022101690555,0.030438763310481,1.43478309120451e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSB,Cathepsin B,29480,-0.0414008491494292,0.00373240871629802,-0.0487163702333734,-0.0340853280654851,1.55801725679619e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMNB2,Lamin-B2,24845,0.0220901513282117,0.00199412951594356,0.0181816574769623,0.0259986451794611,1.87898760819367e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANSC1,MANSC domain-containing protein 1,29566,-0.0217199605447019,0.0019614872804165,-0.0255644756143182,-0.0178754454750856,1.92509866706222e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0208381901757509,0.00188188102861437,0.0171497033596667,0.024526676991835,1.9280869015557e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.0188557600275401,0.00170336551499969,-0.0221943564369395,-0.0155171636181407,2.00148950891293e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0354237467767285,0.00319959887878736,0.0291525329743053,0.0416949605791517,2.02419597389231e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIT,Vitrin,24922,0.0296771867024818,0.00268194589852422,0.0244205727413743,0.0349338006635893,2.14699146658062e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0662361290249699,0.00600838962127235,0.0544596853672761,0.0780125726826637,3.32736584466934e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAS2,Growth arrest-specific protein 2,24445,0.0414361085473505,0.00376582695784825,0.0340550877099679,0.0488171293847331,4.29383492811886e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17D,Interleukin-17D,28931,0.0267298032930818,0.00243095103416294,0.0219651392661225,0.0314944673200412,4.55993788835526e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC16A1,Monocarboxylate transporter 1,28774,0.0450574433868595,0.00411236626658932,0.0369972055043444,0.0531176812693745,7.01628901127751e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.0228984210406726,0.00209116389272852,-0.0269971022704205,-0.0187997398109247,7.51047445205494e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGA11,Integrin alpha-11,29434,-0.0266982872942094,0.00243880752570735,-0.0314783500445958,-0.021918224543823,7.74998256146597e-28
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0515202561880296,0.00471922770030247,0.0422705698954368,0.0607699424806225,1.10884315021453e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG4,Regenerating islet-derived protein 4,29497,0.0385751121884081,0.00353646612476024,0.031643638583878,0.0455065857929382,1.19460822844621e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP12,Macrophage metalloelastase,29466,0.0411618463295912,0.00377709754031563,0.0337587351505725,0.0485649575086098,1.33399808528957e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD1,Programmed cell death protein 1,29661,0.0332324805528806,0.00305255310210616,0.0272494764727526,0.0392154846330087,1.5027642843263e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX2,Sorting nexin-2,24793,0.063089294486805,0.00579463136523971,0.0517318170109352,0.0744467719626749,1.52581060152471e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALCAM,CD166 antigen,29820,0.0151489163521845,0.00139212765363249,0.0124203461510648,0.0178774865533042,1.58509427754208e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0262093703276263,0.00241163148088474,0.0214825726250923,0.0309361680301604,1.84838917827629e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFC1,Cryptic protein,28797,0.0363731355266902,0.00335031540064834,0.0298065173414194,0.0429397537119609,2.09610573800797e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD59,CD59 glycoprotein,28277,0.0177962276096661,0.00164067641196349,0.0145805018422176,0.0210119533771145,2.33619945407544e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYGD,Gamma-crystallin D,24845,0.0746137718472414,0.00689327886234613,0.061102945277043,0.0881245984174399,3.04361829502245e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300C,CMRF35-like molecule 6,29694,0.0266208151310686,0.00246005866752889,0.0217991001427119,0.0314425301194252,3.07093318371029e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK4,Kallikrein-4,29725,-0.0484196301365316,0.00447728225066744,-0.0571951033478398,-0.0396441569252234,3.30236184228348e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0377600821759779,0.00349112386175065,0.0309174794069466,0.0446026849450091,3.32454411984472e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0196499136661072,0.00181938187153555,-0.0232159021343169,-0.0160839251978975,3.95139492205405e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MPO,Myeloperoxidase,29443,0.0352673612356332,0.00326661501466622,0.0288647958068874,0.041669926664379,4.02858413847218e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPCAM,Epithelial cell adhesion molecule,29457,-0.0743119902607116,0.00689647607573141,-0.0878290833691452,-0.060794897152278,5.05450985668766e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CENPF,Centromere protein F,24445,0.0416131239741918,0.0038660045402527,0.0340357550752965,0.049190492873087,5.86103735774836e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAM,Signal transducing adapter molecule 1,24793,0.0282028697653107,0.00262617878941076,0.0230555593380656,0.0333501801925557,7.63909765016564e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0426083416653711,0.0039713260973722,0.0348245425145216,0.0503921408162206,8.55299399169712e-27
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGR2,Anterior gradient protein 2 homolog,28553,0.0768799527439641,0.00717852210923859,0.0628100494098564,0.0909498560780717,1.0300709363449e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN4B,Sodium channel subunit beta-4,24240,0.0325764591839592,0.00304387938249589,0.0266104555942672,0.0385424627736511,1.13915843433397e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM4,Intercellular adhesion molecule 4,29434,-0.0399093516710723,0.00374498552919238,-0.0472495233082893,-0.0325691800338552,1.81257194578392e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA12,Serpin A12,28628,0.0847369635748484,0.00795961461588779,0.0691361189277083,0.100337808221988,2.04278548586827e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0359088948657359,0.00337824912071501,0.0292875265891345,0.0425302631423373,2.43312724928032e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0250179834380977,0.002353819792314,-0.0296314702310331,-0.0204044966451622,2.49607557370263e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0777696485890871,0.00731733348010213,0.0634276749680869,0.0921116222100873,2.51207370688e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA1,Carbonic anhydrase 1,28867,0.0451418773409578,0.00425048048234067,0.0368109355955701,0.0534728190863455,2.67840523743844e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.0218868932951683,0.00206329334388614,0.0178428383411515,0.0259309482491852,3.05707096378652e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD2,Sushi domain-containing protein 2,29443,-0.0215243103384492,0.00203316126947687,-0.0255093064266239,-0.0175393142502745,3.83106436474206e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RCOR1,REST corepressor 1,28916,0.0336093626839673,0.00317873665055695,0.0273790388488756,0.0398396865190589,4.42822751725636e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JAM2,Junctional adhesion molecule B,29694,0.0200855069229921,0.00190050547465775,0.0163605161926629,0.0238104976533213,4.64036426219716e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300LF,CMRF35-like molecule 1,29725,0.0452439431562932,0.00429246123764742,0.0368307191305043,0.0536571671820822,6.25650425572888e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0219116569733781,0.00207931223152538,-0.0259871089471678,-0.0178362049995884,6.42461092892114e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0256973493039009,0.00244119461343093,-0.0304820907462255,-0.0209126078615763,7.26043563410078e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ULBP2,UL16-binding protein 2,29218,0.0285947218473356,0.00271709212322867,0.0232692212858074,0.0339202224088638,7.44912046121432e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0295611554696674,0.00281117656431392,0.0240512494036122,0.0350710615357227,8.15257459294485e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LACRT,Extracellular glycoprotein lacritin,24732,0.0373091436865831,0.00354807548319346,0.0303549157395239,0.0442633716336423,8.3252219944269e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18BP,Interleukin-18-binding protein,29594,0.0230647382187909,0.00219661284143759,0.0187593770495732,0.0273700993880086,9.5739220044571e-26
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0429826950315514,0.00409583921829842,0.0349548501636865,0.0510105398994163,1.01823964043315e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH1,Cadherin-1,28477,0.029970511906193,0.00285592456675472,0.0243728997553537,0.0355681240570322,1.02395727626021e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0440044828239195,0.00419783046074438,0.0357767351208605,0.0522322305269785,1.15431548394815e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST5,Cystatin-D,28890,0.0414289104907084,0.00395543250912866,0.0336762627728162,0.0491815582086006,1.2652600236739e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0276698466911151,0.0026430609740365,0.0224894471820036,0.0328502462002266,1.35794581172748e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH5,Cadherin-5,29820,-0.022606883763947,0.00216111912937622,-0.0268426772575244,-0.0183710902703696,1.44896130614741e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,29378,0.0302794084224224,0.00289848422843102,0.0245983793346976,0.0359604375101472,1.6828539374117e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COPB2,Coatomer subunit beta',24111,0.0320362362814554,0.00306756458057266,0.026023809703533,0.0380486628593778,1.77784762351945e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0348848754611453,0.00334300415443053,0.0283325873184614,0.0414371636038291,1.90217475104421e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0375585143371448,0.00360191736811197,0.0304987562956453,0.0446182723786442,2.06415178697678e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE3,Eosinophil cationic protein,29343,0.0805553477749382,0.00772660866623982,0.0654111947891081,0.0956995007607682,2.09634720666655e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0313966655257031,0.0030175619802571,0.0254822440443992,0.037311087007007,2.61928976322708e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK6,Kallikrein-6,29519,0.0225303812379376,0.0021788615666735,0.0182598125672575,0.0268009499086176,5.10259636851816e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CILP,Cartilage intermediate layer protein 1,24938,0.0401007015431414,0.0038808786233544,0.0324941794413668,0.0477072236449161,5.61903273980934e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR2,Complement factor H-related protein 2,24789,0.0419829264732358,0.00406302885009154,0.0340193899270564,0.0499464630194152,5.62170905131712e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0191680684645023,0.00185604631605254,0.0155302176850393,0.0228059192439652,5.95454621579935e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0307671455294043,0.00298063396949268,0.0249251029491987,0.03660918810961,6.26875514186107e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.028959971087238,0.00280594538110829,0.0234603181402657,0.0344596240342102,6.36370902603213e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRH,Corticoliberin,28751,0.0637177834840806,0.00618536271289442,0.0515944725668076,0.0758410944013537,7.67274041845811e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHI3L1,Chitinase-3-like protein 1,28935,0.0576488721342281,0.0056030991902489,0.0466667977213403,0.068630946547116,8.73939334195136e-25
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.043637780102522,0.0042497533581851,0.0353082635204792,0.0519672966845648,1.10014560981234e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX1,Peroxiredoxin-1,28669,-0.0658582571091315,0.0064229143422745,-0.0784471692199895,-0.0532693449982735,1.25705768381108e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL9,C-X-C motif chemokine 9,29581,0.0484189291582969,0.00472935478006951,0.0391493937893607,0.0576884645272332,1.47312196047894e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,29434,0.0447834462977442,0.00437588014817076,0.0362067212073295,0.0533601713881589,1.53260472236206e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0418918935957758,0.00409483646607382,0.0338660141222711,0.0499177730692805,1.59541359038306e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0266147652396283,0.0026032153369386,0.0215124631792286,0.031717067300028,1.74067270735486e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAX,Apoptosis regulator BAX,28722,0.0655550597109491,0.00642849229557783,0.0529552148116165,0.0781549046102816,2.23700873568428e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM3,Myomesin-3,24381,-0.067841997755678,0.00665525297346112,-0.0808862935836618,-0.0547977019276942,2.36640539062153e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSF,Cathepsin F,29566,0.0290593847763605,0.00285321668216311,0.0234670800793208,0.0346516894734002,2.54370216600655e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKK3,Dickkopf-related protein 3,29820,-0.0211843368140936,0.00209493765177265,-0.025290414611568,-0.0170782590166192,5.33514832758168e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFR,Epidermal growth factor receptor,29820,0.011789369010403,0.0011666165870296,0.00950280049982498,0.014075937520981,5.70262775029569e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A13,Protein S100-A13,24229,0.0252782839921025,0.00250756809569668,0.020363450524537,0.030193117459668,7.4871270435115e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0257543206529051,0.00255976220845869,0.0207371867243261,0.0307714545814841,8.95706071980529e-24
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECE1,Endothelin-converting enzyme 1,28774,0.0252334505697149,0.00251201885572972,0.0203098936124847,0.0301570075269452,1.05659378623421e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A11,Protein S100-A11,29208,0.0324722371605153,0.00323852594621535,0.0261247263059332,0.0388197480150974,1.26848848997732e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0212048517530874,0.00211805190538512,0.0170534700185326,0.0253562334876423,1.48105119660245e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RALY,RNA-binding protein Raly,24793,0.0343164538317089,0.00342991191381248,0.0275938264806365,0.0410390811827814,1.6049651064648e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.031008331275942,0.00310898973438098,-0.0371019511553287,-0.0249147113965553,2.16197954144786e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.02433211614683,0.00244006821786357,-0.0291146498538426,-0.0195495824398174,2.23921573968743e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL21,C-C motif chemokine 21,29581,0.0287186981684916,0.00288954670583106,0.0230551866250627,0.0343822097119205,3.06853342477341e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0279883331795246,0.00281957637735984,0.0224619634798993,0.0335147028791499,3.47453817494904e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,29030,0.0206001579929927,0.00207652274241949,0.0165301734178505,0.0246701425681349,3.69089270130168e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0560339740003668,0.00565046727875087,0.0449590581340151,0.0671088898667185,3.83659532421084e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CX3CL1,Fractalkine,29218,-0.0238387878358519,0.0024045374179853,-0.0285516811751031,-0.0191258944966007,3.93311139224422e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AFAP1,Actin filament-associated protein 1,24381,0.0593224207461231,0.00599452824761334,0.047573145380801,0.0710716961114453,4.78433946329771e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIPF,Gastric triacylglycerol lipase,24240,0.0430941616263888,0.00435508765087521,0.0345581898306733,0.0516301334221042,4.83329091141826e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,28916,0.0380830288370167,0.00385046628784489,0.0305361149128407,0.0456299427611927,4.97990286609458e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD14,Monocyte differentiation antigen CD14,28954,0.0291525285534182,0.00294767677994556,0.0233750820647249,0.0349299750421115,5.00401029215779e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD300E,CMRF35-like molecule 2,29642,0.0286661565294144,0.00289934775531363,0.0229834349289996,0.0343488781298291,5.1403647158728e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA7,Thyroxine-binding globulin,24966,0.0129894995957413,0.00131953777881056,0.0104032055492726,0.01557579364221,8.00901902852183e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,24845,0.0259742488046717,0.00264457225944979,0.0207908871761501,0.0311576104331933,9.98658948054912e-23
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PVALB,Parvalbumin alpha,29599,0.0784354694343019,0.00798909803767912,0.0627768372804508,0.0940941015881529,1.02224198245146e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,XG,Glycoprotein Xg,29693,0.0224885126110708,0.00229141661549467,0.0179973360447013,0.0269796891774404,1.05871815744525e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0588107386716633,0.00599601702317164,0.0470585453062469,0.0705629320370797,1.12554172599085e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0179588985211097,0.00183145555410815,0.0143692456350577,0.0215485514071616,1.15135923975332e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0180151361029154,0.00184274780790166,0.0144033503994282,0.0216269218064027,1.54007478162516e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0268826647581085,0.00275146988543369,0.0214897837826585,0.0322755457335585,1.66196981567651e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0208307412897598,0.00213281608823778,0.0166504217568137,0.0250110608227058,1.69046241119527e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPHS1,Nephrin,24229,0.0237213968784351,0.00243061304993572,0.0189573953005611,0.0284853984563091,1.84918572164313e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.0145515061408436,0.00149223093790323,0.0116267335025533,0.0174762787791339,1.96586074225603e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GC,Vitamin D-binding protein,24966,0.0179771700027629,0.00184399444899649,0.0143629408827297,0.021591399122796,2.04206756821695e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN8,Septin-8,24801,0.0222834553354439,0.00229249254248899,0.0177901699521655,0.0267767407187223,2.71080270960647e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGT,Angiotensinogen,24951,0.0159598993419945,0.00164607657337786,0.0127335892581739,0.0191862094258151,3.44102855271681e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0500236253057548,0.00515994890949421,0.0399101254431462,0.0601371251683635,3.4854745829685e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0194046133230713,0.00200609287630982,0.015472671285504,0.0233365553606385,4.31225278621964e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPA,Apolipoprotein(a),24484,-0.122978243958462,0.0127246558320035,-0.147918569389189,-0.0980379185277347,4.66967308264949e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.026369452033676,0.00273960747622197,0.0209998213802809,0.031739082687071,6.84846821107205e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,24951,-0.018097200629156,0.00188459855003624,-0.021791013787227,-0.0144033874710849,8.49597956571924e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0352674758378785,0.00367817037275993,0.028058261907269,0.0424766897684879,9.64885287852073e-22
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AZU1,Azurocidin,28534,0.0522365907050913,0.00545131660439367,0.0415520101604797,0.0629211712497029,1.02254935330401e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0387386378123701,0.00404360086946646,0.0308131801082159,0.0466640955165244,1.04179305068657e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0250445082467618,0.00261423442096766,0.0199206087816652,0.0301684077118584,1.0424695458813e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRDL1,Chordin-like protein 1,29536,0.0214837461432948,0.0022427668410239,0.0170879231348879,0.0258795691517016,1.05249521897923e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENSA,Alpha-endosulfine,24793,0.0360358633394281,0.00376481468194994,0.0286568265628063,0.04341490011605,1.1458749478977e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSR,Insulin receptor,24229,0.0115658187073253,0.00121100720106342,0.00919224459324104,0.0139393928214096,1.40775704335887e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0397820488932457,0.00417112163598775,0.0316066504867097,0.0479574472997817,1.59667730413432e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR2,Folate receptor beta,29694,-0.0198739783869961,0.00208443958128179,-0.0239594799663084,-0.0157884768076838,1.61772413935115e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL3,Fc receptor-like protein 3,28931,0.0367559177475192,0.00385595724796545,0.0291982415415069,0.0443135939535314,1.65544289864261e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCT,Secretin,24195,0.0318786435586936,0.00334562278983525,0.0253212228906165,0.0384360642267707,1.74116653865745e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFD,Vascular endothelial growth factor D,29732,-0.024242489036113,0.00254781695687915,-0.0292362102715961,-0.0192487678006299,1.94944432968918e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR15L,Protein GPR15L,24805,0.041419080695878,0.00435892931819639,0.0328755792322131,0.0499625821595429,2.23635987400319e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFIC,Nuclear factor 1 C-type,24867,0.0300995727896309,0.00317285440756223,0.0238807781508089,0.0363183674284528,2.5939029722305e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMOX1,Heme oxygenase 1,29165,-0.0324337489647242,0.00342124592349684,-0.039139390974778,-0.0257281069546704,2.72642245707019e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA12,Carbonic anhydrase 12,29349,-0.0219922687089844,0.00232015969478803,-0.0265397817107689,-0.0174447557071998,2.75993201644627e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB6,Integrin beta-6,28931,0.0205179220388548,0.00216507379032964,0.0162743774098087,0.0247614666679008,2.81591513869561e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0784874551508445,0.00829504347209153,0.0622291699455451,0.0947457403561439,3.24205884429396e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.0185742700494268,0.00196318777941712,0.0147264220017693,0.0224221180970844,3.25965137081998e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CABP2,Calcium-binding protein 2,24195,0.0439639480685223,0.00465759605425589,0.0348350598021807,0.0530928363348638,4.08458609862477e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD93,Complement component C1q receptor,28353,-0.0211266151781775,0.00224208060521857,-0.0255210931644059,-0.0167321371919491,4.71637997414045e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0206851683646992,0.00219820259824165,0.0163766912721455,0.0249936454572528,5.38650489721887e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0467905168777944,0.00497947293410084,0.0370307499269568,0.0565502838286321,6.1127978867685e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.0199567314404116,0.00212556931599582,0.0157906155810598,0.0241228472997634,6.48629931994871e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTB,Lymphotoxin-beta,24793,0.0233357858481293,0.0024901454470768,0.0184551007718588,0.0282164709243998,7.75979065041447e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN3,CCN family member 3,29795,0.0225681976040795,0.00240986786505244,0.0178448565885768,0.0272915386195823,8.12997791229912e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.0253764142591624,0.00270997644959561,0.020064860417955,0.0306879681003698,8.19526060775807e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAM,Integrin alpha-M,29443,-0.0210630361286931,0.00225288957771138,-0.0254786997010074,-0.0166473725563788,9.42354054281352e-21
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0513529478214402,0.00550822564518001,0.0405568255568874,0.062149070085993,1.22511661970338e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMBS,Porphobilinogen deaminase,29725,0.0285652398676656,0.0030667489221145,0.0225544119803212,0.03457606775501,1.30710505456176e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLU,Clusterin,24966,0.0209888946627818,0.00226250606437463,0.0165543827766075,0.025423406548956,1.88326437503676e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRLF1,Cytokine receptor-like factor 1,29581,0.0170005231816136,0.00183709445296411,0.013399818053804,0.0206012283094233,2.3032236785025e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF1C,Kinesin-like protein KIF1C,24111,0.0239733363994276,0.00259049021389871,0.0188959755801861,0.029050697218669,2.32920426035325e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YAP1,Transcriptional coactivator YAP1,24845,0.017823249732389,0.0019272933374546,0.014045754790978,0.0216007446738,2.47021254644222e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B2M,Beta-2-microglobulin,24966,0.0204965453627194,0.00221648794380161,0.0161522289928682,0.0248408617325705,2.4809954619241e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1B,Interleukin-1 beta,28745,0.0369776816210855,0.0040097527079762,0.0291185663134521,0.0448367969287188,3.11155917509225e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,24111,0.0300048109026738,0.00326069595383788,0.0236138468331515,0.036395774972196,3.79198378363953e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRL,Prolactin,29694,-0.0496267282949596,0.00539501270329825,-0.0602009531934242,-0.0390525033964951,3.85578706270339e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.018013294878694,0.00195946379238195,0.0141727458456253,0.0218538439117626,4.06281508529218e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDM1,Nuclear protein MDM1,24195,0.0205133374346012,0.00223349045988074,0.0161356961332349,0.0248909787359674,4.45989462480938e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1A,Protein phosphatase 1A,28797,0.0203696197204535,0.00221874177787661,0.0160208858358154,0.0247183536050917,4.56133321697577e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MET,Hepatocyte growth factor receptor,29507,-0.0129137951795552,0.00140745401833468,-0.0156724050554911,-0.0101551853036192,4.7888071321153e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0268762956772888,0.00293236229400427,0.0211288655810405,0.0326237257735372,5.25526300808404e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAA4,Serum amyloid A-4 protein,24966,0.0213450921427071,0.00233341944275219,0.0167715900349128,0.0259185942505014,6.2560877978819e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOBR,Apolipoprotein B receptor,24240,-0.027780005717698,0.00303876660986355,-0.0337359882730306,-0.0218240231623654,6.60720219290907e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0221953218686506,0.00242878338964211,0.0174349064249521,0.0269557373123491,6.80736304429151e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0219534611016891,0.00240656273104385,0.0172365981488432,0.026670324054535,7.90969281718557e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DGCR6,Protein DGCR6,24101,0.0284688612798775,0.00312461936196085,0.0223446073304342,0.0345931152293207,8.76962440916277e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0289647424965182,0.00318178880248266,0.0227284364436522,0.0352010485493842,9.4220784564538e-20
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGBL1,Integrin beta-like protein 1,24938,0.0241591946976703,0.00265630984226367,0.0189528274068335,0.0293655619885071,1.01438002375301e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRP2,Neuropilin-2,29443,-0.0185566959698535,0.00204074872615429,-0.0225565634731159,-0.0145568284665911,1.02158446690495e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6L2,Seizure 6-like protein 2,29349,-0.0155062661713025,0.00170676180374286,-0.0188515193066385,-0.0121610130359665,1.09841062265518e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0384623776295049,0.00424212851003526,0.0301478057498358,0.046776949509174,1.31451648819292e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH15,Cadherin-15,29639,0.0372882358614254,0.00411556610756324,0.0292217262906014,0.0453547454322493,1.37888095114045e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0216387578205937,0.00239391069893488,0.0169466928506814,0.0263308227905061,1.67331211445127e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CR2,Complement receptor type 2,29594,0.0299249976230566,0.00331552470938373,0.0234265691926645,0.0364234260534487,1.89055300631476e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRK1,Protein BRICK1,28774,0.0287474402043046,0.00318724682466771,0.0225004364279559,0.0349944439806534,2.00359365239409e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VEGFB,Vascular endothelial growth factor B,24229,0.0186074653993364,0.00206393617443896,0.0145621504974361,0.0226527803012368,2.10079850149125e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0267749599572346,0.00297507596461072,0.0209438110665976,0.0326061088478717,2.39591004883825e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PZP,Pregnancy zone protein,24966,0.0341554001889936,0.00380205367618095,0.026703374983679,0.0416074253943083,2.80617793161632e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0252051610966391,0.00282169709696098,0.0196746347865955,0.0307356874066826,4.45064045625464e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LUZP2,Leucine zipper protein 2,24793,0.0284912415960055,0.00319354797663544,0.0222318875618001,0.034750595630211,4.91087723798967e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL3,Insulin-like 3,24845,0.0479232731380464,0.00538232344881973,0.0373739191783597,0.058472627097733,5.75616982715752e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH1,Protocadherin-1,29713,0.0134533288163746,0.00151154841613957,0.0104906939207411,0.0164159637120082,5.87563061534219e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,28797,0.0335129757728296,0.00376597392366901,0.0261316668824384,0.0408942846632209,5.96428149250626e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2,Apoptosis regulator Bcl-2,24805,0.0340363832198,0.00382725032194034,0.0265349725887969,0.041537793850803,6.33491001346844e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0218591395807808,0.00246049918980151,0.0170365611687699,0.0266817179927918,6.80831818729869e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EBI3_IL27,Interleukin-27,29674,-0.0195402944076096,0.00220208857494559,-0.023856388014503,-0.0152242008007163,7.47577660825486e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0629410884654638,0.0070945743735954,0.0490357226932168,0.0768464542377107,7.69185008359689e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPM3,Tropomyosin alpha-3 chain,24111,-0.0279053071930573,0.00315002078485513,-0.0340793479313734,-0.0217312664547413,8.63682441177634e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0421765581482648,0.00476273686750529,0.0328415938879544,0.0515115224085751,8.89285153017683e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMPD3,AMP deaminase 3,24845,0.0447234893867538,0.00505209787645463,0.0348213775489027,0.0546256012246049,9.12031799748673e-19
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCP1,Plastin-2,24938,0.0298855086121732,0.00338255228334391,0.0232557061368191,0.0365153110875272,1.06373511500411e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBC1D17,TBC1 domain family member 17,28774,0.0280720507584399,0.00317797727029647,0.0218432153086588,0.034300886208221,1.07282388788625e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSPN,Persephin,29434,0.0589921394804181,0.00669318042287661,0.04587350585158,0.0721107731092563,1.2753102250465e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0342002285031546,0.00388599950643932,0.0265836694705335,0.0418167875357756,1.44640163393907e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMD,Osteomodulin,29581,-0.0270022677507202,0.00307143759411848,-0.0330222854351924,-0.0209822500662479,1.55533784588703e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGA,Fibrinogen alpha chain,24407,0.0192916249648184,0.00220444210137537,0.0149709184461227,0.0236123314835141,2.24395219447347e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0204108585767034,0.00233397001555455,0.0158362773462165,0.0249854398071903,2.36570440801082e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0241301453240298,0.00277734989731665,0.0186865395252892,0.0295737511227705,3.8704297806843e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0223744298763893,0.0025779666388794,0.0173216152641857,0.0274272444885929,4.23582094265618e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0278442909824084,0.00320911060899136,0.0215544341887853,0.0341341477760314,4.32230585576288e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSH,Pro-cathepsin H,28852,0.0451012001092524,0.00522147081690586,0.0348671173081169,0.0553352829103878,6.02941367631603e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,24845,0.146864071917239,0.0170719342397319,0.113403080807365,0.180325063027114,8.2416707428211e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0174037825737082,0.00202794103053783,-0.0213785469935624,-0.0134290181538541,9.77460634472669e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYZL2,Lysozyme-like protein 2,24016,0.0220693565991382,0.00257122587021458,0.0170297538935177,0.0271089593047588,9.77701115474345e-18
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,24793,0.0362432893510691,0.00423080875987857,0.0279509041817071,0.0445356745204311,1.12772780148955e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0201688085008099,0.00235561108725742,0.0155518107697854,0.0247858062318345,1.17386106013164e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.0248851302541842,0.00291119651554623,0.0191791850837136,0.0305910754246548,1.31252593721845e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCN5,CCN family member 5,29443,0.0236561459554237,0.00277067194345154,0.0182256289462587,0.0290866629645887,1.42969894885243e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0342011999491858,0.00400904183086644,0.0263434779606875,0.042058921937684,1.53475686085736e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0205102092101782,0.00240598161507899,0.0157944852446234,0.025225933175733,1.61799613769578e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0240700723395781,0.00283040375004567,0.0185224809894886,0.0296176636896676,1.93159841111353e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHISA5,Protein shisa-5,24938,0.0153549439613968,0.00180574035072606,0.0118156928739737,0.0188941950488198,1.94279819975658e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD209,CD209 antigen,29527,-0.0235200554537513,0.00277040598329992,-0.0289500511810191,-0.0180900597264835,2.16644390913461e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0157854769098442,0.00186053151479021,0.0121388351408554,0.019432118678833,2.2692839492185e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A14,Protein S100-A14,24867,0.0319895554281565,0.00377091120733617,0.0245985694617776,0.0393805413945354,2.31023188872453e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.015088620072243,0.00178013521669272,-0.0185776850969607,-0.0115995550475252,2.45925568159728e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLVRB,Flavin reductase,29443,0.0392473797328162,0.00463593759997008,0.0301609420368748,0.0483338174287575,2.65824009499473e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.0204688847739941,0.00242048389153969,0.0157247363465763,0.0252130332014118,2.88022835908006e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMB,Granzyme B,29434,0.0392822952216086,0.00464532892611399,0.0301774505264251,0.048387139916792,2.88579661327729e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSTL3,Follistatin-related protein 3,29351,0.0191908221600312,0.0022716164805626,0.0147384538581285,0.0236431904619339,3.09593039680374e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0334519507700651,0.00396179142519489,0.0256868395766831,0.0412170619634471,3.24207387799233e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0215627923241005,0.00255762190614696,0.0165498533880525,0.0265757312601486,3.62284773575126e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0183662231544197,0.00218339251857809,-0.0226456724908327,-0.0140867738180066,4.26022838087694e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0461777875523135,0.00549318804328477,0.0354111389874754,0.0569444361171517,4.45893047699991e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSHB,Thyrotropin subunit beta,29478,0.0459801535013593,0.00547576503616761,0.0352476540304707,0.0567126529722478,4.78185730613305e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARF2,Scavenger receptor class F member 2,29694,-0.0174034977793301,0.00207701658883583,-0.0214744502934483,-0.0133325452652118,5.56639389197746e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNLY,Granulysin,29443,0.0311426270391552,0.00371704738940856,0.0238572141559145,0.038428039922396,5.60442933509561e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0201218517294759,0.00240170215150631,-0.0248291879464283,-0.0154145155125235,5.61164332031737e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA7,Carbonic anhydrase 7,24445,-0.0205421540020947,0.00245370931661198,-0.0253514242626542,-0.0157328837415353,5.97099571574272e-17
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.0237157372711268,0.00285696523264386,0.0181160854151449,0.0293153891271088,1.08388902853848e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA1,Annexin A1,24281,0.025244791447426,0.00305132957535195,0.0192641854797362,0.0312253974151158,1.36838667587397e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.0158579700716944,0.00191808439955292,0.0120985246485706,0.0196174154948181,1.42335201762469e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0148201642775075,0.00179500451008608,0.0113019554377387,0.0183383731172762,1.56425433595695e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0248693804113149,0.00301319158537149,0.0189635249039868,0.030775235918643,1.61376116936233e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP4,Guanylate-binding protein 4,28774,0.028863291502396,0.00349891786585766,0.0220054124853149,0.035721170519477,1.6618521357444e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.0250285849234721,0.00303467855439926,0.0190806149568496,0.0309765548900946,1.68495524470366e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,24922,-0.020860955335346,0.00252929834358051,-0.0258183800887638,-0.0159035305819282,1.69329170497609e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,24845,0.0273230109406161,0.00331410281621973,0.0208273694208255,0.0338186524604068,1.74018684537486e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,24801,0.0225884537233008,0.00274004123579364,0.0172179729011453,0.0279589345454564,1.7494977628964e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GZMH,Granzyme H,28916,0.0448627768794736,0.00544541940024374,0.0341897548549959,0.0555357989039513,1.81480811736012e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0311364448057185,0.00379919780341012,0.0236900171110347,0.0385828725004023,2.59700355033309e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,29218,-0.0211357310515723,0.00257952094603394,-0.0261915921057988,-0.0160798699973458,2.63642102951427e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNG,Interferon gamma,28931,0.0663708635318007,0.00810438185255172,0.0504862751007994,0.0822554519628021,2.7300510180833e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,24888,-0.0286006184723959,0.00349272550187813,-0.035446360456077,-0.0217548764887147,2.7678966020345e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNC,Tenascin,29594,-0.0275771504535853,0.00339674254854471,-0.034234765848733,-0.0209195350584377,4.89321459892487e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB37,Ras-related protein Rab-37,28931,0.0475736018464343,0.00585980192900716,0.0360883900655803,0.0590588136272883,4.90020246687861e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0361092726186848,0.00448948229613583,0.0273098873182586,0.0449086579191111,9.14884955023535e-16
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0256337344782875,0.00319809149175105,0.0193654751544555,0.0319019938021196,1.13898996569402e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.0153590870228182,0.00191641733308727,0.0116029090499672,0.0191152649956693,1.14657696099097e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHAD,Chondroadherin,24381,0.0296284771858084,0.00369657731446158,0.0223831856494638,0.0368737687221531,1.14938626064727e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIMAP7,GTPase IMAP family member 7,24381,-0.0184175640476872,0.00230540336412611,-0.0229361546413744,-0.0138989734540001,1.42168940064568e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBS4,Thrombospondin-4,29518,0.025692143316669,0.00321999669935187,0.0193809497859393,0.0320033368473987,1.52914829609425e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGA,Glycoprotein hormones alpha chain,29443,0.045520701381268,0.0057129033505466,0.0343234108141966,0.0567179919483393,1.6698308730274e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNA1,Ephrin-A1,29390,0.0160281902096023,0.00201315246284675,0.0120824113824226,0.0199739690367819,1.7572167021382e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,29581,0.0153043756490082,0.00192357128321685,0.0115341759339031,0.0190745753641132,1.83658735380061e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKD1,Polycystin-1,24922,0.0150761732192151,0.00189521910229449,0.0113615437787178,0.0187908026597123,1.86934642289162e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPH1,Neurexophilin-1,28774,0.0216372788822457,0.00272227540610778,0.0163016190862744,0.0269729386782169,1.96072955949633e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0243886003032696,0.00307478274051793,0.0183620261318544,0.0304151744746847,2.23718803643177e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.01737769093141,0.00219576035488799,-0.0216813812269905,-0.0130740006358296,2.57697549203177e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRCAM,Neuronal cell adhesion molecule,29478,0.0159515664837689,0.00201739496374593,0.0119974723548268,0.0199056606127109,2.72804669524038e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.0131121052679045,0.00166021777573326,0.00985807842746733,0.0163661321083417,2.9356577072954e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP7,Dipeptidyl peptidase 2,29279,0.0338177322008795,0.00428474032828875,0.0254196411574335,0.0422158232443254,3.06244127178209e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP1,"Fatty acid-binding protein, liver",29454,0.0527492090716089,0.00669343008009014,0.0396300861146322,0.0658683320285855,3.36609938350627e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA7A,Semaphorin-7A,29736,0.0154787852679058,0.00196922222541262,0.011619109706097,0.0193384608297145,3.95936404322265e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSM,Oncostatin-M,29293,0.0397593763258187,0.00505988554377929,0.0298420006600113,0.0496767519916261,4.04400875931616e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.027201243823631,0.00346683570435948,0.0204062458430864,0.0339962418041756,4.43818776516644e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRUNE2,Protein prune homolog 2,24445,0.0163667821688387,0.00208624520109212,0.0122777415746981,0.0204558227629792,4.50273253654018e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0194946718125879,0.0024914859109112,0.0146113594272019,0.0243779841979738,5.26421900025471e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0215921993618099,0.00276900559557242,0.0161649483944879,0.0270194503291318,6.50675104942664e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.0136519225719515,0.00175395243183751,-0.017089669338353,-0.01021417580555,7.28098884757197e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICOSLG,ICOS ligand,29349,0.0105557911946234,0.00136012506699536,0.00788994606331245,0.0132216363259343,8.70633809742606e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.0242060593469298,0.00312305736109206,-0.0303272517746702,-0.0180848669191893,9.42814915095765e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA5,Protein disulfide-isomerase A5,24016,0.0339579357124629,0.00438106636111118,0.0253710456446849,0.0425448257802408,9.47267388674528e-15
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PADI4,Protein-arginine deiminase type-4,28722,0.0391439800913458,0.00506177284761371,0.0292229053100229,0.0490650548726687,1.0825443239123e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP3,"Fatty acid-binding protein, heart",24922,0.0279445241406657,0.00361359446048647,0.0208618789981122,0.0350271692832192,1.0886191660561e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0214990528672828,0.00278068991599799,0.0160489006319268,0.0269492051026389,1.09618795203231e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OBP2B,Odorant-binding protein 2b,29137,-0.034433582207208,0.00446103666212489,-0.0431772140649728,-0.0256899503494432,1.2123815685456e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0277882319477467,0.00361505318949095,0.0207027276963444,0.0348737361991489,1.5642875975294e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.0210946398929155,0.00274553159214851,0.0157133979723044,0.0264758818135266,1.60800592611349e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAM,Basal cell adhesion molecule,29443,-0.0131603729442322,0.00171515477120851,-0.0165220762958009,-0.00979866959266356,1.73213016437921e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.0151041384490414,0.00196949590343894,0.0112439264783011,0.0189643504197817,1.78755022113001e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLGN,Calmegin,24195,0.024580508350248,0.00320713487969181,0.0182945239860521,0.030866492714444,1.86524106668677e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA9,Carbonic anhydrase 9,29725,-0.0249172177548076,0.00325738816243896,-0.0313016985531879,-0.0185327369564272,2.07940438426575e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB1A1,Uteroglobin,29523,0.0300004355597475,0.00393828665869197,0.0222813937087112,0.0377194774107837,2.66088933644632e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOB,Apolipoprotein B-100,24951,0.0122176123404594,0.00160525589790142,0.00907131078057263,0.0153639139003462,2.81584785931055e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.0482099686620889,0.00634467003814817,0.0357744153873184,0.0606455219368593,3.08450528900072e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINI1,Neuroserpin,24329,0.0165640462074842,0.00218288810510494,0.0122855855214786,0.0208425068934899,3.36176864128364e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNPEP,Aspartyl aminopeptidase,24845,0.0314852645842981,0.00415694794578537,0.0233376466105588,0.0396328825580375,3.74131128284485e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MST1,Hepatocyte growth factor-like protein,24615,0.0346774101954306,0.00458083904973925,0.0256989656579417,0.0436558547329195,3.86018134262681e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SATB1,DNA-binding protein SATB1,24867,0.0160228698609481,0.00211806035991704,0.0118714715555107,0.0201742681663855,4.01666857222616e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.022783861919455,0.00301245896579254,0.0168794423465016,0.0286882814924084,4.04698994530132e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.0145128217681055,0.00191974346579425,0.0107501245751488,0.0182755189610622,4.1547377206479e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.019617708584646,0.00259579628919501,0.0145299478578237,0.0247054693114682,4.23069063286688e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.0260571328298001,0.00344901687779954,0.019297059749313,0.0328172059102872,4.33927881907854e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.0201193931310276,0.00267357498562458,0.0148791861592034,0.0253596001028518,5.44397757577636e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG3,Desmoglein-3,29589,0.0183222806337596,0.00243560608637327,0.013548492704468,0.0230960685630512,5.51884655078131e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPE,Carboxypeptidase E,29468,-0.0206132648981352,0.00275053209620664,-0.0260043078067002,-0.0152222219895702,6.85332839566023e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,24240,0.0212338920657399,0.00283586154546318,0.0156756034366321,0.0267921806948478,7.25179507176889e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.0114417085546403,0.00152835294968136,-0.0144372803360157,-0.00844613677326482,7.28609834125866e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.0140925966862416,0.0018879856447548,-0.017793048549961,-0.0103921448225222,8.64473180017738e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0257335542927446,0.00344968954682394,0.0189721627809696,0.0324949458045195,8.96573613207474e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL34,Interleukin-34,28722,0.0191990247446969,0.00257578474831764,0.0141504866379943,0.0242475628513994,9.33450937718494e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECM1,Extracellular matrix protein 1,24349,0.0195530640762332,0.00262325473755175,0.0144114847906318,0.0246946433618347,9.37540083552516e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE1,Ribonuclease pancreatic,24951,0.0129604115606073,0.00173892609371289,0.00955211641693,0.0163687067042845,9.41273012742832e-14
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN10,Ataxin-10,28774,0.0384946955704391,0.00518311389429457,0.0283357923376217,0.0486535988032564,1.14218730511624e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0332590689727498,0.0044803181824259,0.0244776453351951,0.0420404926103046,1.17937297649561e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RSPO3,R-spondin-3,29725,0.01499068471838,0.00202003984765107,0.0110314066169839,0.0189499628197761,1.19363491239689e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPC1,Glypican-1,29725,0.0155582351776818,0.00209781089020661,0.0114465258328768,0.0196699445224868,1.23545483026954e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PODXL,Podocalyxin,29349,0.00799530118066868,0.00107925742596058,0.00587995662578595,0.0101106457355514,1.31520767480348e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRELP,Prolargin,29454,0.0122602837068929,0.00165717916855074,0.00901221253653341,0.0155083548772523,1.41635214063716e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTN2,Alpha-actinin-2,24111,-0.0311771749711059,0.00423027589399976,-0.0394685157233455,-0.0228858342188664,1.76107037337966e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0449690926045737,0.00610964977401678,0.0329941790475008,0.0569440061616466,1.89317626628933e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HGFAC,Hepatocyte growth factor activator,24720,0.0147195469803185,0.00200259604337278,0.0107944587353079,0.0186446352253292,2.04005256659029e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM2,Myomesin-2,24111,-0.0267303853472175,0.00364317880776136,-0.0338710158104298,-0.0195897548840053,2.25164386787452e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN2,Prefoldin subunit 2,28774,0.0290778809768182,0.00396391239663081,0.0213086126794218,0.0368471492742146,2.26472231884623e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0157294905473248,0.00215278902326333,0.0115100240617287,0.0199489570329209,2.81184596939175e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.018309629415199,0.00250884094679884,0.0133923011594733,0.0232269576709247,3.00768387908754e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0155979783055648,0.00213919441325051,0.0114051572555938,0.0197907993555358,3.14373641768846e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,29409,0.0239737078150927,0.0032884876099828,0.0175282720995265,0.030419143530659,3.17312712689967e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDC1,Syndecan-1,29478,0.0208716591068003,0.00286306899617845,0.0152600438742905,0.02648327433931,3.17840832389948e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,24867,0.0156559692148834,0.00214747699269134,0.0114469143092084,0.0198650241205584,3.18264622305737e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.0272180912641129,0.00373722830339966,0.0198931237894495,0.0345430587387762,3.34924550326274e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD7,T-cell antigen CD7,24177,0.0226983705258791,0.00311746108363303,0.0165881468019583,0.0288085942497998,3.41376964608501e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0202566736516567,0.00278280944834524,0.0148023671329,0.0257109801704134,3.46013229974502e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.0272853001962931,0.00374934530236632,0.0199365834036551,0.0346340169889311,3.49142804174326e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00912370837438409,0.00125518745494866,0.00666354096268472,0.0115838757860835,3.71704058888953e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIL1,Nucleotide exchange factor SIL1,24240,0.0167445509988655,0.00230696832534169,0.0122228930811957,0.0212662089165352,4.03944181082095e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0172024390248513,0.00237184298032118,0.0125536267834218,0.0218512512662808,4.18509314425577e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,24738,-0.013978164218397,0.00193362396999262,-0.0177680671995826,-0.0101882612372115,5.00697859287441e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN1,Contactin-1,29820,-0.013972761214613,0.00194185573665278,-0.0177787984584524,-0.0101667239707735,6.36673479334973e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UROS,Uroporphyrinogen-III synthase,24195,0.0350360941434258,0.0048722894782005,0.0254864067661528,0.0445857815206988,6.62424556938611e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTPN,Myotrophin,28916,0.0167958536953141,0.0023364015431043,0.0122165066708297,0.0213752007197985,6.69628311096061e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF16,Fibroblast growth factor 16,24229,0.0244272633942998,0.00341933589107683,0.0177253650477892,0.0311291617408104,9.33116078847337e-13
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0129216734649522,0.0018172898665596,0.00935978532649543,0.0164835616034091,1.18342967343323e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL2L15,Bcl-2-like protein 15,24229,0.0286058844597659,0.00402797742248229,0.0207110487117006,0.0365007202078312,1.26546290490724e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIF,Leukemia inhibitory factor,28774,0.0259938609819227,0.00366309075274121,0.0188142031065499,0.0331735188572955,1.31244477659646e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAP,Cartilage-associated protein,24195,0.0246822717354052,0.00348120084721036,0.0178591180748729,0.0315054253959375,1.37639496535052e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD6,Programmed cell death protein 6,29478,-0.0353515998091303,0.00498850859505025,-0.0451290766554288,-0.0255741229628318,1.40527984997278e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB44,Ras-related protein Rab-44,24793,0.0212925962492356,0.00300581528354043,0.0154011982934964,0.0271839942049748,1.44001852567483e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0351022799395029,0.00496715403248245,0.0253666580358373,0.0448379018431685,1.6271130803488e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MATN3,Matrilin-3,29169,-0.0161639339677257,0.00229090615048491,-0.0206541100226762,-0.0116737579127753,1.7557369777384e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OLFM4,Olfactomedin-4,23498,0.0620166332433357,0.0087940586980836,0.0447802781950919,0.0792529882915796,1.81114766016094e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.0194889441570835,0.00277326005504485,0.0140533544491956,0.0249245338649714,2.14918614066783e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRC1,Macrophage mannose receptor 1,24951,0.0141793190352596,0.00202018273643297,0.010219760871851,0.0181388771986682,2.29461302760886e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.0154556316552542,0.00220246250136891,-0.0197724581579373,-0.0111388051525712,2.30855497828772e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROCR,Endothelial protein C receptor,24111,-0.0179196914154891,0.00255992752095658,-0.022937149356564,-0.0129022334744143,2.62528777511349e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.021967793814751,0.00314023978188919,0.0158129238422481,0.0281226637872538,2.71041886351307e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0203273170902331,0.00290962350308548,-0.0260301791562807,-0.0146244550241856,2.88380411575699e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDI2,Protein DDI1 homolog 2,24381,0.0381533721114862,0.00546827763796567,0.0274355479410735,0.048871196281899,3.08785280652615e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGB2A2,Mammaglobin-A,24111,-0.0157302057768919,0.0022552747966691,-0.0201505443783634,-0.0113098671754205,3.14109779052907e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGA4,Pepsin A-4,24951,0.0352951830598791,0.00507337589457162,0.0253513663065188,0.0452389998132395,3.56331728496864e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACAN,Aggrecan core protein,29192,0.014001567176741,0.00201454046460648,0.0100530678661123,0.0179500664873697,3.72290492908989e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GM2A,Ganglioside GM2 activator,24421,0.0190238101209895,0.00274188903912394,0.0136497076043066,0.0243979126376724,4.07013602979738e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN8,Tetraspanin-8,24805,0.049480573291498,0.00714512177157969,0.0354761346192018,0.0634850119637942,4.46352127935808e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM5,Intercellular adhesion molecule 5,29478,0.0221827670220626,0.00320384348804827,0.015903233785488,0.0284623002586372,4.48700734709417e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TK1,"Thymidine kinase, cytosolic",24445,0.0226247952226514,0.00326880660667912,0.0162179342735603,0.0290316561717425,4.58182558142709e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SDK2,Protein sidekick-2,24381,0.0191104671644557,0.00276536639613576,0.0136903490280296,0.0245305853008818,4.94339649608875e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFHR4,Complement factor H-related protein 4,24892,0.0360948450686693,0.00522333949600446,0.0258570996565005,0.046332590480838,4.95294454360791e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LGALS4,Galectin-4,29454,0.0268381865768283,0.00388515502044625,0.0192232827367537,0.034453090416903,5.01945514912225e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BOC,Brother of CDO,28916,-0.0115281763481121,0.00167015073803531,-0.0148016717946613,-0.00825468090156287,5.2158418172077e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.0201121444652413,0.00291467149105175,0.0143993883427799,0.0258249005877027,5.31377321212988e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTG,Protogenin,29725,0.0122414713709795,0.00177544054041488,0.00876160791176632,0.0157213348301926,5.49829513763622e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD1,Bromodomain-containing protein 1,24445,-0.0150723547919152,0.0021913142385916,-0.0193673306995548,-0.0107773788842757,6.20640990895065e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNU13,NHP2-like protein 1,24111,0.0306948764273144,0.0044667388641466,0.0219400682535871,0.0394496846010417,6.49069347377275e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,29116,0.0144166615483,0.0020984268854376,0.0103037448528423,0.0185295782437577,6.53911603786777e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,28774,0.0416272521431972,0.00607051075810712,0.0297290510573073,0.0535254532290872,7.15974676003023e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF7,SLAM family member 7,29434,-0.0285886986554086,0.00417558888101037,-0.0367728528621889,-0.0204045444486283,7.7096028029711e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,29678,0.0132130957690879,0.00193600322258156,0.00941852945282806,0.0170076620853478,8.96564838208188e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP1,Caspase-1,28774,0.0329966941503198,0.00484038499126435,0.0235095395674416,0.0424838487331979,9.48253723359348e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSG4,Desmoglein-4,29242,0.0240591890044026,0.00353079402084872,0.0171388327235391,0.0309795452852661,9.66942173105954e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.0193508279258746,0.00284095686630174,0.0137825524679232,0.024919103383826,9.85699510927633e-12
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0279984011469243,0.0041193659474556,0.0199244438899113,0.0360723584039372,1.09073476319142e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATXN2,Ataxin-2,24101,0.0538256394293696,0.00792127888557288,0.0382999328136468,0.0693513460450925,1.10784595364548e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALPP,"Alkaline phosphatase, placental type",29349,0.0498259270646066,0.00737066877631289,0.0353794162630333,0.0642724378661798,1.40548191260977e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYTL1,Cytokine-like protein 1,24938,0.0116033124146223,0.00172308830784827,0.00822605933123969,0.0149805654980049,1.68624629990701e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN2,Calsyntenin-2,29786,-0.0188650796864187,0.00282012968362358,-0.0243925338663209,-0.0133376255065165,2.27995458738083e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOSB,Protein fosB,28774,0.0184521382607957,0.00276191732771604,0.0130387802984722,0.0238654962231191,2.41782261549258e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPARCL1,SPARC-like protein 1,29489,-0.0130722808305638,0.00195717611645871,-0.0169083460188229,-0.00923621564230478,2.44595496957527e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PREB,Prolactin regulatory element-binding protein,28931,0.0137936271424609,0.00206827531202005,0.00973980753090156,0.0178474467540202,2.61931720166926e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.0124577854397364,0.00187207796031789,-0.0161270582419594,-0.00878851263751332,2.90343232635939e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST1,Cystatin-SN,21656,0.0498923831034458,0.00750789460638345,0.0351769096749342,0.0646078565319574,3.0974935493419e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLASP1,CLIP-associating protein 1,24016,0.0345731115413601,0.00521242160069762,0.0243567652039928,0.0447894578787274,3.36311574994551e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMOD1,Leiomodin-1,24867,-0.0166600810879328,0.00253222722085208,-0.0216232464408029,-0.0116969157350628,4.82324070947008e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMS1,PMS1 protein homolog 1,24195,0.0238398297668279,0.00362527440560941,0.0167342919318334,0.0309453676018223,4.93108504152647e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSBP1,Heat shock factor-binding protein 1,24240,0.0448687119854061,0.00683124337223866,0.0314794749758183,0.0582579489949939,5.19725473239762e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARG1,Arginase-1,29216,0.0242251172338748,0.00368905574139367,0.0169945679807432,0.0314556664870064,5.22868685377586e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLIN3,Perilipin-3,29478,0.0198702976402106,0.00303109578556268,0.0139293499005077,0.0258112453799134,5.6377715966561e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK8,Kallikrein-8,28443,0.0168068958323044,0.00256701229176225,0.0117755517404504,0.0218382399241584,5.96005825754227e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.0108563995642988,0.00166048309781777,0.00760185269257597,0.0141109464360216,6.33336761597816e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0287528398338246,0.00440465129204436,0.0201197233014176,0.0373859563662315,6.7831597775864e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0186094027101903,0.00285327892329963,0.013016976020523,0.0242018293998576,7.06602624354256e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0243527329071868,0.00374193690231996,0.0170185365786396,0.0316869292357339,7.75842195117588e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,29623,0.0379837952466734,0.00585851906645141,0.0265010978764286,0.0494664926169182,9.10196527685344e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0479211999683326,0.0073962428908739,0.0334245639022198,0.0624178360344455,9.40295242592556e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX3,Syntaxin-3,24845,0.0177291927743707,0.00273834612653595,0.0123620343663603,0.0230963511823812,9.6956929286444e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,24111,0.020361816553842,0.00314709922794539,0.0141935020670691,0.026530131040615,9.98668582806964e-11
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,27939,0.0184423533284864,0.00285184016087357,0.0128527466131742,0.0240319600437986,1.01736040962423e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.0102578960489257,0.00158668322800697,0.00714799692203205,0.0133677951758194,1.02889812550997e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0480724700397114,0.0074513792783124,0.0334677666542191,0.0626771734252037,1.12491051042742e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C8B,Complement component C8 beta chain,24966,0.0139909527384254,0.00216893526172759,0.00973983962543936,0.0182420658514115,1.13442512782179e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.032815969680353,0.00508847428506861,0.0228425600816185,0.0427893792790874,1.14600123791237e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDN1,Endothelin-1,24240,0.0134291581166437,0.0020845449845397,0.00934344994694588,0.0175148662863415,1.19926068466696e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRLB,Fc receptor-like B,28797,0.0281166183053706,0.00436667676494574,0.0195579318460769,0.0366753047646642,1.22233620946915e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL1A1,Collagen alpha-1(I) chain,29820,-0.0114184813716367,0.00178168390071406,-0.0149105818170363,-0.00792638092623715,1.48844987441703e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN1,Nectin-1,24229,0.0148025969812124,0.00231152546563063,0.0102720070685764,0.0193331868938485,1.54315204589695e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST7,Cystatin-F,29498,0.0423917210276656,0.00662683139345412,0.0294031314964955,0.0553803105588356,1.60852540675739e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0125473975530361,0.00196404239590135,0.00869787445706944,0.0163969206490027,1.70416177551172e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,24845,0.013541402453331,0.00212433888115526,0.00937769824626672,0.0177051066603953,1.86897636549458e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL6,Interleukin-6,29349,0.0334705643674686,0.00525185388410311,0.0231769307546265,0.0437641979803107,1.87999990797686e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC16,Mucin-16,29349,0.0857626584889065,0.0134610254562348,0.0593790485946864,0.112146268383127,1.9035578391837e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EGFLAM,Pikachurin,24805,0.0140009047793281,0.00219824178603164,0.00969235087870606,0.0183094586799501,1.93427608128423e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEPD,Xaa-Pro dipeptidase,24951,0.0118957925569966,0.00186794629801676,0.00823461781288378,0.0155569673011095,1.94363651780001e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.013291593324103,0.00209590020441499,0.00918362892344957,0.0173995577247563,2.31274969444057e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0168691656499609,0.00266486716415848,0.0116460260082103,0.0220923052917115,2.490215971717e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFHD1,EF-hand domain-containing protein D1,24867,0.0159078288179346,0.00251610796342344,0.0109762572096247,0.0208394004262446,2.61916219774344e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD48,CD48 antigen,29536,0.0134228940657841,0.0021348739322757,0.0092385411585237,0.0176072469730445,3.27253698148219e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNPY2,Protein canopy homolog 2,28916,0.0272965727718158,0.00434184221214713,0.0187865620360075,0.0358065835076242,3.28567452580418e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,28733,0.0127898522475567,0.00204303242390432,0.00878550869670421,0.0167941957984091,3.89843106141264e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0139397431802568,0.00222887619479019,0.00957114583846803,0.0183083405220456,4.06347490780609e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDHR1,Cadherin-related family member 1,28774,0.018980838039524,0.00304912635195287,0.0130045503896964,0.0249571256893516,4.88175253204755e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALB1,Calbindin,29349,0.0193449480759051,0.00311032947207873,0.0132487023106308,0.0254411938411794,5.05203409038447e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.0254458687883882,0.00409512446785039,0.0174194248314014,0.0334723127453749,5.24439177000777e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPS10,40S ribosomal protein S10,24111,-0.0185673040275776,0.00299654883607152,-0.0244405397462778,-0.0126940683088774,5.87683304238166e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0300048218067588,0.00485797096322349,-0.0395264448946768,-0.0204831987188408,6.65928594488824e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0306348720293088,0.00497679367325097,0.0208803564297369,0.0403893876288807,7.57932788352243e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD86,T-lymphocyte activation antigen CD86,24805,0.0131457834568074,0.00213684437163885,0.00895756848839523,0.0173339984252195,7.77015711896777e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSAB1,Tryptase alpha/beta-1,29753,0.0229486337475767,0.00373093418405553,0.0156360027468279,0.0302612647483255,7.8021360490927e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANPEP,Aminopeptidase N,29531,0.012291039610416,0.00199936168929935,0.00837229069938924,0.0162097885214427,7.97303856568907e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KEL,Kell blood group glycoprotein,28774,0.0157298092928062,0.00255886283603754,0.0107144381341726,0.0207451804514397,7.99050053089061e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FABP9,Fatty acid-binding protein 9,29434,0.0244530936250589,0.00399202604656172,0.0166287225737979,0.0322774646763198,9.15529308655951e-10
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL3,Myosin light chain 3,24240,-0.031797385135054,0.00522238932455945,-0.0420332682111906,-0.0215615020589175,1.15567161173463e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHB6,Ephrin type-B receptor 6,29163,0.013817647988154,0.0022733840171155,0.00936181531460767,0.0182734806617004,1.23192659426203e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.037013699595405,0.0060977673190856,-0.0489653235408128,-0.0250620756499972,1.29491566028537e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0331939980598722,0.00547450607431021,0.0224639661542242,0.0439240299655203,1.35282339753629e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAFB2,Scaffold attachment factor B2,24867,0.0118591405645567,0.0019584282262552,0.00802062124109652,0.0156976598880169,1.4204466164738e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.0143488968850919,0.00237229907551541,0.00969919069708173,0.0189986030731021,1.48272193984949e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0207660194465001,0.00344065557240777,-0.0275097043684193,-0.0140223345245809,1.60381400711886e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MILR1,Allergin-1,28931,-0.0215782059707425,0.00359722752455545,-0.0286287719188712,-0.0145276400226139,2.01430623596773e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,F3,Tissue factor,29541,-0.011661257180336,0.00194734855506938,-0.0154780603482719,-0.00784445401239997,2.14527663698488e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LHB,Lutropin subunit beta,28797,0.0370988517651978,0.00620162934149171,0.0249436582558741,0.0492540452745216,2.22858861682355e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBA,Lysosomal acid glucosylceramidase,24195,0.0230139838047411,0.00385123416361247,0.0154655648440606,0.0305624027654215,2.32250447382458e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP2,Guanylate-binding protein 2,28931,0.0255349016898666,0.00427384974445677,0.0171581561907313,0.0339116471890019,2.33230436689564e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0141502271790214,0.0023718601059257,-0.0187990729866357,-0.00950138137140699,2.46719671047028e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEO1,Neogenin,24867,0.00933264725584159,0.00156497654326086,0.0062652932310503,0.0124000012806329,2.50314656341156e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB6A,Ras-related protein Rab-6A,29434,0.0196161694410402,0.00329980676997573,0.0131485481718877,0.0260837907101926,2.80181611475668e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0283509158432388,0.00477281781209609,0.0189961929315305,0.0377056387549471,2.88684923794089e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.0133603410459016,0.00225234392490908,-0.0177749351387234,-0.00894574695307983,3.03812533316878e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPA2,Replication protein A 32 kDa subunit,24229,0.0134566410335855,0.00227273953428333,0.00900207154639017,0.0179112105207808,3.24520466377243e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPEP1,Dipeptidase 1,29163,-0.0204730488485742,0.00346105791678751,-0.0272567223654777,-0.0136893753316707,3.35050268030077e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.020557477680339,0.00348326108984719,0.0137302859442385,0.0273846694164395,3.64240258647003e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.0155687535252205,0.00264050954616235,0.0103933548147423,0.0207441522356987,3.76221169557571e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH3,Cadherin-3,29694,0.0151937654650851,0.00257971798014193,0.0101375182240069,0.0202500127061633,3.91060824400062e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0184632984981273,0.00313499561243148,0.0123187070977616,0.024607889898493,3.92630127212671e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA1,Alpha-1-antitrypsin,24548,-0.00340904543606081,0.000580842057650337,-0.00454749586905547,-0.00227059500306615,4.43683168754657e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.015844737220793,0.00270059345198487,-0.0211379003866834,-0.0105515740549027,4.49017551443248e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLC,Galectin-10,29426,-0.0276973101313135,0.00472425930887363,-0.0369568583767058,-0.0184377618859212,4.60026969511159e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LXN,Latexin,29117,-0.0280442414361799,0.0047935069230358,-0.0374395150053301,-0.0186489678670297,4.95444452292152e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERC2,ERC protein 2,24195,0.0314752203201764,0.00538468892633678,0.0209212300245563,0.0420292106157965,5.12091545398314e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0165486965119676,0.00283433563389438,-0.0221039943544006,-0.0109933986695346,5.32776040777665e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLL4,Delta-like protein 4,24240,0.0356898899880152,0.00613880412803598,0.0236578338970647,0.0477219460789658,6.18298836684936e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AHNAK2,Protein AHNAK2,24240,0.0123436579230139,0.00212488997265174,0.00817887357661648,0.0165084422694113,6.36022669308503e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC1,Sialoadhesin,29581,0.0175735010899573,0.00302609663305654,0.0116423516891664,0.0235046504907481,6.41311256518088e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPO,Erythropoietin,29434,0.0313680745386084,0.00540897271330249,0.0207664880205355,0.0419696610566813,6.72863265450073e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,28722,0.0221192311209258,0.00382473247033393,0.0146227554790713,0.0296157067627803,7.40478975952127e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0170342564324754,0.00295062752427522,-0.0228174863800548,-0.011251026484896,7.87830245879421e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0252598890341417,0.00437839212451017,0.0166782404701017,0.0338415375981816,8.05834740913041e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0154835256889865,0.0026911772958505,-0.0207582331888535,-0.0102088181891196,8.85009004162606e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHGA,Chromogranin-A,24938,-0.0360566051591036,0.00626764536718779,-0.0483411900787916,-0.0237720202394155,8.87963234090136e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRDX2,Peroxiredoxin-2,24556,0.025293533762424,0.00439891111992235,0.0166716679673762,0.0339153995574718,9.03267608433553e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTX2,Neuronal pentraxin-2,24938,-0.0136684206241533,0.00238060819530215,-0.0183344126869455,-0.00900242856136112,9.48937464565505e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PI3,Elafin,29014,0.0225095803246355,0.00392607587874912,0.0148144716022873,0.0302046890469838,9.94405879575615e-09
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAL,Galanin peptides,29581,-0.0262274114058391,0.00459625153745836,-0.0352360644192574,-0.0172187583924207,1.16587334623511e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0588298842620474,0.0103438681455333,0.0385559026968021,0.0791038658272928,1.30225571371547e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRSS53,Serine protease 53,24845,0.0151309149507718,0.00266609078364039,0.00990537701483662,0.0203564528867069,1.399724518229e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,28797,0.019015545619063,0.00335541098888578,0.0124389400808469,0.0255921511572791,1.46596849756118e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VIM,Vimentin,28916,0.0470779350599837,0.00831324295195608,0.0307839788741498,0.0633718912458176,1.50155331248253e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.0114163125213193,0.00201743080673584,-0.0153704769025216,-0.00746214814011709,1.54107857766853e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.0142383319513375,0.00251695994419093,0.00930509046072323,0.0191715734419517,1.55536023369952e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD55,Complement decay-accelerating factor,28490,0.0105980960307244,0.00187379940445033,0.00692544919800174,0.014270742863447,1.56480544142995e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEPACAM2,HEPACAM family member 2,24845,-0.0169090742099041,0.0029985064743081,-0.022786146899548,-0.0110320015202602,1.72732513188369e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLPS,Colipase,29400,0.028501039713473,0.00505498402305867,0.018593271028278,0.038408808398668,1.73406307839732e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEDD9,Enhancer of filamentation 1,24229,0.013391865945701,0.00238190232623637,0.00872333738627773,0.0180603945051243,1.90461908907472e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0157100176670684,0.00279479101318799,0.01023222728122,0.0211878080529169,1.91415479059162e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0108054069988468,0.0019236348439753,0.00703508270465517,0.0145757312930384,1.96171713642865e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMNB1,Lamin-B1,24756,0.0235539254095664,0.00419757838281481,0.0153266717792493,0.0317811790398834,2.02944673422588e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,24445,0.0181548168594754,0.00325032980107387,0.0117841704493706,0.0245254632695802,2.35466066959897e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0150965427242054,0.0027100588987154,-0.0204082581656876,-0.00978482728272326,2.56634802219227e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-0.0105342399646747,0.00189213320398632,-0.0142428210444879,-0.0068256588848615,2.60846305085145e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SNX18,Sorting nexin-18,24805,0.017656208676094,0.00318496501408648,0.0114136772484845,0.0238987401037035,2.993118430963e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK14,Kallikrein-14,29725,-0.0181876040314471,0.00328590085319284,-0.0246279697037051,-0.0117472383591891,3.13776196092913e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITM2A,Integral membrane protein 2A,29434,-0.0238056528752313,0.00430365951097819,-0.0322408255167485,-0.015370480233714,3.20219142542208e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF3,Granulocyte colony-stimulating factor,28931,0.019090180567229,0.00345218687729861,0.0123238942877237,0.0258564668467342,3.23217048508486e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF8,SLAM family member 8,28797,0.0210930041601744,0.00382231282464133,0.0136012710238774,0.0285847372964714,3.45068876405892e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,QSOX1,Sulfhydryl oxidase 1,24502,0.0167894181690555,0.00304333460591887,0.0108244823414545,0.0227543539966565,3.48751735126425e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0215597300806638,0.00391862070977079,0.0138792334895131,0.0292402266718146,3.79498454485281e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0218144756543474,0.00396754150741731,-0.0295908570088853,-0.0140380942998095,3.86799528404137e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0278709248829811,0.00507066418538208,0.0179324230796322,0.03780942668633,3.90578622813533e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RCC1,Regulator of chromosome condensation,24793,0.0201315719784104,0.00367586139262077,0.0129268836488737,0.0273362603079471,4.37552169327865e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLIC5,Chloride intracellular channel protein 5,24195,-0.0124085792374842,0.00227688041076379,-0.0168712648425812,-0.00794589363238718,5.0914361606183e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,24229,0.0250667650045991,0.00460330930172142,0.0160442787732251,0.0340892512359731,5.21976403369854e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FMR1,Synaptic functional regulator FMR1,28797,0.0137379819259065,0.00253453369323047,0.00877029588717477,0.0187056679646382,5.99702549456482e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHB4,Ephrin type-B receptor 4,29820,-0.00962566328420282,0.00177786398579224,-0.0131102766963556,-0.00614104987205002,6.20477512384391e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.0144861224231928,0.00268184323701294,0.00922970967864746,0.0197425351677382,6.65775757719146e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPP1,Osteopontin,29757,-0.0177426816765717,0.0032859004055976,-0.024183046471543,-0.0113023168816004,6.728550859742e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MBL2,Mannose-binding protein C,24610,-0.0416218012730551,0.00771533837516955,-0.0567438644883874,-0.0264997380577228,6.92782322160866e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPON1,Spondin-1,29497,0.0126004953436504,0.00234050911325642,0.00801309748166782,0.017187893205633,7.35450949479459e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0269462068860299,0.00503142421164278,-0.0368077983408497,-0.01708461543121,8.60402232652081e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00819520943064101,0.00153094665977859,0.00519455397747497,0.0111958648838071,8.72599127738283e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.022240679872815,0.00415885567619306,0.0140893227474766,0.0303920369981534,8.98350369616355e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.010926995498648,0.00204343427300047,0.00692186432356703,0.0149321266737289,9.00321965147025e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH12,Protocadherin-12,24867,0.00975178960247814,0.00182371496202222,0.0061773082769146,0.0133262709280417,9.01077135030076e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,29478,0.0120953186378918,0.00226374701760157,0.0076583744833927,0.0165322627923908,9.20721519829735e-08
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EXTL1,Exostosin-like 1,24111,0.0181088877454325,0.00340052656796058,0.0114438556722297,0.0247739198186352,1.01678844101948e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1R1,Interleukin-1 receptor type 1,29390,-0.00872597434772286,0.00164066743399142,-0.011941682518346,-0.00551026617709968,1.05360802703448e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.0137438407261695,0.00258749604171696,0.00867234848440428,0.0188153329679348,1.09575990904757e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,29581,0.0107994746749487,0.00203627455535519,0.00680837654645252,0.0147905728034449,1.14390353747466e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCAN,Versican core protein,29694,-0.0113291114589846,0.00214152053234232,-0.0155264917023756,-0.00713173121559369,1.23035665925565e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK11,Kallikrein-11,29296,0.0116266914109459,0.00219984077168507,0.00731500349844314,0.0159383793234486,1.26436521676565e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPA4,Carboxypeptidase A4,23902,0.0165548674087099,0.00313345442342554,0.0104132967387959,0.022696438078624,1.28014074204891e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSLN,Mesothelin,29293,0.0210508685052428,0.00398922056294837,0.013231996201864,0.0288697408086217,1.32294533099684e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD160,CD160 antigen,29786,0.0176282468777786,0.00334177805032581,0.0110783618991401,0.0241781318564172,1.33602946006562e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRIM26,Tripartite motif-containing protein 26,24016,0.0210914030223253,0.00400229577677031,0.0132469032998555,0.0289359027447951,1.37732013698663e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX5,Syntaxin-5,24229,0.0153824934699507,0.00291903948693675,0.00966117607555469,0.0211038108643468,1.37808207245267e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN4,Contactin-4,29443,-0.00903640260354203,0.00171594575676164,-0.0123996562867948,-0.00567314892028921,1.40303380967475e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0243426197768359,0.00463340562908189,0.0152611447438354,0.0334240948098364,1.50306082454121e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,24381,0.019800034948493,0.00377947694039596,0.012392260145317,0.0272078097516691,1.62941470059033e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.0116427191011522,0.00222894736168665,0.00727398227224633,0.016011455930058,1.76850489164835e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DSC2,Desmocollin-2,29135,-0.0127888934090216,0.00244990645654746,-0.0175907100638546,-0.00798707675418856,1.79998203950867e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0182719142667934,0.00351643319535768,0.0113797052038923,0.0251641233296944,2.04845434602193e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0127270479327411,0.0024505592118415,0.0079239518775318,0.0175301439879505,2.07722929734063e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0190303402746724,0.00367263138397033,0.0118319827620906,0.0262286977872543,2.21686966541745e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOA4,Apolipoprotein A-IV,24966,0.0132148093040842,0.00255126853252058,0.00821432298034385,0.0182152956278245,2.23967325178372e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC13A1,Solute carrier family 13 member 1,24793,0.0225298667601867,0.00436050201300095,0.0139832828147048,0.0310764507056685,2.39973000164415e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNGR1,Interferon gamma receptor 1,29581,0.00770537994631693,0.00149944432274814,0.00476646907373057,0.0106442908189033,2.78220045812044e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00711926439410063,0.00138747440167564,-0.00983871422138487,-0.00439981456681638,2.90216798895506e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0212935953225902,0.00415387171410943,0.0131520067629357,0.0294351838822446,2.97543997242327e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0164289615067637,0.0032076003100853,0.0101420648989965,0.0227158581145309,3.04760601101271e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMG4,Proteasome assembly chaperone 4,24229,0.0205312248590019,0.00400957299086853,0.0126724617968996,0.0283899879211042,3.06975514533807e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTX1,Neuronal pentraxin-1,29443,0.0148279639844652,0.00289877422286696,0.00914636650764593,0.0205095614612844,3.15285009968033e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA2,Ephrin type-A receptor 2,28347,0.0114654744129615,0.00224350035468355,0.00706821371778174,0.0158627351081412,3.23342369706966e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPH3,Neurexophilin-3,24229,0.0110384019403067,0.0021615057943992,0.00680185058328431,0.0152749532973292,3.30122989718706e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDK1,Cyclin-dependent kinase 1,24016,0.0133141016629008,0.00260738380375869,0.00820362940753378,0.0184245739182678,3.31026100077093e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.0134551495861721,0.00263862104773835,-0.0186268468397393,-0.00828345233260494,3.43463357622885e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17RA,Interleukin-17 receptor A,29443,0.0159192061274176,0.00314134633915036,0.00976216730268287,0.0220762449521523,4.05218148618542e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROBO4,Roundabout homolog 4,24240,-0.00651710046690637,0.00128638577424774,-0.00903841658443195,-0.0039957843493808,4.08793629949827e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYT1,Synaptotagmin-1,24845,0.0142564642676491,0.00282149450231876,0.00872633504310437,0.0197865934921939,4.38452567573943e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QL2,Complement C1q-like protein 2,24229,0.0153706245855943,0.00306812274868123,0.00935710399817905,0.0213841451730095,5.48751384647417e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA2,GDNF family receptor alpha-2,29349,0.00749364646164936,0.00149948081136535,0.00455466407137327,0.0104326288519254,5.84139835687861e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.00984683862128066,0.00197327918302667,0.00597921142254837,0.0137144658200129,6.06953278451e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,29434,0.0169688856852758,0.00340356086068246,0.0102979063983381,0.0236398649722134,6.21118753100534e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.0151826812892733,0.0030491884791317,0.00920627187017515,0.0211590907083714,6.41907176371711e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0144550425684845,0.00290539150309492,0.00876047522241845,0.0201496099145505,6.56102731587825e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0196772820260631,0.00396463007352841,0.0119066070819474,0.0274479569701787,6.97339769622265e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCN,Decorin,28916,-0.00809564142405432,0.00163214125471712,-0.0112946382832999,-0.00489664456480877,7.08433680687392e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYMP,Thymidine phosphorylase,29301,0.0234120002492893,0.00473950477761857,0.0141225708851569,0.0327014296134217,7.86507216083809e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDRG1,Protein NDRG1,28774,0.0236743896694807,0.00480968731917691,0.014247402523894,0.0331013768150675,8.60364751583808e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWF,von Willebrand factor,29820,-0.0253459125926402,0.00516970267349662,-0.0354785298326936,-0.0152132953525869,9.49864710513569e-07
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0120910123553434,0.00247781026118976,0.0072345042434115,0.0169475204672754,1.06786415864797e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.0102749311804478,0.00210616864838677,0.00614684062960975,0.0144030217312859,1.07456771492547e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.0181598057685751,0.00373454904879338,0.0108400896329401,0.0254795219042101,1.16551472498264e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EP300,Histone acetyltransferase p300,24229,0.0104812138410999,0.00215814151277231,0.0062512564760662,0.0147111712061337,1.2016801987055e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTF4,Neurotrophin-4,28797,0.0136379540920182,0.00281539338362266,0.00811978306011776,0.0191561251239186,1.27868773911741e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00946857220561678,0.00195560704800251,0.00563558239153186,0.0133015620197017,1.29341025025458e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM171B,Protein FAM171B,24793,0.00937579274708994,0.0019387046274641,0.0055759316772603,0.0131756538169196,1.33197406230707e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0127158218733915,0.00263614842661907,0.00754897095721812,0.0178826727895649,1.41820386591495e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",24101,0.025056441199581,0.00519904763261639,0.0148663078396529,0.0352465745595091,1.44846194291201e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB39B,Ras-related protein Rab-39B,24111,0.0309124060664832,0.00645512399873425,0.0182603630289641,0.0435644491040024,1.68763822068462e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0210700219433014,0.00441409820392425,0.0124183894636099,0.029721654422993,1.8225236599173e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM3D,Protein FAM3D,24805,0.0287803060022454,0.00603590128504618,0.0169499394835548,0.0406106725209359,1.8694640517449e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DRAXIN,Draxin,29218,0.0145607382629515,0.00305853129933962,0.00856601691624586,0.0205554596096572,1.93850024702912e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0133829973301943,0.00281426318627104,-0.0188989531752856,-0.0078670414851031,1.99143751611268e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.0174986988968351,0.00368876677327383,0.0102687160212185,0.0247286817724518,2.10771623526106e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUC2,Mucin-2,24938,0.0309729861741665,0.00653350111435909,0.0181673239900227,0.0437786483583103,2.14218973388316e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RLN1,Prorelaxin H1,24867,-0.0232742019835889,0.00491769855122915,-0.032912891143998,-0.0136355128231797,2.22724886691485e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD99,CD99 antigen,29443,-0.00663110897388208,0.00140242162201244,-0.00937985535302646,-0.00388236259473771,2.27424340579913e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.0118529488156918,0.00250885785729835,0.00693558741538702,0.0167703102159966,2.31833603696012e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0129223699926869,0.00273609462997512,-0.0182851154674382,-0.00755962451793571,2.33537518266002e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.0107679278294711,0.0022948802570925,-0.0152658931333724,-0.00626996252556984,2.7158774802582e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CFD,Complement factor D,24966,0.00654413354780838,0.00139593395099111,0.0038081030038658,0.00928016409175096,2.77350283936116e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0291014072514127,0.00621398597683366,0.0169219947368187,0.0412808197660066,2.83947143399991e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA4,Ephrin type-A receptor 4,24381,0.00951712884231907,0.002043737731417,0.00551140288874176,0.0135228547958964,3.22969940503082e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0163272078643136,0.00351047307446317,-0.0232077350902615,-0.00944668063836583,3.31761078740842e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CENPJ,Centromere protein J,24445,0.0238032447492569,0.00513191196303218,0.0137446973017138,0.0338617921968,3.53140227006958e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0094216941197808,0.00203698280859556,-0.0134141804246281,-0.00542920781493351,3.75626100616634e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACHE,Acetylcholinesterase,24381,0.0109037134024896,0.00235907060001724,0.00627993502645578,0.0155274917785233,3.81935701678981e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOD3,Extracellular superoxide dismutase,24951,-0.0196642859979735,0.0042755346802394,-0.0280443339712428,-0.0112842380247043,4.26081648415951e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.014541871047705,0.00316228777200976,0.00834378701456582,0.0207399550808441,4.27617217559128e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD200,OX-2 membrane glycoprotein,29434,-0.00869415259951257,0.00189170302845006,-0.0124018905352747,-0.00498641466375044,4.32591981606536e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0135900883391204,0.00296959927125526,-0.0194105029107807,-0.00776967376746009,4.75403377627258e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JCHAIN,Immunoglobulin J chain,28931,-0.0200687210494942,0.00439382887137169,-0.0286806256373827,-0.0114568164616057,4.95660699426981e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.00685076407018664,0.00150055111297105,-0.0097918442516099,-0.00390968388876338,5.00757859741171e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0174967348560952,0.00384521403962109,0.00996011533843787,0.0250333543737525,5.37978815896452e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD3,Bromodomain-containing protein 3,24111,0.0155179693001561,0.00342235652352228,0.00881015051405239,0.0222257880862597,5.80747914827463e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDHB15,Protocadherin beta-15,24793,-0.0129267246273765,0.00285863861872317,-0.0185296563200739,-0.00732379293467911,6.1545811897907e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NTF3,Neurotrophin-3,29434,0.011173093047201,0.00247496519486253,0.00632216126527043,0.0160240248291316,6.37289713410981e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA11,Serpin A11,29820,-0.0131664486461312,0.0029186230672049,-0.0188869498578528,-0.00744594743440957,6.47123808847037e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLA2G1B,Phospholipase A2,29787,-0.0137979511757755,0.00307172854106128,-0.0198185391162556,-0.00777736323529534,7.08499442567123e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.0190456537605341,0.00424244293309143,0.0107304656116749,0.0273608419093933,7.17856333530655e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,29434,0.0149290275748292,0.00333857007505339,0.0083854302277246,0.0214726249219339,7.78963501530842e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFAP,Glial fibrillary acidic protein,28753,0.0147365855123891,0.00329897327064306,0.00827059790192875,0.0212025731228495,7.9618262144104e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,29349,0.00830031642933025,0.00185961494380809,0.0046554711394664,0.0119451617191941,8.09468698283044e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.0119710228911195,0.00269121268850228,-0.0172457997605839,-0.00669624602165499,8.69845939608713e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,0.0107441614739518,0.00242175536852233,0.005997520951648,0.0154908019962555,9.17564183472716e-06
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.0110833412149535,0.00251081345343384,0.00616214684622317,0.0160045355836838,1.01802061151339e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.00763098467082273,0.00172942122524701,0.00424131906933858,0.0110206502723069,1.02568378311425e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NME1,Nucleoside diphosphate kinase A,24229,-0.00690352818910439,0.00156544673104901,-0.00997180378196045,-0.00383525259624833,1.03843877408906e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INHBB,Inhibin beta B chain,24381,0.0162790367914879,0.00370302375679231,0.00902111022817495,0.0235369633548008,1.10655215564706e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH6,Cadherin-6,29478,-0.0120115835799929,0.00273400451863557,-0.0173702324365186,-0.00665293472346715,1.11979162175923e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTP1,Glutathione S-transferase P,28604,-0.0218432951199475,0.00497469894130878,-0.0315937050449127,-0.0120928851949823,1.13298844728588e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C9orf40,Uncharacterized protein C9orf40,24805,0.0250862404953109,0.00572718470920554,0.013860958465268,0.0363115225253537,1.19053889539531e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,24229,0.0331625425168315,0.00758070063195194,0.0183043692782057,0.0480207157554573,1.22162612808548e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00882410299620185,0.00202090683976387,0.00486312559026465,0.012785080402139,1.26736903087624e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENO1,Alpha-enolase,29392,0.0245440515397687,0.00562130184718008,0.0135262999192958,0.0355618031602417,1.26825171658389e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALCB,Calcitonin gene-related peptide 2,24845,0.0124573924525685,0.00286750370244928,0.00683708519576789,0.0180776997093691,1.40253064029373e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TERF1,Telomeric repeat-binding factor 1,24229,-0.00908917875057354,0.00209870902864014,-0.0132026484467082,-0.00497570905443886,1.49136597134913e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRTN,Neurturin,28931,0.0152622234238508,0.00352701590758011,0.00834927224499375,0.0221751746027078,1.51499792167927e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ELAVL4,ELAV-like protein 4,24101,0.0261909627284689,0.00605403401296064,0.0143250560630661,0.0380568693938718,1.52313906203763e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LEG1,Protein LEG1 homolog,23603,-0.0216229477445138,0.00500340936741057,-0.0314296301046386,-0.0118162653843891,1.55505480398344e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA6,Corticosteroid-binding globulin,24966,0.00515007005937235,0.00120244931969067,0.00279326939277864,0.00750687072596606,1.8509339930704e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMOD4,Tropomodulin-4,24016,-0.0125303940485171,0.00293001352208243,-0.0182732205517987,-0.00678756754523556,1.90532182442271e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP290,Centrosomal protein of 290 kDa,24445,0.0162046946573247,0.00379351928229599,0.00876939686402453,0.0236399924506248,1.94740288953537e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.00972926185404486,0.00228497062851742,0.00525071942215071,0.014207804285939,2.06961127953927e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00960914570634033,0.00225699870622875,-0.0140328631705487,-0.00518542824213199,2.07368538361208e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUP50,Nuclear pore complex protein Nup50,24111,-0.0102800972707606,0.00241561256705113,-0.0150146979021808,-0.00554549663934042,2.09192798298771e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARTN,Artemin,28931,0.01358368014631,0.00319345523678643,0.00732450788220862,0.0198428524104114,2.11021925939335e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",24111,0.0170820327901789,0.00402992546814925,0.00918337887260632,0.0249806867077514,2.25557511562825e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKCQ,Protein kinase C theta type,28931,0.0131743996867318,0.00310825845358445,0.00708221311770632,0.0192665862557574,2.25700447098106e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,24805,0.0165861208961417,0.00391401387509739,0.00891465370095081,0.0242575880913326,2.26713141923806e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF2,Trefoil factor 2,29536,0.0173977466606823,0.00411070518644375,0.00934076449525251,0.025454728826112,2.32009400455798e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD109,CD109 antigen,29443,-0.0101750618033825,0.00240609657097314,-0.0148910110824898,-0.00545911252427513,2.35580276503485e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR1,Folate receptor alpha,29383,0.00866519931020287,0.00205855707659491,0.00463042744007685,0.0126999711803289,2.56860766260855e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHRDL2,Chordin-like protein 2,29478,0.0160143115106739,0.00380490314976109,0.00855670133714212,0.0234719216842056,2.57420186284026e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0139300458934068,0.00331400668599181,-0.0204254989979508,-0.00743459278886289,2.63720737634622e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.0196023672368669,0.00467233946531637,0.0104445818848468,0.028760152588887,2.73179484712325e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL15,Interleukin-15,29434,0.00977527593149854,0.00233857266854343,0.00519167350115343,0.0143588783618437,2.92327924231186e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.0109251466560389,0.00261413260392499,0.00580144675234589,0.0160488465597318,2.9348166993163e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP152,Centrosomal protein of 152 kDa,24016,0.0124370954826813,0.00298118302130143,0.00659397676093049,0.0182802142044321,3.03177535921407e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNN,Tenascin-N,24938,0.0129075148735356,0.00310563266858508,0.00682047484310886,0.0189945549039624,3.24717171458928e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,28774,0.011381162306097,0.00273948528163707,0.00601177115408834,0.0167505534581057,3.26955988105649e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,24445,0.0206644237477847,0.00497719573086608,0.0109091201152872,0.0304197273802822,3.30959149025816e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,24016,0.0125240399563808,0.00302141598594691,0.0066020646239248,0.0184460152888367,3.40845994213869e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NINJ1,Ninjurin-1,28797,0.0163381010648111,0.00394868328101426,0.00859868183402311,0.024077520295599,3.51942962171777e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMMD9,COMM domain-containing protein 9,24793,0.0116545717823895,0.00281827108870527,0.00613076044852719,0.0171783831162519,3.55562150072202e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.010103081650993,0.00245319300604435,-0.0149113399428399,-0.00529482335914611,3.8264826827154e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.0152663468397374,0.00370734159749004,0.00799995730865695,0.0225327363708179,3.83631049437484e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,29673,0.0124011060137961,0.0030208938778887,0.00648015401313424,0.0183220580144579,4.05200959298304e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUK1,Guanylate kinase,24111,-0.0117698113481393,0.00286709255090422,-0.0173893127479115,-0.00615030994836698,4.05403734593668e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC12A2,Solute carrier family 12 member 2,24111,-0.00807141785954606,0.00197081275834584,-0.0119342108659039,-0.00420862485318822,4.22675461347106e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN2B,Sodium channel subunit beta-2,24195,-0.00847376714285327,0.00206993761990877,-0.0125308448778745,-0.00441668940783209,4.2586567072053e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0540636295653397,0.0132100275819414,0.0281719755047345,0.0799552836259448,4.27665848266819e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0119116987394149,0.0029165433361534,-0.0176281236782755,-0.0061952738005542,4.43748829567459e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00544449588212696,0.0013332550417742,0.00283131600024953,0.00805767576400439,4.44793193406996e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0205260650426242,0.00503484630432932,0.0106577662861388,0.0303943637991097,4.5804040720776e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0155302320974346,0.00380950387113299,-0.0229968596848553,-0.00806360451001395,4.58245001419233e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0179828345254789,0.004427517717883,0.00930489979842824,0.0266607692525296,4.88895548623695e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDS,Iduronate 2-sulfatase,29786,0.00257080783011064,0.000633544772055864,0.00132906007688115,0.00381255558334013,4.96601725436357e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCC,Netrin receptor DCC,24195,0.00663292881011102,0.00163465106891096,0.00342901271504554,0.00983684490517651,4.97133057529767e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,24229,0.0059037078368931,0.00145737834884648,0.003047246273154,0.0087601694006322,5.11778864951532e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCL28,C-C motif chemokine 28,29327,0.0170625627806248,0.00422585498134263,0.00877988701719326,0.0253452385440564,5.41243829026998e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.0160744559199777,0.00398424682073003,0.00826533215134686,0.0238835796886086,5.48843690886409e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.00987397799063697,0.00245345443737972,-0.0146827486879012,-0.00506520729337272,5.72659310152512e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MELTF,Melanotransferrin,24922,0.00850026174699303,0.00211510729449809,0.00435465144977677,0.0126458720442093,5.86591363562976e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSAP,Gamma-secretase-activating protein,28797,0.0248693274415815,0.00620218500578753,0.0127130448302379,0.0370256100529251,6.09314811963174e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00987771464781787,0.00246472765078684,0.00504684845227567,0.0147085808433601,6.14810484453035e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0210817679617979,0.00527562697843265,0.0107415390840699,0.0314219968395259,6.4588284216397e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HYAL1,Hyaluronidase-1,29265,0.00653857041270432,0.0016402910294087,0.00332359999506328,0.00975354083034537,6.72954968735843e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP7,Retinoid-binding protein 7,24805,0.0171143742537856,0.0042980793024955,0.00869013882089447,0.0255386096866768,6.85713833028072e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AOC3,Membrane primary amine oxidase,29594,-0.00853785409893366,0.00215191661316403,-0.0127556106607352,-0.00432009753713216,7.27839594625645e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR101,Probable G-protein coupled receptor 101,24101,-0.0174069850165782,0.00440817384276499,-0.0260470057483976,-0.00876696428475882,7.87681493215973e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,METAP1,Methionine aminopeptidase 1,28774,0.00841462523518212,0.00213336743836066,0.00423322505599522,0.012596025414369,8.02256530006126e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MKI67,Proliferation marker protein Ki-67,24229,0.0109992202820835,0.00278903824998927,0.00553270531210452,0.0164657352520625,8.04489956802841e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,24445,0.0149886662134173,0.00381754772672557,0.00750627266903519,0.0224710597577994,8.65153317242732e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.0093737476435836,0.00238928908551931,-0.0140567542512014,-0.00469074103596575,8.7566072365938e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP8,Neutrophil collagenase,29640,0.0202037239250696,0.00516080073860457,0.0100885544774047,0.0303188933727346,9.06654736838156e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0195184450328189,0.00499128653258564,0.00973552342895105,0.0293013666366867,9.23077420076782e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,29443,-0.00883785941613103,0.00226351895735363,-0.0132743565725441,-0.00440136225971792,9.46396125980832e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOM1,Myomesin-1,24101,0.0133213510557082,0.00341179126882998,0.00663424016880146,0.020008461942615,9.46762651145486e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00820502286831271,0.00210294101783137,0.00408325847336324,0.0123267872632622,9.57818213577323e-05
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMBN,Ameloblastin,28931,-0.00793422416636291,0.00203972319626948,-0.0119320816310511,-0.00393636670167473,0.000100529201779587
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN2,Contactin-2,29725,0.0122975449371662,0.00318131557999215,0.00606216640038156,0.0185329234739508,0.000111073322119534
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNL1,Thioredoxin-like protein 1,24069,0.027111592591443,0.00701694835208304,0.0133583738213602,0.0408648113615257,0.000111961541143453
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LIFR,Leukemia inhibitory factor receptor,29434,-0.00667724131660072,0.0017332200534415,-0.0100743526213461,-0.00328013001185537,0.000117162811418688
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP164,Centrosomal protein of 164 kDa,28931,0.0172737780018205,0.00449978072834467,0.00845420777426494,0.026093348229376,0.000123898009695181
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FSTL1,Follistatin-related protein 1,24240,-0.00624898284717703,0.00163235716199527,-0.00944840288468776,-0.00304956280966631,0.000129410616222943
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTXR,Neuronal pentraxin receptor,29478,0.00927493293617729,0.00242644350403401,0.00451910366827064,0.0140307622040839,0.000132409621943244
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0803082632803078,0.0210479021388072,0.0390543750882456,0.12156215147237,0.000136185308737021
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00808564593919044,0.00212472558230098,0.00392118379788052,0.0122501080805004,0.000141865867668602
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.0071056631501365,0.00186860887363491,-0.0107681365424609,-0.00344318975781207,0.000143508253198656
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0173420335622004,0.00456102804489004,0.00840241859421594,0.0262816485301849,0.000143705077391542
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPS,Calcyphosin,24845,0.0257093615731499,0.00676631021202374,0.0124473935575834,0.0389713295887164,0.000145267707659226
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.0165046057703536,0.00434548890899842,0.00798744750871669,0.0250217640319905,0.000146104082335702
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLMP,CXADR-like membrane protein,29725,0.00570551675631597,0.0015097201286124,0.00274646530423566,0.00866456820839628,0.000157647610020642
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCP2,Non-specific lipid-transfer protein,28797,0.0205225199484552,0.00543599956970314,0.00986796079183702,0.0311770791050733,0.000160137196281792
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEFL,Neurofilament light polypeptide,28674,0.0120577367235545,0.00319683438175637,0.00579194133531206,0.018323532111797,0.000162416770621275
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSTN1,Calsyntenin-1,28774,0.0138880861084009,0.00368480428953466,0.006665869700913,0.0211103025158889,0.000164219711122841
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COMP,Cartilage oligomeric matrix protein,29214,0.00903841313292182,0.00239833741492178,0.00433767179967512,0.0137391544661685,0.000164477834514794
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PADI2,Protein-arginine deiminase type-2,28931,0.0151687313709911,0.00402523122538869,0.00727927816922925,0.0230581845727529,0.00016461520459183
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.0108106154971011,0.00286958320386565,-0.0164349985766778,-0.00518623241752443,0.000165407342210541
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY6D,Lymphocyte antigen 6D,29283,0.0103171928182036,0.0027393331155448,0.00494809991173576,0.0156862857246714,0.000165998615359045
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL5,Fc receptor-like protein 5,29443,-0.0153858608903416,0.00410077727175719,-0.0234233843429857,-0.00734833743769753,0.000175809708740511
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANSC4,MANSC domain-containing protein 4,24111,0.0177839063693868,0.00475992641914642,0.00845445058785982,0.0271133621509138,0.000187273442098029
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.00858805977238786,0.00229955460152776,-0.0130951867913823,-0.00408093275339345,0.000188395361189704
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCDH17,Protocadherin-17,29478,0.00958155696012569,0.00256857412153454,0.00454715168191798,0.0146159622383334,0.00019160904595641
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRAL,GDNF family receptor alpha-like,24025,-0.016660464945068,0.0044776074762347,-0.025436575598488,-0.00788435429164796,0.000199013092015593
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ASPN,Asporin,24922,0.00730987089111953,0.00196607918250356,0.00345635569341256,0.0111633860888265,0.000201250857660448
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYO6,Unconventional myosin-VI,24867,0.00991169617038165,0.00266854119218915,0.00468135543369092,0.0151420369070724,0.000204232755767788
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REN,Renin,29478,-0.0201101187573543,0.00541783581433352,-0.030729076953448,-0.00949116056126062,0.000206139851112163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00601575179409214,0.00162089502779659,0.00283879753961083,0.00919270604857345,0.000206510019775853
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.0165334297805454,0.00446205341937185,0.00778780507857655,0.0252790544825142,0.000211576810589621
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100G,Protein S100-G,24867,-0.0122679676550401,0.00331707571639045,-0.0187694360591654,-0.0057664992509148,0.000217405333820409
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,24845,0.0185162731221249,0.00500993133783495,0.00869680769996835,0.0283357385442814,0.000219568350878887
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,29820,0.00797096984855856,0.00216391203301987,0.00372970226383961,0.0122122374332775,0.00023037642536718
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.0084448547029056,0.00229743784251138,0.0039418765315833,0.0129478328742279,0.000237647111817992
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.0120204730706349,0.00327474212986218,0.00560197849610498,0.0184389676451647,0.000242444737512252
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGMA,Repulsive guidance molecule A,29694,-0.00822417963043498,0.00224329860075493,-0.0126210448879146,-0.00382731437295533,0.000246697393213554
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.0136557512320812,0.00373645087441424,0.00633230751822926,0.0209791949459331,0.00025798328749405
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.0145986571800916,0.0039984419149172,0.00676171102685384,0.0224356033333293,0.000261669332394921
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0153012277798376,0.00419179761459827,-0.0235171511044502,-0.00708530445522497,0.000262510008198045
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.012865021206893,0.00352581518371728,0.00595442344680708,0.0197756189669788,0.000264001009921394
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPESP1,Sperm equatorial segment protein 1,24922,0.0078562321670837,0.00216862828603738,0.00360572072645043,0.012106743607717,0.000292153240738139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.0150506328807705,0.00416003906692745,0.00689695630959269,0.0232043094519483,0.0002974964140677
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,28774,0.010257883436164,0.00285125717931978,0.00466941936469726,0.0158463475076308,0.000321618618341833
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCRL6,Fc receptor-like protein 6,29434,0.0173990840668526,0.00484397613026921,0.00790489085152491,0.0268932772821802,0.000328809121723445
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.015827814915659,0.0044142005206581,-0.0244796479361489,-0.00717598189516912,0.000336766184997697
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0382984872062215,0.0106959640228332,0.0173343977214684,0.0592625766909746,0.000343294488083525
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SH3GL3,Endophilin-A3,24307,0.0214132692368684,0.00598920152076215,0.00967443425617461,0.0331521042175623,0.000350487839846301
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",24111,0.0160327062586839,0.00448805750562414,0.00723611354766056,0.0248292989697072,0.000354543934332101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0125069267192574,0.00350491925761975,-0.0193765684641921,-0.00563728497432273,0.000359747963189428
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RALB,Ras-related protein Ral-B,24229,0.00752364656227062,0.00211344436060556,0.00338129561548372,0.0116659975090575,0.000371709091843328
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA3G,Semaphorin-3G,24381,0.0112482489752867,0.00316009469948823,0.00505446336428978,0.0174420345862836,0.000372316708279295
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00805413610468586,0.00226792090651601,-0.0124992610814572,-0.00360901112791448,0.000384017496599243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.0068735890621435,0.0019454448422267,0.00306051717137916,0.0106866609529078,0.000411247332637432
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.0171958726314113,0.00486937766255357,0.0076518924128063,0.0267398528500163,0.000414065501687327
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH7B,Myosin-7B,24016,-0.011195387290976,0.00317210845130197,-0.0174127198555278,-0.00497805472642409,0.000417407559996086
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUCA2A,Guanylin,29333,-0.00859630282888222,0.00244244718288862,-0.0133834993073439,-0.00380910635042052,0.000432942702892754
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0220147792234656,0.00627309162519777,0.00971951963807793,0.0343100388088532,0.000449945272975827
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH23,Cadherin-23,24845,-0.0066323999897707,0.00189464974380107,-0.0103459134876208,-0.00291888649192061,0.000465036137026018
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NLGN2,Neuroligin-2,24101,-0.0118930248083043,0.00339899553315703,-0.0185550560532921,-0.00523099356331656,0.000467880665503022
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00510781546506937,0.00146066654725516,-0.00797072189768949,-0.00224490903244925,0.000471532646863076
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,24445,-0.0108578222943314,0.00313662779203855,-0.017005612766727,-0.00471003182193585,0.000537846969483252
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.00939464869682356,0.00271922216812321,0.00406497324730208,0.014724324146345,0.000551434864591469
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLSPN,Claspin,28719,0.00855836245122099,0.00247800080920493,0.00370148086517932,0.0134152440372626,0.000553674328493758
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAG,S-arrestin,24101,-0.0130376448980826,0.0037764659651537,-0.0204395181897838,-0.00563577160638134,0.000556700775880091
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",29378,0.016631023514001,0.00483511000075367,0.00715420791252377,0.0261078391154781,0.000583303754214676
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RETN,Resistin,29362,0.0103488055023527,0.00301014727185121,0.00444891684952428,0.016248694155181,0.000586898753624849
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPR158,Probable G-protein coupled receptor 158,24867,0.00876053457324477,0.00256141459268768,0.00374016197157693,0.0137809071749126,0.00062677060895009
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSC1,Hamartin,24229,0.0183450719552787,0.00536614710963936,0.00782742362038555,0.0288627202901718,0.000630322109605645
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JUN,Transcription factor AP-1,28931,0.0121938070903243,0.00357743974446529,0.00518202519117233,0.0192055889894763,0.000654031950475238
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,24229,0.0299345465836897,0.00878888263295176,0.0127083366231043,0.0471607565442752,0.000660398881709851
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.012162682782681,0.0035727266896319,0.00516013847100245,0.0191652270943595,0.000664210177622695
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,24381,0.00684379997728351,0.00201224714708244,0.00289979556900193,0.0107878043855651,0.000672295671870951
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0135101918737715,0.00397241877200783,0.00572425108063618,0.0212961326669069,0.000672308888345119
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00666985702106433,0.00196816324243102,0.00281225706589953,0.0105274569762291,0.00070271829851418
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00643288511770276,0.0018983157849005,-0.0101535840561077,-0.00271218617929778,0.000703251461111048
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0114654965146731,0.00338848649879431,0.00482406297703624,0.01810693005231,0.000716211474051013
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRR4,Proline-rich protein 4,24203,-0.0168008962353976,0.00498360187343785,-0.0265687559073358,-0.00703303656345941,0.000749489149589117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00702118476885142,0.0020838524823858,0.00293683390337525,0.0111055356343276,0.00075468940317139
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF1,Trefoil factor 1,29319,0.0189422906822884,0.00562828744537778,0.007910847289348,0.0299737340752289,0.000764888744916909
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.0147476502938007,0.00439022204820304,-0.0233524855082787,-0.00614281507932277,0.000782886280012974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,29786,0.0141034509743013,0.00419893865124896,0.00587353121785337,0.0223333707307493,0.000783760875366792
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNXB,Tenascin-X,29443,-0.00618037136398004,0.00184106736342861,-0.00978886339630013,-0.00257187933165996,0.000789070834472547
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOX9,Transcription factor SOX-9,24195,0.00655335214177127,0.00195267661396537,0.00272610597839914,0.0103805983051434,0.000791754522509602
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.0114741643624038,0.00341908238819079,-0.0181755658432577,-0.0047727628815498,0.000792238296641974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM19,Probable RNA-binding protein 19,24111,-0.0114802593880118,0.00342097510137093,-0.0181853705866988,-0.00477514818932476,0.000792453225618426
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NMI,N-myc-interactor,24706,0.0172059598726019,0.00514725722665884,0.00711733570835056,0.0272945840368532,0.000830777990412829
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CST6,Cystatin-M,28830,0.0115831650037377,0.00348263248420122,0.00475720533470326,0.018409124672772,0.000882184027766509
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPN1,Epsin-1,24445,0.0103638463073072,0.00312434403058181,0.00424013200736681,0.0164875606072475,0.000910809204462822
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.0115528327074019,0.00348371022411466,-0.0183809047466666,-0.00472476066813718,0.000913698283692133
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,0.0105717668990449,0.00319112162017007,0.00431716852351153,0.0168263652745782,0.00092454351144226
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB1,Integrin beta-1,29474,0.00512138785630216,0.00154834242194567,0.00208663670928865,0.00815613900331567,0.000941921053725833
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,24111,0.00942121835209696,0.00285622582970853,0.00382301572586825,0.0150194209783257,0.000973488606404921
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00858725260972234,0.00260451081716771,0.00348241140807363,0.013692093811371,0.000978387753683524
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.0134881321682354,0.00409821137078202,0.00545563788150265,0.0215206264549682,0.000998963033748296
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0100943942373767,0.00308082618307807,0.00405597491854365,0.0161328135562097,0.00105237713014766
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.011927580678076,0.00365294869466384,0.0047678012365349,0.0190873601196172,0.00109542944165678
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRXN3,Neurexin-3,24195,0.00821014803845727,0.00252273571274383,0.00326558604147937,0.0131547100354352,0.00113763330744299
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNG,Uracil-DNA glycosylase,24793,0.00800240240079912,0.00245968256684995,0.00318142456977322,0.012823380231825,0.00114173910774397
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA3,Carbonic anhydrase 3,29761,0.0139073917927198,0.00427765463769863,0.00552318870283051,0.0222915948826091,0.00115058073118296
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,24240,0.0132721283776589,0.00409602684666284,0.00524391575819975,0.0213003409971181,0.00119588374547652
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00910456283401737,0.00281615193902403,0.00358490503353027,0.0146242206345045,0.00122670934532167
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0199638646992515,0.0061840500592305,0.00784312658315972,0.0320846028153433,0.00124702911344699
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00591065067105866,0.00183534024141655,-0.0095079175442351,-0.00231338379788223,0.00128147102631329
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,29288,0.0051498998215134,0.00160231333375927,0.00200936568734522,0.00829043395568158,0.00131023046909939
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN3,Neuronal-specific septin-3,24867,-0.0173689140240956,0.00540813369286996,-0.0279688560621207,-0.00676897198607051,0.00132153098678192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCG3,Secretogranin-3,29497,-0.00761341037707132,0.00237189039490479,-0.0122623155510847,-0.00296450520305792,0.00132946823815962
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYH4,Myosin-4,24111,-0.0106628915578614,0.00333853338346398,-0.0172064169894508,-0.00411936612627198,0.00140552575063758
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.00969336895823032,0.00303653101076174,0.00374176817713731,0.0156449697393233,0.00141316311459821
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,29278,0.00625985777939793,0.00196138199033084,0.00241554907834949,0.0101041664804464,0.0014165879376188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.0135259060402897,0.00423985804783752,0.00521578426652813,0.0218360278140512,0.00142334148018898
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.0167433561619311,0.00524934810093666,0.00645463388409529,0.027032078439767,0.00142615868975197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,29673,0.00690720168459567,0.00217033972834129,0.00265333581704675,0.0111610675521446,0.00146137878347267
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RYR1,Ryanodine receptor 1,24111,-0.0077568859273989,0.00243939026911189,-0.0125380908548582,-0.0029756809999396,0.00147539685686546
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRG3,Proteoglycan 3,24938,-0.0113357287627826,0.00356515738489647,-0.0183234372371796,-0.00434802028838547,0.00147665367775933
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP112,Centrosomal protein of 112 kDa,24111,0.0104151839166,0.00327852066376278,0.00398928341562492,0.016841084417575,0.00149100670386847
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.0076711316935892,0.00241787846925747,-0.0124101734933338,-0.00293208989384455,0.00151199033871475
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.0190488803749109,0.00603295116899252,0.00722429608368554,0.0308734646661362,0.00159338506965106
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PKLR,Pyruvate kinase PKLR,29491,0.0144562870650429,0.00460185193326491,0.00543665727584365,0.0234759168542421,0.00168304854197339
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEF,Thyrotroph embryonic factor,24111,0.00962245653300959,0.00306380725177828,0.00361739431952417,0.015627518746495,0.00168756418504305
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0143736924200662,0.0045783673884809,-0.0233472925014888,-0.00540009233864367,0.00169450085580987
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF5,Fibroblast growth factor 5,28931,-0.0073307298233874,0.00236190576451774,-0.0119600651218422,-0.00270139452493263,0.00191278664056817
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00735048939207687,0.00236974751540467,0.00270578426188372,0.01199519452227,0.00192567026780109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACE,Angiotensin-converting enzyme,24951,-0.00578806935478918,0.00187002597583492,-0.00945332026742562,-0.00212281844215275,0.00196910447423479
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.0149857361104799,0.00485749827867882,0.00546503948426941,0.0245064327366904,0.00203695336616608
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OPTC,Opticin,29349,-0.00987826797538111,0.00321806078390399,-0.0161856671118329,-0.0035708688389293,0.00214517108895466
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17C,Interleukin-17C,28931,-0.0154194146193822,0.00502380169596758,-0.0252660659434786,-0.00557276329528571,0.00214779692483911
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNL1,Interferon lambda-1,28774,0.00991413426121434,0.00323300705484929,0.00357744043370973,0.0162508280887189,0.00216755276396433
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00769254795661849,0.00251515955201296,0.0027628352346731,0.0126222606785639,0.00222667870048377
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,29662,0.00885458130148022,0.00290343287375512,0.0031638528689202,0.0145453097340402,0.00229276837455827
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B4,Protein ATP1B4,24016,-0.0091370536888598,0.00300640095976674,-0.0150295995700026,-0.003244507807717,0.00237462589826758
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.0147414962196215,0.00485361422980794,0.00522841232919797,0.0242545801100451,0.00238984687906248
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HCG22,Protein PBMUCL2,24111,-0.0120312814461617,0.00396434935753962,-0.0198014061869393,-0.00426115670538401,0.00240896659031967
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAT1,Diamine acetyltransferase 1,24111,-0.0109322959322421,0.00360501122752264,-0.0179981179381865,-0.00386647392629772,0.00242772784744216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.0061049232636149,0.00202347235755934,0.0021389174427986,0.0100709290844312,0.0025550410406599
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TUBB3,Tubulin beta-3 chain,24101,-0.00605653276471323,0.00201197400414867,-0.0100000018128446,-0.00211306371658183,0.00261308121493665
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STX1B,Syntaxin-1B,24195,0.00893226564907626,0.00297689334383376,0.00309755469516208,0.0147669766029904,0.00269782555017664
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00877593991558889,0.00293185687496878,0.00302950044065007,0.0145223793905277,0.00276200581689714
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR4,Toll-like receptor 4,24229,0.00603988359245472,0.00202731832965697,0.00206633966632705,0.0100134275185824,0.00289243586553076
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0250695100002691,0.00841860723618799,0.00856903981734061,0.0415699801831975,0.00290500588260539
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA6C,Semaphorin-6C,24229,0.00556676453700217,0.00187276615892188,0.00189614286551529,0.00923738620848905,0.00295692630680195
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.00784683809918971,0.00264115879292462,0.00267016686505746,0.013023509333322,0.00297132315537953
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.0100588821049235,0.00338832728498237,0.00341776062635802,0.0167000035834889,0.00299361479797419
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTNNA1,Catenin alpha-1,24101,-0.00743001165274087,0.00251268107152561,-0.0123548665529311,-0.00250515675255068,0.00310943972242392
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL5A1,Collagen alpha-1(V) chain,24381,0.00846272699201062,0.00288500468213286,0.00280811781503021,0.014117336168991,0.00335638500102405
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,24793,0.00779773527447435,0.00265947415144253,0.00258516593764699,0.0130103046113017,0.00337030598709271
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.010463910565121,0.00357600661846853,-0.0174728835373193,-0.00345493759292264,0.00343512425639766
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0127003089491458,0.00434263918351408,-0.0212118817488334,-0.00418873614945822,0.00345263313272083
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.0088390058078152,0.00302453803604649,0.00291091125716408,0.0147671003584663,0.0034758014620373
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP4,Bone morphogenetic protein 4,29169,-0.00958468647646273,0.0032974781383097,-0.0160477436275497,-0.00312162932537572,0.00365571370434039
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00599885783351831,0.00206589035584992,-0.0100480029309841,-0.00194971273605247,0.0036904090563358
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SULT1A1,Sulfotransferase 1A1,29694,-0.0264470429716236,0.00914967741910647,-0.0443804107130723,-0.00851367523017491,0.00384921630923424
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00805273316668082,0.00279594442853921,0.00257268208674396,0.0135327842466177,0.00397828706401064
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSB,Lupus La protein,28774,0.0122402251872949,0.00425325363288079,0.00390384806684856,0.0205766023077413,0.00400690464334228
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP9,Matrix metalloproteinase-9,29411,0.0123944391938091,0.00431439912038682,0.0039382169178509,0.0208506614697672,0.00407132775661866
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00927746872661222,0.00323245868567227,0.00294184970269457,0.0156130877505299,0.00410643917357322
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTTG1,Securin,24445,0.00848867726639077,0.00295827530994033,0.00269045765890772,0.0142868968738738,0.00411515106453854
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCND2,G1/S-specific cyclin-D2,24445,0.00753960989559882,0.00263420822718815,0.00237656177031005,0.0127026580208876,0.00421079337049635
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD33,Myeloid cell surface antigen CD33,29566,0.016161271416601,0.00565191291068289,0.00508352211166252,0.0272390207215395,0.00424694904396783
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM3,Intercellular adhesion molecule 3,29820,-0.00531167800390942,0.00185968213697309,-0.00895665499237668,-0.00166670101544216,0.00429002151032015
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.0110877806780762,0.00388697720815658,-0.018706256006063,-0.00346930535008926,0.00434074789956327
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.00642275311191652,0.00225621801219816,0.00200056580800812,0.0108449404158249,0.0044207460660957
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TJP3,Tight junction protein ZO-3,24101,-0.00871364881985264,0.00306380259601373,-0.0147187019080396,-0.00270859573166572,0.00445796979763584
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6,Seizure protein 6 homolog,24195,-0.00631447727404601,0.00223296480585711,-0.0106910882935259,-0.00193786625456607,0.00469010711255775
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.0113439827697475,0.00402559413966976,0.00345381825599477,0.0192341472835002,0.00483684695875053
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00866405120927444,0.00307505039819423,-0.0146911499897351,-0.00263695242881375,0.00484337747266654
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GBP6,Guanylate-binding protein 6,24111,-0.00927176622388844,0.00329924185223253,-0.0157382802542642,-0.00280525219351269,0.00495395925485623
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0193648375707941,0.00694102264614762,0.00576043318434478,0.0329692419572435,0.00527627491010084
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.0184470812408103,0.00661643827013813,0.00547886223133954,0.031415300250281,0.00530650861056196
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TTN,Titin,24111,-0.0133410983741176,0.0048015059168768,-0.0227520499711961,-0.00393014677703903,0.00546487748797498
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THY1,Thy-1 membrane glycoprotein,29694,0.00565339241543443,0.00203580058558569,0.00166322326768647,0.00964356156318239,0.00548997215476349
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,0.0055583294578898,0.00200550489435808,0.00162753986494796,0.00948911905083165,0.00558338312898383
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPM1B,Protein phosphatase 1B,24229,0.0123323079838864,0.00446886203369472,0.00357333839784475,0.021091277569928,0.00579142164554108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK15,Kallikrein-15,24754,0.0101496922714963,0.00369725401443531,0.00290307440320313,0.0173963101397895,0.00605181470688222
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.0123261132126609,0.00450581291681345,-0.0211575065296153,-0.00349471989570657,0.00623115880424828
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RLN2,Prorelaxin H2,24326,0.0221261658259788,0.00810895028154162,0.00623262327415726,0.0380197083778004,0.00636475070797933
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK1,Kallikrein-1,29199,-0.0247582708747122,0.00909149648925927,-0.0425776039936604,-0.00693893775576405,0.00646847071312115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00454171373783367,0.00166861728295434,0.00127122386324316,0.00781220361242418,0.00649654611260336
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOP56,Nucleolar protein 56,24111,0.0215397263237196,0.00793752402398526,0.00598217923670847,0.0370972734107307,0.00665921108935888
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL19,Interleukin-19,28654,0.0136091210265971,0.0050221612026626,0.00376568506937838,0.0234525569838158,0.00673610770842607
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.0163728990306767,0.00606213560129376,0.00449111325214088,0.0282546848092124,0.00692027966829867
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAPPA,Pappalysin-1,28931,0.00908137266515959,0.0033648083514035,0.00248634829640874,0.0156763970339104,0.00696038081805301
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYB5A,Cytochrome b5,24016,0.0138830175881127,0.00516772386836075,0.00375427880612563,0.0240117563700998,0.00722576903215177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALM3,Paralemmin-3,24111,0.0141781018185344,0.00527982887715917,0.0038296372193024,0.0245265664177664,0.00725070524117209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.0109928364571651,0.00413540126132801,0.00288744998496217,0.019098222929368,0.00786047800593316
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSN,Gelsolin,24845,-0.00361196261878167,0.00136065179412075,-0.00627884013525834,-0.000945085102304996,0.00794572146727981
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.00713264070759471,0.00268859453006937,0.00186299542865873,0.0124022859865307,0.00798492341080113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.00963086268815181,0.0036323371986336,-0.0167502435974737,-0.00251148177882996,0.0080205802546693
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNW1,Interferon omega-1,24111,-0.00679752140667942,0.00257755336342584,-0.0118495259989941,-0.00174551681436477,0.0083647396944697
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL36G,Interleukin-36 gamma,24149,0.012828693432519,0.00486496372430452,0.00329336453288218,0.0223640223321559,0.00837073567330883
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUMF1,Formylglycine-generating enzyme,24229,0.0125341196175127,0.00475352767239066,0.00321720537962702,0.0218510338553984,0.00837446504067906
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTRC,Chymotrypsin-C,29456,0.0119456593852485,0.0045532786066536,0.00302123331620745,0.0208700854542896,0.00870688520069637
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00481103245592441,0.00184662836421307,0.00119164086206678,0.00843042404978203,0.00918488931254935
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,24101,0.0081522465085723,0.00313611683644535,0.00200545750913942,0.0142990355080052,0.00934243574758496
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTO1,Protein LTO1 homolog,28931,0.00763384836435329,0.00293687366745124,0.00187757597614886,0.0133901207525577,0.00934585115767502
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNR,Tenascin-R,29218,-0.00781805251752321,0.00300902790617055,-0.0137157472136175,-0.00192035782142894,0.00937612922660552
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM25,Transmembrane protein 25,24867,-0.0083521495616308,0.00322809848612786,-0.0146792225944414,-0.0020250765288202,0.00967797000402709
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK3,Prostate-specific antigen,24938,-0.0163285208408807,0.00635235727994202,-0.028779141109567,-0.00387790057219431,0.0101619200552763
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00879404343046031,0.00342360848236779,-0.0155043160559012,-0.00208377080501944,0.0102155901532389
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GKN1,Gastrokine-1,28114,0.00514536646348704,0.00200482094746467,0.00121591740645628,0.0090748155205178,0.0102782906346174
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSLNL,Mesothelin-like protein,24195,-0.00683296327816414,0.00269411549456176,-0.0121134296475052,-0.0015524969088231,0.0112107555092602
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DKKL1,Dickkopf-like protein 1,29349,-0.0154485142647733,0.00612225733899612,-0.0274481386492057,-0.0034488898803409,0.0116299548006826
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00693108038985505,0.0027488578760817,-0.0123188418269752,-0.00154331895273492,0.0116939527560303
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BMP10,Bone morphogenetic protein 10,24381,-0.00513578763066293,0.00203795075374409,-0.00913017110800134,-0.00114140415332452,0.011739337414389
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIF20B,Kinesin-like protein KIF20B,24101,0.0137392441584197,0.0054717880546132,0.00301453957137787,0.0244639487454616,0.0120480546910515
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.0108753665352546,0.00435714592602544,0.00233536052024476,0.0194153725502645,0.0125663543423668
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POF1B,Protein POF1B,24229,0.00815717814670237,0.00328047847356832,0.00172744033850846,0.0145869159548963,0.0129043757482799
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00684252811531769,0.0027527021781522,0.00144723184613938,0.012237824384496,0.0129346007025098
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS5,Transmembrane protease serine 5,29079,-0.00674196026391775,0.00271667838211567,-0.0120666498928645,-0.00141727063497105,0.0130816149366623
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00596775503388431,0.00240738467684457,-0.0106862290004997,-0.00124928106726895,0.0131842460709756
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00566508079909593,0.00229684998020822,0.00116325483788782,0.010166906760304,0.0136524229721917
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GLI2,Zinc finger protein GLI2,24229,-0.00586260598688297,0.00238624704403347,-0.0105396501931886,-0.00118556178057737,0.0140238199635088
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,29725,0.0102512852478741,0.00417984013955521,0.00205879857434589,0.0184437719214023,0.0141903018669791
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB118,Beta-defensin 118,24101,0.0100588143285577,0.00411988478885995,0.00198384014239224,0.0181337885147233,0.014632397293889
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MTR,Methionine synthase,24111,0.011382722003783,0.00466560091415636,0.00223814421203652,0.0205272997955294,0.0147061398121531
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,29478,-0.00469764272798517,0.00193262600896176,-0.00848558970555023,-0.000909695750420107,0.015075425273593
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,24240,0.00659740448233124,0.00271906344029882,0.00126804013934555,0.0119267688253169,0.0152587262737719
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,0.0122872091971696,0.00507423073782046,0.0023417169510415,0.0222327014432977,0.015462907273906
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA10,Annexin A10,28774,0.0141432956793155,0.00585605824553594,0.00266542151806503,0.0256211698405659,0.01573465611681
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CADPS,Calcium-dependent secretion activator 1,24195,-0.00743268612167137,0.00308190372654672,-0.013473217425703,-0.0013921548176398,0.0158849096219469
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00842897727326063,0.00350340220647933,-0.0152956455979601,-0.00156230894856113,0.0161383479878188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL11,Interleukin-11,28931,0.0106803947308199,0.0044542636433571,0.00195003798983998,0.0194107514717998,0.0165005591799681
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRING1,SREBP regulating gene protein,24016,0.0101832146224511,0.00425859254805586,0.00183637322826159,0.0185300560166406,0.0168003243547687
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,29333,0.00443223115826972,0.001860400686694,0.000785845812349486,0.00807861650418995,0.0172062229525266
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.0111716436990012,0.00469196858664846,0.00197538526917022,0.0203679021288322,0.0172727320939283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP13,Collagenase 3,28774,-0.00551535852297324,0.00233621378822486,-0.010094337547894,-0.000936379498052522,0.0182416688951228
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00731073314670361,0.00310002723567628,-0.0133867865286291,-0.00123467976477809,0.0183677653163756
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,0.00614396797660639,0.00260563210532739,0.00103692905016471,0.0112510069030481,0.0183823354391609
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00880212581216434,0.00374620419058756,-0.016144686025716,-0.00145956559861272,0.0188010682592074
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.0050775849920176,0.00216331450137715,-0.00931768141471682,-0.000837488569318387,0.0189266247439395
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_DRA,,29322,-0.0060412199891251,0.00257761542364374,-0.0110933462194668,-0.00098909375878338,0.0190989214755011
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00667024195459645,0.00284719791665021,-0.0122507498712309,-0.00108973403796203,0.0191508539250405
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MN1,Transcriptional activator MN1,24195,-0.00986532076630751,0.00423422246012617,-0.0181643967881548,-0.00156624474446022,0.0198195505662787
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.006689500537617,0.00287773271044308,-0.0123298566500854,-0.00104914442514857,0.0201030120922529
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.0139454746961413,0.00600349843379463,0.0021786177659038,0.0257123316263787,0.0201932430279392
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00620367982819351,0.00269270437431765,0.000925979254530918,0.0114813804018561,0.0212363411131353
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCARB1,Scavenger receptor class B member 1,28774,0.00943368635781807,0.00410310013760664,0.00139161008810906,0.0174757626275271,0.0215029506078284
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GDF15,Growth/differentiation factor 15,29820,0.00727198227158105,0.00316645310049094,0.0010657341946188,0.0134782303485433,0.0216501939270587
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,YY1,Transcriptional repressor protein YY1,24229,0.00458061731630848,0.0019977894201371,0.00066495005283976,0.0084962845797772,0.0218655813356644
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.0057709964664422,0.00252783211849351,0.000816445514194921,0.0107255474186895,0.0224400251949529
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0160741496471405,0.00704491938364146,-0.0298821916390778,-0.00226610765520328,0.0225177755989488
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL14,C-X-C motif chemokine 14,28931,0.0096739284322558,0.00424729755884659,0.00134922521691648,0.0179986316475951,0.0227537055841217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00770462437767366,0.00338521510777878,-0.0143396459889201,-0.00106960276642726,0.0228569282546623
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAMA1,Laminin subunit alpha-1,24111,-0.00879633007897683,0.00386532600870391,-0.0163723690560365,-0.00122029110191717,0.0228725900249461
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBX2,Chromobox protein homolog 2,24111,-0.00655268763535512,0.00288145077084816,-0.0122003311462175,-0.000905044124492723,0.0229691359439484
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.00328079813981418,0.0014430927451755,-0.00610925992035815,-0.0004523363592702,0.0230062476625836
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHPK,Sedoheptulokinase,24445,-0.00674159342827728,0.00296736246010878,-0.0125576238500905,-0.000925563006464077,0.0231003366014049
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB7,Integrin beta-7,29725,0.00741574474950108,0.00326816713730061,0.0010101371603919,0.0138213523386103,0.0232703750987687
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00703605734098653,0.00311235289829124,0.000935845660335698,0.0131362690216374,0.0237872471599944
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD5,Sushi domain-containing protein 5,24273,-0.00553824482199439,0.00245196058779743,-0.0103440875740773,-0.000732402069911425,0.0239108571473594
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD5L,CD5 antigen-like,24833,0.00753729129782414,0.00337536684469699,0.000921572282218042,0.0141530103134302,0.0255559262719197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,24805,-0.00801260822837408,0.00359734362458095,-0.0150634017325527,-0.000961814724195419,0.0259316282198762
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,29349,0.0109592108481659,0.00492046032763066,0.00131510860600982,0.020603313090322,0.025936558537029
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.00999966061969645,0.00449324150612566,-0.0188064139717027,-0.00119290726769016,0.0260576337350406
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MSMB,Beta-microseminoprotein,29313,0.0110394729857065,0.0049611944343848,0.00131553189431233,0.0207634140771008,0.026077790305222
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRNN,Cornulin,28580,0.0105812521218188,0.00476849067308186,0.00123501040257837,0.0199274938410592,0.0264949607428338
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,0.00409575751853186,0.00185226192492996,0.000465324145669138,0.00772619089139458,0.0270296840042501
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELL,L-selectin,24966,0.00365810990336823,0.00165666055859814,0.000411055208515886,0.00690516459822058,0.0272447758114007
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR1,Toll-like receptor 1,24229,0.00415863684992511,0.00188668646641891,0.000460731375744035,0.00785654232410618,0.0275195593378842
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.0123010637954402,0.00560043529167318,0.00132421062376074,0.0232779169671196,0.0280678592771134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.0109436092774374,0.00505519138504489,-0.0208517843921254,-0.00103543416274945,0.0304108046559997
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00410612806213928,0.00189683967526104,0.000388322298627641,0.00782393382565093,0.0304189071423138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL33,Interleukin-33,28931,0.00600950390604677,0.00278088574818646,0.000558967839601309,0.0114600399724922,0.0307032500421609
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAN,Neurocan core protein,29694,0.00575704660327582,0.00266410370354712,0.00053540334432347,0.0109786898622282,0.0307056754661997
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MUCL3,Mucin-like protein 3,24016,-0.00676511285124871,0.00313973970022717,-0.012919002663694,-0.000611223038803468,0.0311973367870812
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,24883,0.0022756600732439,0.00105796637322367,0.000202045981725504,0.0043492741647623,0.0314877133007454
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLNS1A,Methylosome subunit pICln,24195,0.00514560956826739,0.00239724341531634,0.000447012474247367,0.0098442066622874,0.0318454680234033
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERVV_1,,24111,-0.00704529678097755,0.00330054937565642,-0.0135143735572641,-0.000576220004690961,0.0328051430838152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEZ6L,Seizure 6-like protein,29566,0.00418288010536716,0.00196033424102115,0.000340624992965716,0.00802513521776861,0.032870753446974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TG,Thyroglobulin,24793,-0.0169990362627524,0.00797854572167176,-0.0326369858772291,-0.00136108664827577,0.033132478561435
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NME3,Nucleoside diphosphate kinase 3,29497,0.00359602928932556,0.00170428195317013,0.000255636661112107,0.00693642191753902,0.0348670429634983
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,29443,0.00528977063711609,0.00250839411671827,0.000373318168348279,0.0102062231058839,0.0349678954053042
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HIP1,Huntingtin-interacting protein 1,24111,0.00504466694687686,0.00239334550612734,0.000353709754867266,0.00973562413888645,0.0350595587705592
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0187346981081335,0.00892674350297976,0.00123828084229315,0.0362311153739738,0.035850646417467
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG1A,Lithostathine-1-alpha,29353,-0.00734983327846838,0.00351048914094691,-0.0142303919947243,-0.000469274562212437,0.0362972510055325
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMIGO1,Amphoterin-induced protein 1,24195,0.00751359290773723,0.00358981675339944,0.000477552071074338,0.0145496337444001,0.0363569013318667
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OTOA,Otoancorin,24101,-0.00803387612549519,0.0038421130483965,-0.0155644177003523,-0.000503334550638062,0.0365381018877017
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REST,RE1-silencing transcription factor,24016,-0.0052434115938559,0.00250802699662203,-0.0101591445072351,-0.000327678680476718,0.0365697649089561
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD2,T-cell surface antigen CD2,24111,0.00573067895336699,0.0027480166596032,0.000344566300544714,0.0111167916061893,0.0370446579669886
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00448209313897528,0.00215182916583415,-0.00869967830401021,-0.00026450797394036,0.0372688208372527
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0098571160584676,0.00476291326586234,-0.0191924260595578,-0.000521806057377406,0.0385026647437026
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.0115033409546229,0.00557228467852847,0.00058166298470709,0.0224250189245387,0.0389901282350393
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FRMD7,FERM domain-containing protein 7,24195,0.00491565210086475,0.00239829794209585,0.00021498813435688,0.00961631606737261,0.0404101455780974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDNRB,Endothelin receptor type B,24229,0.0066763912935842,0.00326838189926583,0.000270362771023178,0.0130824198161452,0.0410909019351628
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.016713879905664,0.00824989146306409,0.000544092638058366,0.0328836671732696,0.0427804173524185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RTKN2,Rhotekin-2,24111,-0.00749067698610229,0.00370278527348482,-0.0147481361221325,-0.00023321785007205,0.0430857719195057
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.008788298665286,0.00436086187518076,0.000241009389931712,0.0173355879406403,0.0438878194856231
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AKAP12,A-kinase anchor protein 12,24381,-0.00308954027402336,0.0015389664479903,-0.00610591451208434,-7.31660359623745e-05,0.0447029692733765
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGF,Beta-nerve growth factor,29218,0.00172374672269948,0.000867458766386434,2.35275405820717e-05,0.00342396590481689,0.0469181639043848
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBN2,Fibrillin-2,24195,0.00855620466933589,0.00432121981438329,8.66138331446342e-05,0.0170257955055271,0.0477099207073518
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0167644645522516,0.00846849866188761,0.000166207174951923,0.0333627219295514,0.0477568756946919
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CORO6,Coronin-6,24101,-0.00529945439441376,0.0026881628667175,-0.0105682536131801,-3.06551756474593e-05,0.0486891381502657
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,24805,0.0207325355409183,0.0105220318253021,0.000109353163326196,0.0413557179185104,0.0488044825643697
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,28586,0.00538848850487871,0.00273759320554812,2.28058220043863e-05,0.010754171187753,0.0490396630646466
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCN1,Transcobalamin-1,24546,0.00478839481724132,0.00244244119282463,1.21007930505099e-06,0.0095755795551776,0.0499492103571965
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCGN,Secretagogin,28931,-0.00616365457224104,0.00314667037826433,-0.0123311285136391,3.81936915705254e-06,0.0501474248756566
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF9,Fibroblast growth factor 9,23970,0.00569758743992172,0.00291876714383505,-2.31961619949787e-05,0.0114183710418384,0.0509435753431977
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,23037,0.0074010880967053,0.00380309963200158,-5.29871820177993e-05,0.0148551633754284,0.0516587979014883
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00681554130523743,0.00351557110867637,-7.49780677682449e-05,0.0137060606782431,0.0525528861276285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGN,Mimecan,29443,0.00581533057292375,0.00300318277194645,-7.0907660091284e-05,0.0117015688059388,0.0528296176849677
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0170088444425777,0.00880419304620259,-0.000247373927979397,0.0342650628131348,0.0533813176152185
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00688403212571142,0.00356699985840086,-0.000107287596754262,0.0138753518481771,0.053628204410753
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00412651008000576,0.00213824659759264,-6.44532512758074e-05,0.00831747341128733,0.0536343328411038
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,24805,0.00690159055007231,0.003576716465204,-0.000108773721727525,0.0139119548218721,0.0536692561734586
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.00423236880386514,0.0022001630161065,-7.99507077035924e-05,0.00854468831543388,0.0544084502359497
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PROK1,Prokineticin-1,29434,0.00841683365639058,0.00437867920586141,-0.000165377587097787,0.016999044899879,0.0545863218401339
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DENND2B,DENN domain-containing protein 2B,24111,-0.00696439303332348,0.00363463066879598,-0.0140882691441636,0.000159483077516639,0.0553614829859637
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPHS2,Podocin,24229,-0.0140882319486918,0.0073890383367546,-0.0285707470887308,0.000394283191347227,0.0565791173046858
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00752817624684071,0.00398172866762339,-0.000276011941701132,0.0153323644353826,0.0586786798232817
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASA1,Ras GTPase-activating protein 1,28774,0.00438231020457625,0.00232136115169971,-0.000167557652755179,0.00893217806190767,0.0590602815259703
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFF3,Trefoil factor 3,29426,0.00621803876536531,0.00330386479779186,-0.000257536238306734,0.0126936137690374,0.0598390910487342
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00376889023665679,0.00200835570135561,-0.000167486938000214,0.00770526741131379,0.0605842752063303
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGM2,Phosphoglucomutase-2,24195,0.0080635569538387,0.00430383628853134,-0.000371962171682729,0.0164990760793601,0.0610011778623109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD58,Lymphocyte function-associated antigen 3,29409,-0.00235672075232127,0.0012579270310843,-0.0048222577332465,0.000108816228603962,0.0610098944908064
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN1,Tetraspanin-1,28916,0.00754722361003764,0.00404799346957089,-0.000386843590321293,0.0154812908103966,0.0622706700973333
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD82,CD82 antigen,24445,-0.00554328379963242,0.00297429441331834,-0.0113729008497364,0.000286333250471532,0.0623715193914432
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PODXL2,Podocalyxin-like protein 2,29566,0.00370704481207318,0.00198956823962989,-0.000192508937601405,0.00760659856174777,0.0624383005995732
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CXCL12,Stromal cell-derived factor 1,28931,0.00532140909365451,0.00285701919773867,-0.000278348533913286,0.0109211667212223,0.0625323870831671
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,REG1B,Lithostathine-1-beta,29820,0.00747285387253282,0.00401812005073071,-0.000402661426899358,0.015348369171965,0.0629252849931571
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BEX3,Protein BEX3,24016,-0.00627891348637603,0.0033781687801136,-0.0129001242953987,0.000342297322646633,0.0630856342415369
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SELENOP,Selenoprotein P,24966,0.0029964831125069,0.00161562385504147,-0.000170139643374388,0.00616310586838819,0.0636521453678774
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00807796334347901,0.00436173491402572,-0.0166269637749694,0.000471037088011406,0.0640370484429693
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.0054440260915692,0.00295018044759716,-0.0112263797688596,0.000338327585721224,0.0650033128864198
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,29434,0.00616705187997718,0.00334418134917572,-0.000387543564407228,0.0127216473243616,0.0651765660179521
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00856635271206659,0.00464975703001221,-0.0176798764908905,0.000547171066757337,0.0654402511490045
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,24101,0.014155919487573,0.00774062004198379,-0.00101569579471526,0.0293275347698612,0.067444381359522
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTN4,Alpha-actinin-4,28931,0.00416822394034576,0.00228389286138326,-0.000308206067965425,0.00864465394865694,0.068003446902785
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEX33,Testis-expressed protein 33,24445,-0.00506369355434086,0.00278868674137117,-0.0105295195674283,0.000402132458746627,0.0694135206028074
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RELB,Transcription factor RelB,24229,0.00640940030311141,0.00353204513508817,-0.000513408161661406,0.0133322087678842,0.0695911871293821
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH22,Cadherin-22,24445,-0.00369676682750992,0.00204351931265502,-0.00770206468031375,0.000308531025293918,0.0704602197223705
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCLRE1C,Protein artemis,24016,-0.00399935573729952,0.00222516534610993,-0.00836067981567499,0.000361968341075939,0.0722958610484504
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",27986,0.0037313014536018,0.00207815079747339,-0.000341874109446051,0.00780447701664965,0.0725862643965217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COPE,Coatomer subunit epsilon,28774,0.00603794818858385,0.00338023996030167,-0.000587322133607433,0.0126632185107751,0.0740695801642887
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD70,CD70 antigen,29434,-0.00544296381089003,0.00304836375744581,-0.0114177567754838,0.00053182915370375,0.0741846840515105
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CPLX2,Complexin-2,24016,-0.00391945324707798,0.00220150111926418,-0.00823439544083578,0.000395488946679816,0.0750305481219803
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.00888089349382682,0.00498860539332568,-0.0186585600647451,0.000896773077091509,0.0750495792412669
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUSP29,Dual specificity phosphatase 29,24195,-0.00850429711603524,0.00478007572628679,-0.0178732455395574,0.000864651307486867,0.0752337188260047
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0115818207149366,0.00652980608645739,-0.00121659921451992,0.0243802406443931,0.0761278599854267
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.0109532227022077,0.00617898338523014,-0.00115758473284336,0.0230640301372588,0.0762978967002322
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NXPE4,NXPE family member 4,24111,-0.00435783153373292,0.00245915849479286,-0.00917778218352691,0.000462119116061081,0.0763935105676524
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00624342950142914,0.00352403872201884,-0.0131505453965861,0.00066368639372778,0.0764621410377841
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DHODH,Dihydroorotate dehydrogenase,24111,0.00600405962168126,0.00338902503056956,-0.000638429438235077,0.0126465486815976,0.076470533490266
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00884128512741282,0.00501758489920733,-0.0186757515298592,0.000993181275033558,0.0780718606594606
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,29581,0.00353560078515936,0.0020122918377579,-0.000408491216846123,0.00747969278716484,0.0789278174507039
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHP1,Calcineurin B homologous protein 1,24101,0.00920442939919695,0.0052389055992013,-0.0010638255752376,0.0194726843736315,0.0789411769836753
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL1A,Interleukin-1 alpha,28931,0.00696613772384598,0.00397137839069363,-0.000817763921913526,0.0147500393696055,0.0794264293939705
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSLP,Thymic stromal lymphopoietin,28916,0.00756594685705043,0.00431593990936988,-0.000893295365314531,0.0160251890794154,0.079608464269538
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MERTK,Tyrosine-protein kinase Mer,29786,0.00317813051632919,0.00181466692400375,-0.000378616654718159,0.00673487768737653,0.0798946467554809
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,24195,0.00453808553018363,0.00259328936828406,-0.000544761631653129,0.00962093269202038,0.080142366837372
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00585947186128308,0.00334888827597324,-0.0124232928821906,0.000704349159624472,0.0801868915750332
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESPL1,Separin,24016,-0.00693785775109932,0.00396678843780619,-0.0147127630891994,0.000837047587000803,0.0803062077433541
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNNI3,"Troponin I, cardiac muscle",28916,0.0105048937031449,0.00600874879477357,-0.00127225393461128,0.0222820413409011,0.0804285233962202
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL3A1,Collagen alpha-1(III) chain,24938,0.00290279812172858,0.00166463895155578,-0.000359894223320747,0.00616549046677791,0.0812062240615431
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00368533783245617,0.00211833833425795,-0.00783728096760175,0.000466605302689403,0.0819187285593738
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.0040522289063425,0.00234476325545191,-0.00864796488702823,0.000543507074343237,0.0839644981677321
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,H2AP,Huntingtin-interacting protein M,24016,-0.006309657581037,0.00366461613076643,-0.0134923051973392,0.000872990035265198,0.0851225194486836
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.0031127907556221,0.00181887105659464,-0.0066777780265476,0.000452196515303401,0.0870227698861237
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DNLZ,DNL-type zinc finger protein,24101,-0.0110422195894879,0.00646082095726734,-0.0237054286657319,0.00162098948675605,0.0874444351863376
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,24445,0.0047253700861029,0.00277271446578671,-0.000709150266839047,0.0101598904390448,0.0883490296529348
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FBLN2,Fibulin-2,24938,-0.00380073567945436,0.00224333852659307,-0.00819767919157677,0.000596207832668048,0.0902337202111545
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCUN1D1,DCN1-like protein 1,24101,-0.00907362851291034,0.0053600027640208,-0.0195792339303911,0.00143197690457042,0.0904988074954972
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00608309352637475,0.00360127070128877,-0.0131415841009007,0.000975397048151236,0.0912032463212496
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NPTN,Neuroplastin,28797,0.00982749106923976,0.00582673883019435,-0.00159291703794116,0.0212478991764207,0.0916873855459731
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DEFB116,Beta-defensin 116,24101,-0.00927457361725163,0.00552154671517307,-0.0200968051789908,0.00154765794448758,0.0930275543072549
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXDC1,Plexin domain-containing protein 1,28797,0.00397530404214433,0.00236791803410265,-0.000665815304696867,0.00861642338898552,0.093198322761629
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEPTIN7,Septin-7,24445,0.00630432628239776,0.00376896986177662,-0.00108285464668442,0.0136915072114799,0.0944007202531841
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC44A4,Choline transporter-like protein 4,24195,-0.00826666878492596,0.00496078209549726,-0.0179898016921006,0.00145646412224867,0.0956458597369283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00438914965355891,0.00265510741649035,-0.00959316018987999,0.000814860882762169,0.0983241851349144
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,0.0139457560495254,0.00847147525341241,-0.00265833544716289,0.0305498475462138,0.0997329396828965
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.00596288704249704,0.00365799026886752,-0.0131325479694774,0.0012067738844833,0.103091196954737
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00412211268231886,0.00253344515680666,-0.000843439825022185,0.0090876651896599,0.103733445296398
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00851608874407632,0.00524419583149491,-0.0187947125738063,0.0017625350856537,0.104408644767908
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN15,Tetraspanin-15,24111,-0.00587230346142301,0.00361794044972172,-0.0129634667428776,0.00121885982003157,0.10457967386128
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENOPH1,Enolase-phosphatase E1,24793,0.00642111531686137,0.00396101338000639,-0.00134247090795116,0.0141847015416739,0.105013436600925
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00898533352287615,0.00555161481009676,-0.0018958315049135,0.0198664985506658,0.105566185195561
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRR5,Proline-rich protein 5,24229,0.00550751339845643,0.00340826763433643,-0.00117269116484297,0.0121877179617558,0.106123016230905
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANGPT2,Angiopoietin-2,29725,-0.0043827678920832,0.00271816905332872,-0.00971037923660749,0.000944843452441083,0.106886177180835
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL10,Interleukin-10,28931,0.00933300262986222,0.00583908490218729,-0.00211160377842486,0.0207776090381493,0.109972173462152
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00949892453662884,0.00596212366417905,-0.0211846869184198,0.0021868378451621,0.111125668050971
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SOX2,Transcription factor SOX-2,24826,0.00271245441335606,0.00170305788739082,-0.00062553904592994,0.00605044787264205,0.111241021282971
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.00953620347378233,0.00600274813306878,-0.0213015898145971,0.00222918286703248,0.112154950817595
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00707479163874276,0.00445537537925487,-0.00165774410459679,0.0158073273820823,0.112316581854949
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00610403475274464,0.00386775307605617,-0.00147676127632545,0.0136848307818147,0.114536004534596
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00645491638022697,0.00409992790943896,-0.0144907750827273,0.00158094232227339,0.115408707650343
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL4,Interleukin-4,28931,0.0102727226912751,0.00655193601647815,-0.00256907190102208,0.0231145172835723,0.116917472420067
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCNE1,G1/S-specific cyclin-E1,24229,0.0103248541070731,0.00661632780487757,-0.00264314839048694,0.0232928566046331,0.118652176927597
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAB6B,Ras-related protein Rab-6B,28774,0.00534303208822157,0.00342892796343123,-0.00137766672010364,0.0120637308965468,0.11919155882203
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WIF1,Wnt inhibitory factor 1,29725,-0.00376016512781317,0.00242862043869979,-0.00852026118766476,0.000999930932038412,0.121567463478764
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.00939400354714626,0.00607578363381155,-0.0213025394694169,0.00251453237512438,0.122084162546464
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANXA5,Annexin A5,28650,0.00333515092249642,0.00217249076607335,-0.000922930979007359,0.00759323282400019,0.124752188051617
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL36A,Interleukin-36 alpha,24229,-0.00639163828425779,0.00416525461895678,-0.0145555373374131,0.0017722607688975,0.124916507724867
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAMDC2,MAM domain-containing protein 2,24922,-0.00378514984599778,0.00247527267031081,-0.00863668427980697,0.00106638458781141,0.126231285999346
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLXDC2,Plexin domain-containing protein 2,24845,0.00295471437145477,0.00193247388607082,-0.000832934445244047,0.00674236318815358,0.126282082421996
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.0038970401144554,0.00255117481016935,-0.00110326251347653,0.00889734274238733,0.126638062074566
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00402756325318005,0.00265709142839385,-0.00118033594647189,0.00923546245283198,0.12958618722041
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.00531925402964852,0.00351127841849011,-0.0122013597298891,0.00156285167059211,0.129807122585005
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FZD10,Frizzled-10,24195,0.00648207820769298,0.00430704035077686,-0.00195972087982968,0.0149238772952156,0.132338183704998
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,INSL4,Early placenta insulin-like peptide,24793,-0.00552602371857628,0.00367394640826917,-0.0127269586787839,0.0016749112416313,0.132565497547408
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00754921058042183,0.00506618744519262,-0.0174789379729994,0.0023805168121557,0.136206644412299
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HLA_A,,24867,0.00348010565624861,0.00233561916007385,-0.00109770789749613,0.00805791920999334,0.136233198914611
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,29566,0.00290453003913859,0.00194940558056427,-0.000916304898767376,0.00672536497704455,0.136246275709263
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.0052648625749311,0.00355091055682706,-0.0122246472663121,0.00169492211644994,0.138172639742029
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL25,Interleukin-25,23913,0.00366893714934416,0.00247492318719361,-0.00118191229755531,0.00851978659624363,0.138235151342075
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,0.00629476770725685,0.00425433505959961,-0.00204372900955839,0.0146332644240721,0.138989737758372
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00355565104340665,0.00241688194470076,-0.00118143756820683,0.00829273965502014,0.14125704462391
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00749053905373185,0.00509892127109953,-0.00250334663762324,0.0174844247450869,0.141833898480598
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAD1,Glutamate decarboxylase 1,24016,-0.00272650810977741,0.00186145490400521,-0.00637495972162763,0.000921943502072804,0.143010734043134
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00333130315595549,0.00228109878404318,-0.00780225677268011,0.00113965046076914,0.144194888281862
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00565447418835263,0.00388626293888667,-0.0132715495485705,0.00196260117186523,0.145684865593443
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A3,Protein S100-A3,24793,0.00459800474902867,0.00317359815685455,-0.00162224763840625,0.0108182571364636,0.147397670899812
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.00798023602900914,0.00551145635751602,-0.0187826904897405,0.00282221843172225,0.147647968104583
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SERPINB5,Serpin B5,28916,0.0049891824323563,0.00347221268935933,-0.00181635443878799,0.0117947193035006,0.150760507019556
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBM25,RNA-binding protein 25,24016,-0.00474985406655602,0.00332323965797057,-0.0112634037961783,0.0017636956630663,0.152935568578135
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WNT9A,Protein Wnt-9a,28931,0.00290899333275593,0.0020591386716581,-0.00112691846369395,0.00694490512920582,0.157747838467969
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00492946794297187,0.00350702889029625,-0.0118032445679525,0.00194430868200878,0.159856885020153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AREG,Amphiregulin,29349,-0.00457109797835941,0.00325520562768852,-0.0109513010086289,0.00180910505191008,0.160257247257704
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NENF,Neudesin,24793,0.0109906890862829,0.00785419089044002,-0.00440352505897956,0.0263849032315453,0.161723353938491
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP1,DNA topoisomerase 1,24805,0.0112248499058141,0.00809159526648285,-0.00463467681649224,0.0270843766281205,0.165386137558875
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.00439385499486636,0.00317276165967202,-0.0106124678478235,0.0018247578580908,0.166105698077817
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,24195,0.0101872904928453,0.00737611331839437,-0.0042698916112077,0.0246444725968982,0.167255127164177
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTLA,B- and T-lymphocyte attenuator,24016,0.00859716620735771,0.00624312163137117,-0.00363935219012978,0.0208336846048452,0.168505890383865
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00565158949924905,0.00410606912382224,-0.00239630598344253,0.0136994849819406,0.168710972570752
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00321106366239953,0.00233483689483485,-0.00136521665147677,0.00778734397627584,0.169056221378083
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00454229329332054,0.00335204399362837,-0.00202771293419105,0.0111122995208321,0.175401858593946
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00322153061950118,0.002398049545553,-0.00792170772878506,0.0014786464897827,0.179154176437597
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.00833764361324162,0.00620874821011015,-0.0205067901050575,0.00383150287857426,0.179321056923938
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00466048128442874,0.00348263044759264,-0.00216547439285284,0.0114864369617103,0.1808394168668
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.00261279197800548,0.00196794033235469,-0.00124437107340972,0.00646995502942067,0.184294565445115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00444841789363826,0.00335097791577129,-0.00211949882127346,0.01101633460855,0.184356437725005
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPT,Microtubule-associated protein tau,28774,0.00500802457324046,0.00377534681083518,-0.0023916551759965,0.0124077043224774,0.184682298266163
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMEM132A,Transmembrane protein 132A,24240,0.00594232400828643,0.00448091557962338,-0.0028402705277754,0.0147249185443483,0.18480563755241
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00347104110978144,0.0026430215253335,-0.00865136329943511,0.00170928107987222,0.189099410663707
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RRP15,RRP15-like protein,24101,-0.00845594833752469,0.00651231187239811,-0.021220079607425,0.00430818293237561,0.194143227971101
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,0.00263231777685974,0.00203113568477635,-0.0013487081653019,0.00661334371902138,0.194991468261156
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHH,Sonic hedgehog protein,24229,-0.0039815659076988,0.00307491123526556,-0.0100083919288193,0.0020452601134217,0.195382407440132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMCN2,Hemicentin-2,24343,0.00531059797751722,0.00411938533122745,-0.00276339727168858,0.013384593226723,0.197350405903731
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCUN1D2,DCN1-like protein 2,24016,-0.00739593800161776,0.00573930421201877,-0.0186449742571745,0.00385309825393903,0.197533205223959
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00902405461671626,0.00701911930053612,-0.00473341921233454,0.0227815284457671,0.198581379211683
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THBS2,Thrombospondin-2,29443,0.00342393784915253,0.00266814115981885,-0.00180561882409242,0.00865349452239748,0.199408609418572
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00415114336617314,0.00325955816601475,-0.0105398773715621,0.00223759063921577,0.202842513152772
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTN5,Contactin-5,29511,-0.00336099926981999,0.00264234040806055,-0.00853998646961866,0.00181798792997868,0.203390909792996
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GH2,Growth hormone variant,28797,0.0150221231969286,0.0118123011129382,-0.0081299869844302,0.0381742333782874,0.203477372090341
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HRAS,GTPase Hras,24421,0.00889115896201617,0.00704687308177332,-0.00492071227825954,0.0227030302022919,0.207062725907354
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,0.00515763890607111,0.00408872820394739,-0.00285626837366577,0.013171546185808,0.207164420960685
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZPR1,Zinc finger protein ZPR1,24101,0.00869880846674122,0.0069149150053267,-0.00485442494369911,0.0222520418771816,0.208412037168359
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TGFBR1,TGF-beta receptor type-1,24229,0.00194861909454578,0.00155116402299239,-0.0010916623905193,0.00498890057961086,0.209044638817166
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.00285888473958339,0.00228557550556253,-0.00733861273048595,0.00162084325131917,0.211005730216047
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYOC,Myocilin,29443,-0.00404645376281525,0.00325749879538525,-0.0104311514017703,0.00233824387613983,0.214173951211989
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC123,Cell division cycle protein 123 homolog,24016,0.00563207652921131,0.00453410521036075,-0.00325476968309575,0.0145189227415184,0.214190289455416
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,24938,-0.00190803182839797,0.00153935319387168,-0.00492516408838645,0.00110910043159052,0.215171207309494
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PMCH,Pro-MCH,24111,-0.00725681961002331,0.00598452722402153,-0.0189864929691055,0.00447285374905889,0.225295833761188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CGN,Cingulin,24195,0.00345920157955298,0.00285430800666723,-0.00213524211351478,0.00905364527262074,0.225553691130767
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,29566,-0.0036405402707148,0.00301494280272542,-0.00954982816405663,0.00226874762262703,0.227249712880519
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FZD8,Frizzled-8,24101,0.00380123877824536,0.00314814514691401,-0.0023691257097061,0.00997160326619683,0.227269410757926
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00271609825524332,0.00226831677066139,-0.001729802615253,0.00716199912573964,0.23115779832366
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00239440178913798,0.00200857798402063,-0.00154241105954245,0.00633121463781842,0.233238119069083
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,24405,-0.0045063079639396,0.00378125517090118,-0.0119175680989059,0.00290495217102671,0.233371181134559
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,24111,-0.0061450526096514,0.00521137746464752,-0.0163593524403605,0.00406924722105773,0.238345749185591
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PYDC1,Pyrin domain-containing protein 1,24240,-0.00352649862294333,0.00300115065892725,-0.00940875391444074,0.00235575666855408,0.239986722525979
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00296626717580987,0.00252483855811214,-0.00791495074970966,0.00198241639808992,0.240072586262999
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00313222979568445,0.00266652241720418,-0.00835861373340465,0.00209415414203576,0.240146492653304
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF7,Fibroblast growth factor 7,24016,-0.00666466162088559,0.00568025790607514,-0.0177979671167929,0.00446864387502168,0.240686105377641
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00459739494065809,0.00392492461375694,-0.00309545730230552,0.0122902471836217,0.241474531206335
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDAC8,Histone deacetylase 8,24229,0.0051252702905607,0.00438796157575629,-0.00347513439792163,0.013725674979043,0.242806207007081
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.0042067308085908,0.00360595422736322,-0.0112744010942227,0.00286093947704111,0.243380596396807
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00315324783028398,0.00270294644111116,-0.00845102285486184,0.00214452719429389,0.243384866461521
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00346367156190378,0.00299478266023988,-0.00240610245216639,0.00933344557597394,0.24745977770182
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KDM3A,Lysine-specific demethylase 3A,24229,-0.00746461395805076,0.00648256780059002,-0.0201704468472072,0.00524121893110568,0.249541951586904
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,-0.00529261779436627,0.00461498057780326,-0.0143379797268607,0.00375274413812812,0.251459425025262
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPA33,Cell surface A33 antigen,29349,0.0110228336807858,0.00961963171396243,-0.00783164447858058,0.0298773118401521,0.251858883073636
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00602024363037323,0.0052718510728083,-0.00431258447233104,0.0163530717330775,0.253481952801509
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB5,Integrin beta-5,29566,0.00306662608012714,0.00268708976043803,-0.00220006985033139,0.00833332201058568,0.2537774896022
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RBP1,Retinol-binding protein 1,24195,0.0055845042323668,0.00496235676642905,-0.00414171502983413,0.0153107234945677,0.260442013926054
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DUOX2,Dual oxidase 2,28916,0.00571466821724366,0.0050924847790459,-0.0042666019496863,0.0156959383841736,0.26179660197766
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STC2,Stanniocalcin-2,29396,0.00206696057579507,0.00185071857923847,-0.00156044783951233,0.00569436899110248,0.264070942287516
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD177,CD177 antigen,29413,-0.0101315056595577,0.0091328872444178,-0.0280319646586166,0.00776895333950117,0.26729126283027
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00350793215468567,0.00316560983736439,-0.00971252743591987,0.00269666312654852,0.267813380455248
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,L1CAM,Neural cell adhesion molecule L1,29566,0.00227855494779497,0.00206441160603732,-0.00176769180003818,0.00632480169562811,0.269718860300535
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHIT1,Chitotriosidase-1,29579,0.0119661424504305,0.0108719250295618,-0.00934283060751065,0.0332751155083717,0.271059651715351
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00260896247949614,0.00238916751895884,-0.00729173081665547,0.0020738058576632,0.274843758496755
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCP11,T-complex protein 11 homolog,24445,-0.00461971353349097,0.0042453718919804,-0.0129406424417726,0.00370121537479062,0.276527972335849
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CBLN1,Cerebellin-1,24101,-0.007390259498601,0.0068347397303123,-0.0207863493700131,0.00600583037281111,0.279583919029405
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00438276602335059,0.00406371970524477,-0.0123476566456303,0.00358212459892915,0.28081665551392
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTF,Ciliary neurotrophic factor,24101,-0.00260753355034744,0.00244099890231329,-0.00739189139888148,0.0021768242981866,0.285430197973189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,29725,-0.00438359070016822,0.00410633292197546,-0.0124320032272401,0.00366482182690369,0.285745961107289
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,24101,-0.00449066308160058,0.00422300162210257,-0.0127677462609216,0.00378642009772046,0.287619501705097
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PITHD1,PITH domain-containing protein 1,23970,-0.00606196011080498,0.00570705061106186,-0.0172477793084862,0.00512385908687627,0.288161098776008
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00475269762966614,0.00447552418357396,-0.0135247250294711,0.00401932977013881,0.288277682053376
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH17,Cadherin-17,29478,-0.00514155886542187,0.00484336953727131,-0.0146345631584736,0.00435144542762989,0.288441228095864
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MMP15,Matrix metalloproteinase-15,24922,0.00371822336392721,0.00351631597755144,-0.00317375595207361,0.010610202679928,0.290330134978025
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAD2,Glutamate decarboxylase 2,24229,-0.00350273984798895,0.00331434803674843,-0.00999886200001586,0.00299338230403797,0.290594570605348
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLL1,Delta-like protein 1,29566,0.00225025343828329,0.00213174416038668,-0.0019279651160746,0.00642847199264118,0.2911629960708
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,24445,0.00585348767218149,0.00558630867755947,-0.00509567733583507,0.016802652680198,0.294728470909884
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.00597384277854695,0.00570562753001719,-0.00520918718028675,0.0171568727373806,0.295106018712849
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPHA10,Ephrin type-A receptor 10,28774,0.00488269407855683,0.00466940187484095,-0.00426933359613142,0.0140347217532451,0.295718188874159
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00248764350946368,0.00238200448666809,-0.00218108528440578,0.00715637230333314,0.296332780705057
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF12,Fibroblast growth factor 12,24229,0.0034936609713858,0.00334831860028701,-0.00306904348517674,0.0100563654279483,0.29676998570454
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.00271508008926201,0.00262437502992966,-0.00785885514792415,0.00242869496940012,0.300881760909092
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00360898986444149,0.0034996812306414,-0.00325038534761566,0.0104683650764986,0.302441454544624
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00464833806326233,0.00451053816868039,-0.00419231674735123,0.0134889928738759,0.302761788271771
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00295658639906228,0.00287038750986376,-0.00858254591839526,0.0026693731202707,0.30300593145705
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA11,Carbonic anhydrase-related protein 11,28797,0.00232517724446944,0.00227630577702228,-0.00213638207849423,0.00678673656743311,0.307040570694476
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF75D,Zinc finger protein 75D,24445,0.00438881178597882,0.0043006382312716,-0.00404043914731352,0.0128180627192712,0.307500340207187
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VASN,Vasorin,29065,0.00199661587412078,0.00196167616829724,-0.00184826941574181,0.00584150116398337,0.308776188902084
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAC1,Cartilage acidic protein 1,29820,0.00217510564976392,0.00214440320863872,-0.00202792463916798,0.00637813593869581,0.310439521279129
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00180475080791276,0.00181556600522707,-0.00536326017815781,0.00175375856233229,0.320211549112207
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.00343050537421349,0.00345752230831876,-0.0102072490985182,0.00334623835009127,0.321116694215113
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00394299764462869,0.00397853119617614,-0.0117409187891339,0.00385492349987655,0.321661963963448
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDAN1,Codanin-1,24845,0.00158725232426002,0.00161233882948186,-0.00157293178152443,0.00474743643004447,0.324908357421421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00439063037576596,0.00447589182503646,-0.0131633783528374,0.0043821176013055,0.326626774610892
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVPL,Envoplakin,24445,-0.00237176932180971,0.00242701661604895,-0.00712872188926565,0.00238518324564623,0.328461737930155
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00289674985768823,0.00296449793681301,-0.00870716581384174,0.00291366609846528,0.328506225703494
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00456960409289925,0.0047140890352694,-0.0138092186020273,0.00467001041622876,0.332380158253825
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00287593371223321,0.00298422329940477,-0.00297314395460013,0.00872501137906655,0.335199652914976
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00344750052851015,0.00357765798259974,-0.00356470911738533,0.0104597101744056,0.335246716197237
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00353048840616424,0.00366878747335026,-0.0107213118539308,0.00366033504160228,0.335906605099205
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,28931,0.00408339243644696,0.00424640903728421,-0.00423956927663009,0.012406354149524,0.336253227000457
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OSTN,Osteocrin,24195,-0.00287237288098854,0.00299047540179288,-0.00873370466850259,0.00298895890652551,0.336809659096107
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FH,"Fumarate hydratase, mitochondrial",24101,0.00576578142589181,0.00600674142565257,-0.00600743176838724,0.0175389946201709,0.337122695052157
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL31,Interleukin-31,24229,-0.00389478053553828,0.00407106237573097,-0.011874062791971,0.00408450172089442,0.338728849280201
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.00287816894837401,0.00301750164682878,-0.00879247217615841,0.00303613427941039,0.340181435329319
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.017964586603683,0.0188718090251738,-0.0549533322930237,0.0190241590856577,0.341143447122354
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NECTIN4,Nectin-4,29566,-0.00215852516415316,0.00227919053263067,-0.00662573860810928,0.00230868827980295,0.343617072244299
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00238267834601331,0.00252915172731487,-0.00257445903952382,0.00733981573155045,0.346156536207344
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00276491351417541,0.00293534647600354,-0.00298836557879153,0.00851819260714234,0.346233849761491
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00533340082600073,0.00568907719318838,-0.01648399212465,0.00581719047264849,0.348520545748206
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,29349,0.0030688037258548,0.00327585482422439,-0.00335187172962501,0.00948947918133461,0.348871838822466
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CA8,Carbonic anhydrase-related protein,24229,0.00181125920452961,0.00194796201494528,-0.00200674634476314,0.00562926475382235,0.352472185506098
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00319508091142007,0.00347614013495229,-0.00361815375308641,0.0100083155759266,0.358028319907987
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,24867,0.00500421617028855,0.00546501516919958,-0.00570721356134262,0.0157156459019197,0.359842578577974
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.00267472041611386,0.00292565938760087,-0.00840901281581157,0.00305957198358384,0.360604433303506
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TCN2,Transcobalamin-2,29757,-0.00194615377993702,0.00213939959461299,-0.00613937698537848,0.00224706942550443,0.363002424699609
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGFL4,Insulin growth factor-like family member 4,24229,0.00490185598950593,0.00538880888680262,-0.0056602094286272,0.0154639214076391,0.363023420277125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBZ,Hemoglobin subunit zeta,24922,0.00684973931369669,0.00756512168501433,-0.00797789918893139,0.0216773778163248,0.365242803321497
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF20,Fibroblast growth factor 20,24229,-0.00284157860250122,0.00314093674076269,-0.00899781461439609,0.00331465740939366,0.365637874492303
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00330740116949101,0.00366823781215101,-0.010497147281307,0.00388234494232497,0.367261314643939
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCAM1,Neural cell adhesion molecule 1,29594,-0.00192833373823155,0.00215354209615543,-0.0061492762466962,0.0022926087702331,0.370567647899017
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00443960647967673,0.0049718690150761,-0.00530525678987242,0.0141844697492259,0.371895416079246
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAP1,Antigen peptide transporter 1,24445,-0.00383320495198891,0.00429476861475955,-0.0122509514369176,0.00458454153293982,0.37211831971488
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-0.0018827630842943,0.00211329628020947,-0.00602482379350485,0.00225929762491626,0.372984708567476
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,-0.00182358302526512,0.00205819616514151,-0.00585764750894248,0.00221048145841225,0.375619118842782
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLHL41,Kelch-like protein 41,24867,0.003120195207702,0.00355271608091897,-0.00384312831089917,0.0100835187263032,0.379813146617831
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00261119983108878,0.00297894955939047,-0.00844994096749409,0.00322754130531654,0.380739511737311
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.00417851034216225,0.00479204277785943,-0.0135709141867667,0.00521389350244224,0.383234251142545
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GJA8,Gap junction alpha-8 protein,24016,0.00386738385085607,0.00444999370509397,-0.00485460381112811,0.0125893715128403,0.384814115138904
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00425168945584644,0.00496084906764198,-0.0139749536284247,0.00547157471673184,0.391426470308114
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00353138611198602,0.00412683767907423,-0.00455721573899947,0.0116199879629715,0.392165430111342
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DBH,Dopamine beta-hydroxylase,24919,0.00667746683977581,0.00780396895742414,-0.00861831231677551,0.0219732459963271,0.392199579328928
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00145122111093932,0.00170185952666944,-0.00478686578321141,0.00188442356133278,0.393819080990848
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00151199036355054,0.00177517618041906,-0.00499133567717189,0.00196735495007081,0.394366041375432
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCNA,Proliferating cell nuclear antigen,24016,0.00384731092831738,0.00452740319328213,-0.0050263993305156,0.0127210211871504,0.395454137748115
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KLK12,Kallikrein-12,28797,-0.00839001799626188,0.00989242892997904,-0.0277791786990208,0.010999142706497,0.396375316592432
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDCL2,Phosducin-like protein 2,24016,0.00321169297027878,0.00379512450275239,-0.0042267510551159,0.0106501369956735,0.397411611477355
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,24016,0.00201742619462556,0.00239272981015624,-0.00267232423328067,0.00670717662253179,0.399153882033706
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00392905055154521,0.00470711345561221,-0.0131549929245451,0.00529689182145473,0.403892170766661
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRYBB2,Beta-crystallin B2,24845,0.00411820532777731,0.0049417075935125,-0.00556754155550719,0.0138039522110618,0.404651580862243
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,-0.00155032960501149,0.00187185287775851,-0.00521916124541816,0.00211850203539519,0.407546729258416
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NEB,Nebulin,24111,-0.00223688082111285,0.00271117409296892,-0.00755078204333193,0.00307702040110624,0.40934579451442
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRTN3,Myeloblastin,28671,0.00278589500554815,0.00338754893101378,-0.00385370089923886,0.00942549091033517,0.410860360339511
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00256415309914116,0.00312079765398562,-0.00355261030267066,0.00868091650095298,0.411293316135816
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LY96,Lymphocyte antigen 96,29218,-0.00208062617802804,0.00253654494461676,-0.00705225426947688,0.0028910019134208,0.412074638868673
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,24793,0.0029953801796664,0.00372077195581132,-0.00429733285372378,0.0102880932130566,0.420802782843208
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL5,Interleukin-5,28931,0.00811885655898409,0.0101447517283781,-0.0117648568286371,0.0280025699466052,0.423542906755586
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,24229,-0.00245966511369967,0.00310520789377741,-0.00854587258550338,0.00362654235810405,0.42830450787847
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY2B,Alpha-amylase 2B,27585,-0.00274719813026949,0.00350212545251794,-0.00961136401720465,0.00411696775666568,0.432790248914009
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HSP90B1,Endoplasmin,28626,0.00374853356572714,0.00478973568292898,-0.00563934837281366,0.0131364155042679,0.433857919969821
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.0030301214457401,0.00388452065834802,-0.00458353904462203,0.0106437819361022,0.435368942452276
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF830,Zinc finger protein 830,24793,-0.00441730822592756,0.00566326787777368,-0.015517313266364,0.00668269681450885,0.435402557411936
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.00267493343864265,0.00343757316615907,-0.00941257684431443,0.00406270996702912,0.436490610020297
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSCA,Prostate stem cell antigen,24805,0.0142327147587501,0.0185317620549718,-0.0220895388689947,0.0505549683864949,0.442484193288857
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TBR1,T-box brain protein 1,24195,0.00263624389472469,0.00345596923824124,-0.00413745581222815,0.00940994360167753,0.445584847882705
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DAND5,DAN domain family member 5,24229,-0.00296615832486368,0.00389317994754956,-0.0105967910220608,0.00466447437233346,0.446135615798396
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPB41L5,Band 4.1-like protein 5,24195,0.00342380728869322,0.00449816699145152,-0.00539260001455175,0.0122402145919382,0.446571252375456
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACTA2,"Actin, aortic smooth muscle",28916,-0.00234188122847386,0.00310839607231717,-0.00843433753021552,0.0037505750732678,0.451212699642523
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.00181748875221797,0.00243377492304212,-0.00658768760138053,0.00295271009694458,0.455205095023893
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.00263204911511727,0.00353516687543509,-0.00956097619097004,0.00429687796073551,0.456561251368578
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.00313334876911181,0.00423925298011159,-0.00517558707190691,0.0114422846101305,0.459835502053234
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.00727799728504783,0.00985218444196394,-0.0265882787912972,0.0120322842212015,0.460084512942229
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00288035383915418,0.00393763266201297,-0.0105981138566996,0.00483740617839124,0.464484737672816
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GFRA3,GDNF family receptor alpha-3,29157,-0.00146538383727462,0.00200904023036851,-0.00540310268879691,0.00247233501424767,0.465765956122077
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DLGAP5,Disks large-associated protein 5,24867,-0.00269442052004629,0.00369640222588519,-0.00993936888278126,0.00455052784268868,0.466051012846453
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,-0.00271707638734168,0.00375465606359177,-0.0100762022719815,0.00464204949729819,0.469284467681785
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RAP1A,Ras-related protein Rap-1A,24229,-0.00355462070152123,0.004957098128141,-0.0132705330326776,0.00616129162963513,0.473333546963919
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CHGB,Secretogranin-1,29590,0.00209020831040397,0.00293482462920301,-0.00366204796283393,0.00784246458364186,0.476341025646334
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNIP4,Kv channel-interacting protein 4,28774,0.00259280455287933,0.0036437607306602,-0.00454896647921466,0.00973457558497333,0.476734527089771
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FAM171A2,Protein FAM171A2,24867,0.00804178996183338,0.011320058650779,-0.0141455249936935,0.0302291049173603,0.47746167749887
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAX,Integrin alpha-X,24445,0.00268933418959612,0.00382886139743663,-0.00481523414937967,0.0101939025285719,0.482445890462005
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN4,Prefoldin subunit 4,24016,0.00261733294521583,0.00382940186318711,-0.0048882947066309,0.0101229605970626,0.49430797772262
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPRR1B,Cornifin-B,24445,0.00416290259157701,0.00612033831361202,-0.00783296050310254,0.0161587656862566,0.496399952122137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOLR3,Folate receptor gamma,29461,-0.00904868096816479,0.0133706509198189,-0.0352551567710098,0.0171577948346803,0.498565490767897
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UNC5D,Netrin receptor UNC5D,24229,0.0012771478127835,0.0018882408123067,-0.00242380417933763,0.00497809980490463,0.498812765941418
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD27,CD27 antigen,29566,0.00200151698149371,0.00296602009486149,-0.00381188240443482,0.00781491636742224,0.499798131764981
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SEMA4C,Semaphorin-4C,29349,0.00132853608644575,0.00200641946731657,-0.00260404606949472,0.00526111824238623,0.507884947438502
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KHDC3L,KH domain-containing protein 3,24016,-0.0031744417145374,0.00483484662426582,-0.0126507410980984,0.0063018576690236,0.511460217874383
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00145032283239085,0.002234399584482,-0.00292910035319386,0.00582974601797557,0.516286402386192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RGS8,Regulator of G-protein signaling 8,28931,0.00301224408128839,0.00465289564430588,-0.00610743138155113,0.0121319195441279,0.517383875325912
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPEP,Glutamyl aminopeptidase,24111,0.00205858743710005,0.00318564283668281,-0.00418527252279826,0.00830244739699835,0.518150904548216
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL4,Myosin light chain 4,24240,0.00238511314398158,0.00372042916809174,-0.00490692802547824,0.00967715431344139,0.521473207491117
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HBQ1,Hemoglobin subunit theta-1,29725,-0.0027386826626097,0.00428904327116516,-0.0111452074740934,0.00566784214887402,0.523133674411347
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,24195,0.00229186360218833,0.00359361010604326,-0.00475161220565646,0.00933533941003311,0.523635449210207
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHD,SH2 domain-containing adapter protein D,24059,0.00388428891979478,0.00609677816483221,-0.00806539628327636,0.0158339741228659,0.524062403585138
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00178365616890781,0.0028016315308195,-0.00370754163149842,0.00727485396931404,0.524359488244665
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.00209527289616795,0.00332937670693233,-0.00443030544941942,0.00862085124175531,0.529139556160251
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTNL10,Butyrophilin-like protein 10,24016,-0.00183092220578444,0.00292556527721786,-0.00756503014913144,0.00390318573756256,0.531428885333259
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00252358814106239,0.00405606253151445,-0.0104734707028307,0.00542629442070593,0.533831484400044
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00314020832205491,0.00511263954120368,-0.0131609818228141,0.00688056517870431,0.539085646851041
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSG1,Tryptase gamma,24229,0.00117205440017717,0.00191261658455995,-0.00257667410556034,0.00492078290591467,0.540013323311373
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TSPAN7,Tetraspanin-7,24101,-0.00412333034432023,0.00673834648168038,-0.0173304894484138,0.00908382875977332,0.540596330160405
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LPO,Lactoperoxidase,28452,-0.00262955401018643,0.00429743512871446,-0.0110525268624668,0.00579341884209391,0.540615979788451
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.00131861097037867,0.00215628938601309,-0.00554493816696433,0.00290771622620698,0.540861945432756
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDH4,Cadherin-4,24101,0.00209860822940319,0.00344172684661616,-0.00464717638996449,0.00884439284877087,0.542030237057528
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,0.00624747807456026,0.0102718770581936,-0.0138854009594991,0.0263803571086197,0.543052684477992
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TAGLN3,Transgelin-3,24016,-0.00262753497722376,0.00432348584202532,-0.0111015672275934,0.00584649727314585,0.543368794757102
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,APOH,Beta-2-glycoprotein 1,29443,-0.00154785973860236,0.00256314288031453,-0.00657161978401884,0.00347590030681411,0.545920554534589
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ICAM2,Intercellular adhesion molecule 2,29820,0.00136118841744535,0.00227026043246416,-0.0030885220301844,0.00581089886507511,0.548794945473222
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EVI2B,Protein EVI2B,24016,-0.00174158617282235,0.00293928035025127,-0.00750257565931483,0.00401940331367014,0.553507153124136
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYTH3,Cytohesin-3,24016,0.0030889803077096,0.00524644648638876,-0.00719405480561237,0.0133720154210316,0.556017276063787
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GAGE2A,G antigen 2A,24016,0.00265241833094852,0.00454646206229238,-0.00625864731114454,0.0115634839730416,0.559627709223979
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,0.00197675014136389,0.00339352321314732,-0.00467455535640487,0.00862805563913265,0.560229970044778
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RUVBL1,RuvB-like 1,28797,0.00428916538793433,0.00738536273892947,-0.0101861455803674,0.0187644763562361,0.561402919663731
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ISM2,Isthmin-2,24938,-0.00181756225561995,0.00314191311234203,-0.00797571195581033,0.00434058744457043,0.562939231401753
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,0.00208847952474252,0.0036203761161256,-0.00500745766286366,0.0091844167123487,0.564033001653199
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDSN,Corneodesmosin,29676,-0.00176909681589962,0.00309306552710965,-0.00783150524903453,0.00429331161723529,0.567356243207417
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTSV,Cathepsin L2,29618,0.00168470499639575,0.00295450831735166,-0.0041061313056135,0.007475541298405,0.568536202640354
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPBGL,Trophoblast glycoprotein-like,24195,-0.00167839144976835,0.00294508636382164,-0.00745076072285876,0.00409397782332207,0.568753875290632
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00379838263436679,0.00669044001712622,-0.0169116450679342,0.00931487979920059,0.570221686787552
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PALLD,Palladin,24229,-0.00159316720119253,0.00285581376862031,-0.00719056218768833,0.00400422778530328,0.576939661053333
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MYL6B,Myosin light chain 6B,24195,0.00364932019513593,0.00656316289958716,-0.00921447908805491,0.0165131194783268,0.578194998733189
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,0.00135618262653928,0.00245586132336006,-0.00345730556724645,0.00616967082032501,0.580799879238566
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NRN1,Neuritin,24867,-0.00140493921988839,0.00255290378707006,-0.0064086306425457,0.00359875220276893,0.582098083473412
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PXDNL,Peroxidasin-like protein,24793,0.00227452671058449,0.00413543333077076,-0.00583092261772619,0.0103799760388952,0.58231796566575
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BSND,Barttin,24016,-0.00133286343972291,0.00242415802684988,-0.00608421317234869,0.00341848629290286,0.582444312647704
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCIN,Adseverin,24101,0.00288779567179656,0.00525590732613579,-0.00741378268742959,0.0131893740310227,0.582709935360634
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,-0.00101688267277466,0.00185097504549977,-0.00464479376195421,0.0026110284164049,0.582752010597297
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,-0.00115951162800862,0.00212934371950004,-0.0053330253182287,0.00301400206221146,0.586075190205707
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRND,Prion-like protein doppel,24845,-0.0019871984645563,0.00368148975356745,-0.00920291838154849,0.00522852145243589,0.589352866345116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EXOSC10,Exosome component 10,24111,-0.00234165033150345,0.00433937537497404,-0.0108468260664526,0.00616352540344567,0.589458290673184
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TEX101,Testis-expressed protein 101,24195,0.00195242956907975,0.00362190170961451,-0.00514649778176468,0.00905135691992418,0.589849039551062
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLAU,Urokinase-type plasminogen activator,29443,0.00111435005006735,0.00207469799650127,-0.00295205802307514,0.00518075812320984,0.591192695093153
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00192243438954139,0.0035925668429994,-0.00511899662273743,0.00896386540182021,0.592575666221031
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UBQLN3,Ubiquilin-3,24111,-0.0019228839918188,0.00360043550065104,-0.00897973757309485,0.00513396958945724,0.593298145890397
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADA2,Adenosine deaminase 2,29328,0.00162048639172189,0.0030514630315379,-0.0043603811500924,0.00760135393353618,0.595386576658324
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL9,Interleukin-9,24445,-0.00215093325616493,0.00406055259794758,-0.0101096163481422,0.00580774983581234,0.596314763380735
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00649672713236525,0.0123230918098484,-0.0306499870796681,0.0176565328149377,0.598059813294212
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.00217526062190609,0.00413231556313461,-0.00592407788183774,0.0102745991256499,0.598613504796516
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNPO1,Transportin-1,24445,0.00133015412944225,0.00253193513746203,-0.00363243873998332,0.00629274699886782,0.599344122257073
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,29223,0.00150082266315536,0.00288479400329511,-0.00415337358330306,0.00715501890961378,0.602891209791691
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENG,Endoglin,29820,0.000638453428699659,0.00122736114185286,-0.00176717440933194,0.00304408126673126,0.602939312752503
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00173849616062885,0.00337230724768964,-0.00487122604484286,0.00834821836610055,0.606193507130703
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TLR2,Toll-like receptor 2,24445,0.000845940400688476,0.00164558340408039,-0.00237940307130908,0.00407128387268603,0.607209680288298
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CDC25A,M-phase inducer phosphatase 1,24016,-0.00147649010093847,0.00289537713479615,-0.00715142928513892,0.00419844908326198,0.610092987637457
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,28797,-0.001740755638553,0.00349602358818181,-0.00859296187138935,0.00511145059428335,0.618541094256537
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BRD2,Bromodomain-containing protein 2,24101,0.00122338109664246,0.00248254368708478,-0.00364240453004371,0.00608916672332863,0.622163080216197
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SHC1,SHC-transforming protein 1,24016,-0.00410444504575107,0.00834606547084017,-0.0204627333685978,0.0122538432770957,0.622877936503611
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC1A4,Neutral amino acid transporter A,24195,0.00180514674532593,0.00369460034148714,-0.00543626992398886,0.00904656341464073,0.625136048444651
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGAV,Integrin alpha-V,29725,-0.000571510938635759,0.00118355266085963,-0.00289127415392063,0.00174825227664911,0.629186283201288
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,24016,0.00216338097306577,0.0045327471924266,-0.00672080352409037,0.0110475654702219,0.633168448406562
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ESR1,Estrogen receptor,24229,0.00195953259314205,0.00411944934709714,-0.00611458812716834,0.0100336533134524,0.634307885835931
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,24751,0.00136163141562495,0.00288272986435696,-0.00428851911851469,0.00701178194976459,0.636687599290522
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IFNL2,Interferon lambda-2,24101,0.00208298107455415,0.00442949390023316,-0.00659882696990285,0.0107647891190111,0.638178807434673
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FOS,Proto-oncogene c-Fos,23970,-0.00117803735414035,0.00253891201751186,-0.0061543049084636,0.0037982302001829,0.64265699086353
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS1,"Nitric oxide synthase, brain",28774,-0.00177473442487049,0.0038628680274924,-0.00934595575875559,0.00579648690901462,0.645925728059285
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP53BP1,TP53-binding protein 1,24229,0.00278465642700831,0.00625139769694694,-0.0094680830590077,0.0150373959130243,0.656001882134188
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MB,Myoglobin,29820,-0.00164697334247688,0.00374125423269524,-0.00897983163855955,0.00568588495360578,0.659781276801873
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00202260802955767,0.00461520044407499,-0.0110684008999447,0.0070231848408293,0.661209501575223
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,-0.000990114885361922,0.00227029786558701,-0.00543989870191246,0.00345966893118861,0.662755233423554
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,AMY2A,Pancreatic alpha-amylase,28334,-0.00144728493923098,0.00341834170823894,-0.00814723468737931,0.00525266480891735,0.672015396752383
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HDAC9,Histone deacetylase 9,24101,-0.00196239142700589,0.00463832173794254,-0.0110535020333733,0.00712871917936148,0.672239056225296
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RSPO1,R-spondin-1,29218,0.00104282743396411,0.00250001271988447,-0.00385719749700945,0.00594285236493766,0.676587229011595
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PRC1,Protein regulator of cytokinesis 1,24793,0.00135090774782776,0.0032461581333384,-0.0050115621935155,0.00771337768917103,0.677299556816108
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PSMA1,Proteasome subunit alpha type-1,28797,0.00137446461691168,0.00330919861714287,-0.00511156467268835,0.0078604939065117,0.67789123901861
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANK2,Ankyrin-2,24111,-0.00212693853101758,0.00516039611550979,-0.0122413149174168,0.00798743785538162,0.680221606153877
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00225293463279745,0.00547784396971681,-0.0129895088134424,0.00848363954784749,0.680869857779279
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITGB2,Integrin beta-2,29274,0.000836995852482047,0.00205046062673684,-0.00318190697592216,0.00485589868088625,0.683130613914457
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,S100A16,Protein S100-A16,28722,-0.0017682693251412,0.00438947909477479,-0.0103716483508998,0.00683510970061739,0.687066993979023
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.000776373717170786,0.00194172511869999,-0.00458215494982277,0.0030294075154812,0.689279377109692
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF3,Fibroblast growth factor 3,24229,0.000856164547931477,0.00214747209049573,-0.00335288074944015,0.0050652098453031,0.690128961503549
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00113299953082968,0.0028454780668039,-0.00671013654176532,0.00444413748010596,0.690504383195662
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.00103183941130046,0.00259363324812761,-0.00405168175502966,0.00611536057763058,0.690754950402451
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EPGN,Epigen,24793,-0.00136056659373611,0.00342972998144142,-0.0080828373573613,0.00536170416988908,0.691593684037744
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00160074507633462,0.00404066117357695,-0.00952044097654545,0.00631895082387621,0.69199110095143
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ALMS1,Alstrom syndrome protein 1,24445,-0.00124831171935127,0.00319492582903612,-0.00751036634426206,0.00501374290555953,0.696009865215068
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00132741031850741,0.0034934130662535,-0.00817449992836426,0.00551967929134945,0.703967188650281
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,24195,0.0011352223934826,0.00303464001595142,-0.00481267203778218,0.00708311682474738,0.708342131332832
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.000982731813342603,0.00268306045616158,-0.0042760666807341,0.00624153030741931,0.714164809755637
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,24101,0.00156072848229832,0.00429477497073392,-0.00685703046034017,0.0099784874249368,0.716308028699967
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPSD1,Tryptase delta,24867,0.00096529225645035,0.00267224729160016,-0.00427231243508597,0.00620289694798667,0.717931603991161
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEP350,Centrosome-associated protein 350,24016,0.000942142931157174,0.00264624735642843,-0.00424450188744254,0.00612878774975689,0.721821373419985
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.00174277637959317,0.00491771826530499,-0.0078959514204046,0.0113815041795909,0.723051788554418
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00161180845984854,0.00456463828314168,-0.00733488257510916,0.0105584994948062,0.724010877898242
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,24229,0.0010241365501627,0.0029200581531468,-0.00469917743000502,0.00674745053033042,0.725797936415953
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.00194222703526814,0.00555947489905007,-0.00895434376687,0.0128387978374063,0.726826302455859
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARG2,"Arginase-2, mitochondrial",24793,0.00106781527966331,0.00309770128668673,-0.00500367924224268,0.00713930980156931,0.730313706380471
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00100646356309322,0.00295235051568701,-0.00679307057383976,0.00478014344765332,0.733179444714674
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00133247835067943,0.00401402496224741,-0.00653501057532549,0.00919996727668435,0.739925620287103
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TPT1,Translationally-controlled tumor protein,28931,0.00153073057287351,0.00466004963491749,-0.00760296671156477,0.0106644278573118,0.742551552954742
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00136316038148787,0.00421685324143232,-0.00690187197171948,0.00962819273469521,0.746497486796217
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20,Interleukin-20,28931,0.00111121552672688,0.00349570972636761,-0.00574037553695363,0.0079628065904074,0.750578407189803
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGLON5,IgLON family member 5,24016,-0.00209812799046845,0.00667592498698853,-0.015182940964966,0.0109866849840291,0.753309038362343
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00141113851034481,0.00450371705427891,-0.0102384239367315,0.00741614691604186,0.754034516336067
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TET2,Methylcytosine dioxygenase TET2,24421,0.00220381752367549,0.00717882321395643,-0.0118666759756791,0.0162743110230301,0.758854601029406
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LAYN,Layilin,29163,0.000760357908599518,0.00249322753228061,-0.00412636805467047,0.0056470838718695,0.760391695349928
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",24845,0.00130158368460095,0.00428409987874208,-0.00709525207773353,0.00969841944693543,0.761269626805421
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.00070487143061192,0.00232772590352228,-0.00385747134029175,0.00526721420151559,0.762033101524652
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,0.00128412332483921,0.00426101429936774,-0.00706746470192155,0.00963571135159997,0.763138289670454
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.000767118760259407,0.00260994404599226,-0.00588260909040424,0.00434837156988542,0.768820316468011
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC4A1,Band 3 anion transport protein,24938,0.000952100693254996,0.00334157709592571,-0.00559739041475939,0.00750159180126938,0.775703547924953
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,24805,-0.000931212565463369,0.00332723195353829,-0.00745258719439841,0.00559016206347167,0.779574930908283
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TFRC,Transferrin receptor protein 1,29565,-0.000768911200047264,0.0027493028001168,-0.0061575446882762,0.00461972228818167,0.779728834632792
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,-0.000586387370667356,0.00218387965920465,-0.00486679150270846,0.00369401676137375,0.788310872527389
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NLGN1,Neuroligin-1,24195,-0.00129593255207849,0.00489424633339481,-0.0108886553655323,0.00829679026137533,0.791175848552255
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DPEP2,Dipeptidase 2,29349,-0.0005482367838173,0.00208849263742196,-0.00464168235316434,0.00354520878552974,0.792935072810313
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,24101,-0.00143727200827679,0.00552711396860409,-0.0122704153867408,0.00939587137018722,0.794834961432647
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.00122630154248573,0.00479204003789524,-0.0106187000167604,0.00816609693178894,0.798027228550005
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,EFNB2,Ephrin-B2,24195,0.00105412882794804,0.00413113795321777,-0.00704290156035878,0.00915115921625486,0.798596521612132
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.00310070017201391,0.0122595192314705,-0.0209279575216682,0.027129357865696,0.800330402712321
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MORN4,MORN repeat-containing protein 4,24016,0.00141889122154544,0.00561289168110187,-0.00958237647341422,0.0124201589165051,0.800431513064782
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,29388,0.000864258200434231,0.00343425213722936,-0.00586687598853532,0.00759539238940378,0.801306919247109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PCARE,Photoreceptor cilium actin regulator,24101,0.00150200607195337,0.00605952090985326,-0.010374654911359,0.0133786670552658,0.80423293933815
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LMOD2,Leiomodin-2,24101,0.00108787092307631,0.0045313421611543,-0.00779355971278612,0.00996930155893873,0.810272625826783
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.0012791812563883,0.0053343547058732,-0.0117345164798998,0.00917615396712318,0.810486911784903
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.00092360968583999,0.00389465077684819,-0.00855712520846243,0.00670990583678245,0.812543773947997
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LCN15,Lipocalin-15,24867,-0.00101664536932109,0.00444937157311422,-0.00973741365262496,0.00770412291398277,0.819265731520687
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SKIV2L,Helicase SKI2W,24111,-0.000650917929812072,0.00286357532479156,-0.00626352556640352,0.00496168970677938,0.820185000085569
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HK2,Hexokinase-2,28916,-0.000434085805848459,0.00195848119385431,-0.0042727089458029,0.00340453733410598,0.82459251359261
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASP4,Caspase-4,24445,-0.00266613572637167,0.0120387625431292,-0.0262621103109049,0.0209298388581616,0.824734100662515
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL21R,Interleukin-21 receptor,24229,0.000863677098770569,0.00393676675090024,-0.00685238573299391,0.00857973993053505,0.826350118234902
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,24195,-0.000567397047918182,0.00262043113609067,-0.00570344207465589,0.00456864797881953,0.828577928914215
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,BCAN,Brevican core protein,29218,0.000479149918912443,0.00242459358566903,-0.00427305350899885,0.00523135334682373,0.843343201297
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IKZF2,Zinc finger protein Helios,28797,0.00124190048625346,0.00652171756552959,-0.0115406659421845,0.0140244669146915,0.848977161258192
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,24951,0.000427136165065509,0.00229547762905304,-0.00407199998787844,0.00492627231800946,0.852385695591116
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TXK,Tyrosine-protein kinase TXK,24445,0.000970552912849353,0.00533028167599174,-0.00947679917209445,0.0114179049977932,0.855519213138729
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,0.00063791562779992,0.00352652091383242,-0.00627406536331162,0.00754989661891146,0.856454693150327
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,UPK3A,Uroplakin-3a,24101,-0.000594235066893415,0.00352376222200022,-0.00750080902201384,0.00631233888822701,0.866083953797031
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CASQ2,Calsequestrin-2,24111,0.000588698702708596,0.0034964746151597,-0.00626439154300442,0.00744178894842161,0.866294234571957
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,24195,0.000787496817911586,0.00470659743006621,-0.00843743414501819,0.0100124277808414,0.867121516932713
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CRX,Cone-rod homeobox protein,28916,-0.00126510884616114,0.00765708727998571,-0.0162729999149331,0.0137427822226108,0.868771477202386
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC39A14,Zinc transporter ZIP14,28774,0.000387518653931085,0.00239154342071068,-0.00429990645066184,0.00507494375852401,0.871277811700125
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.000457630151646048,0.00292623802927406,-0.00619305668902321,0.00527779638573111,0.875728049594952
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.000789432321862415,0.0055924463917083,-0.0117506272496107,0.0101717626058859,0.887744355095056
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PI16,Peptidase inhibitor 16,24951,-0.000240694887170792,0.00175256384137465,-0.00367572001626511,0.00319433024192353,0.890764169410996
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL24,Interleukin-24,28931,0.000460681686353261,0.00347861689479629,-0.00635740742744748,0.007278770800154,0.894643187037089
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.000342940721557962,0.00268771881711388,-0.00561086960310116,0.00492498815998523,0.898470010588515
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,29662,0.000572189320582327,0.00454317597636836,-0.00833243559309966,0.00947681423426432,0.899776485759303
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,STEAP4,Metalloreductase STEAP4,24101,0.000656079892427199,0.00529998581936812,-0.00973189231353433,0.0110440520983887,0.90148338223348
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TP73,Tumor protein p73,24195,0.000301003165204958,0.00247331694270347,-0.00454669804249385,0.00514870437290376,0.903137466544972
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.000291244433678859,0.00246280011213794,-0.00453584378611151,0.00511833265346923,0.905864667384009
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.000550272443856151,0.00468231048894691,-0.0086270561144798,0.0097276010021921,0.90644756276717
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.000402726266151087,0.00351358279259426,-0.00648389600733366,0.00728934853963583,0.908747415749845
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAGEA3,Melanoma-associated antigen 3,24445,0.000685974550067338,0.00608604759810937,-0.011242678742227,0.0126146278423617,0.910259298317901
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,24445,0.000588467280295906,0.00525331515835994,-0.00970803043008957,0.0108849649906814,0.910809839972701
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,0.000616004449743833,0.00552134466343094,-0.0102058310905808,0.0114378399900685,0.911166857618808
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.000499141856824109,0.0045065094871812,-0.00933190045169927,0.00833361673805105,0.911807285971868
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PGR,Progesterone receptor,24229,0.000806286579498201,0.00728248408910827,-0.013467382235154,0.0150799553941504,0.911842576529258
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17A,Interleukin-17A,28879,0.000336080186575144,0.00304796453144604,-0.0056379302950591,0.00631009066820939,0.912200923015022
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CAPN3,Calpain-3,24793,-0.000293895177760643,0.00271145767559464,-0.00560835222192613,0.00502056186640485,0.913687128862906
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.000349082141000763,0.00324563319126472,-0.00671052319587961,0.00601235891387809,0.914349895025688
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MLLT1,Protein ENL,24016,-0.000521969731516989,0.00494840112911759,-0.0102208359445875,0.00917689648155349,0.915993835438381
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,0.000205084101200977,0.00212320033252208,-0.00395638855054229,0.00436655675294425,0.92305121141261
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NCLN,Nicalin,28931,-0.000344719064736265,0.00373396432030347,-0.00766328913253107,0.00697385100305854,0.926444548967977
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,FGF6,Fibroblast growth factor 6,24229,-0.000264022935159377,0.00294551473361441,-0.00603723181304362,0.00550918594272487,0.928577547091876
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CLINT1,Clathrin interactor 1,24016,0.000298834551455508,0.00341207937027764,-0.00638884101428867,0.00698651011719969,0.930210148483339
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SUSD4,Sushi domain-containing protein 4,24793,0.000239409538155009,0.00299388735761282,-0.00562860968276611,0.00610742875907613,0.936264852407469
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HEBP1,Heme-binding protein 1,28916,-0.00028378462932834,0.00380127398646679,-0.00773428164280324,0.00716671238414656,0.940489620357843
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.00023430295696306,0.00322678254068362,-0.00609019082277684,0.00655879673670296,0.942115412336517
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,24016,0.000281888163287592,0.00398465220924113,-0.00752803016682502,0.0080918064934002,0.943602504967438
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL2,Interleukin-2,28931,0.0001586165718577,0.00225355653827337,-0.00425835424315811,0.00457558738687351,0.943887718416278
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.000332233925741379,0.004735998394262,-0.0096147907784949,0.00895032292701214,0.944074233144498
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLC51B,Organic solute transporter subunit beta,24111,-0.000340382793156198,0.00546285553067164,-0.0110475796332726,0.0103668140469602,0.950317609429501
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ACRV1,Acrosomal protein SP-10,24229,-0.000334309482710791,0.00549125688902363,-0.0110971729851971,0.0104285540197755,0.951455024274209
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SCN3B,Sodium channel subunit beta-3,24101,-0.000189415449797606,0.00330026937039568,-0.00665794341577315,0.00627911251617794,0.954231869300213
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.00035240015641379,0.00617299932534358,-0.0117466785212596,0.0124514788340872,0.954476088698288
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,-0.000176842077815485,0.00318877889743873,-0.00642684871679539,0.00607316456116442,0.955774342051728
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.000359599212118954,0.00648884230296623,-0.0123585317016949,0.0130777301259328,0.955805845701853
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,HMMR,Hyaluronan mediated motility receptor,23975,0.000186829814022411,0.0034655686097055,-0.00660568466100036,0.00697934428904518,0.957007086588481
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,24111,0.000432776712163052,0.00810509268496602,-0.0154532049503703,0.0163187583746965,0.957417111734718
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PFDN6,Prefoldin subunit 6,24195,0.00023383808988283,0.00467955392330159,-0.00893808759978829,0.00940576377955396,0.960146574811137
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL13,Interleukin-13,28931,0.000144834406386818,0.00343824886772171,-0.00659413337434773,0.00688380218712137,0.966399765209928
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,NOS2,"Nitric oxide synthase, inducible",24111,0.000119373971174173,0.00283704802458576,-0.00544124015701392,0.00567998809936227,0.966437803970344
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,LRP2BP,LRP2-binding protein,24195,0.000235795431982109,0.00591387587314267,-0.0113554012793775,0.0118269921433417,0.968195857395315
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,24445,0.000149520271362244,0.00386183270234618,-0.00741967182523627,0.00771871236796075,0.969115986021078
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,MAG,Myelin-associated glycoprotein,24195,-0.000129646745227019,0.00339358209969625,-0.00678106766063166,0.00652177417017762,0.969525738314109
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.000122317295980593,0.00348360797800806,-0.00670555434091521,0.0069501889328764,0.971990528356194
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ABO,Histo-blood group ABO system transferase,24951,-0.000336185054907656,0.0103045153303696,-0.0205330351024321,0.0198606649926168,0.973973875679687
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,24229,-7.0360551987509e-05,0.00231576832970555,-0.00460926647821039,0.00446854537423537,0.975761659198977
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,24229,4.81384896074503e-05,0.00302101450773308,-0.00587304994554939,0.00596932692476429,0.987286742380308
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL17F,Interleukin-17F,28931,-7.6528024706129e-05,0.00547020426084462,-0.0107981283759616,0.0106450723265493,0.988838074997564
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,PDIA2,Protein disulfide-isomerase A2,24016,-3.66079911349653e-05,0.00291750809964593,-0.00575492386644099,0.00568170788417106,0.989988757793589
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL3,Interleukin-3,24016,-4.88221160150767e-05,0.00433218777092927,-0.00853991014703645,0.0084422659150063,0.991008427071682
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,IL22,Interleukin-22,24793,4.74766728957434e-05,0.00483284775097521,-0.00942490491901566,0.00951985826480715,0.992161989210238
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-1.72861580596079e-05,0.00248562231778595,-0.00488910590092008,0.00485453358480086,0.994451236346055
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ZNF174,Zinc finger protein 174,24229,1.37446554131438e-05,0.00270500643817496,-0.00528806796340978,0.00531555727423606,0.995945855144673
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,OMP,Olfactory marker protein,24101,1.59961544169477e-05,0.00353153795946159,-0.00690581824612778,0.00693781055496167,0.996386019723828
NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,24101,8.704367081972e-06,0.00287294627148519,-0.005622270325029,0.00563967905919295,0.997582621900531
